Obesity treatment systems

ABSTRACT

In some embodiments, an extragastric balloon is described in which the balloon is contoured to fit a portion of the stomach but not circumscribe the stomach. In some embodiments, the extragastric balloon comprises multiple material components. In some embodiments, the extragastric balloon comprises multiple inflateable compartments. In some embodiments, the extragastric balloon is filled with one or more of a gas, liquid, solid, or foams to create portions of the balloon with differing densities or buoyancies. In some embodiments, multiple anchors contact the stomach, each of which are inflateable with a fluid such as a liquid, gas, or gel. In some embodiments, a pressure sensor is described which is programmable from a place external to the patient and can be programmed to increase its sampling frequency when an ingestion event is detected.

RELATED APPLICATIONS

The present application is a continuation-in-part of patent applicationSer. No. 11/981,383 filed Oct. 21, 2007 now abandoned which is acontinuation in part of PCT US2006015881 filed Apr. 26, 2006 which is acontinuation of application Ser. No. 11/278,806 filed Apr. 5, 2006 nowU.S. Pat. No. 8,001,976 “Management Systems for the Surgically TreatedObese Patient,” which is a continuation-in-part of patent applicationSer. No. 11/295,281 titled “Obesity Treatment Systems” filed Dec. 6,2005 now U.S. Pat. No. 7,832,407 which is a continuation-in-part ofInternational Patent Application PCT/US2005/033683 filed Sep. 19, 2005,which is a continuation-in-part of U.S. Non-Provisional patentapplication Ser. No. 11/148,519 entitled “Methods and Devices forPercutaneous, Non-Laparoscopic Treatment of Obesity,” filed on Jun. 9,2005 now abandoned by Michael Gertner, MD, and is also acontinuation-in-part of U.S. Non-Provisional patent application Ser. No.11/153,791 entitled “Methods and Devices for the Surgical Creation ofSatiety and Biofeedback Pathways,” filed on Jun. 15, 2005 now U.S. Pat.No. 7,946,976, both of which are continuation-in-parts of U.S.Non-Provisional patent application Ser. No. 11/125,547 by MichaelGertner, M.D., entitled “Percutaneous Gastroplasty” filed May 10, 2005now U.S. Pat. No. 7,670,279, which is a continuation-in-part ofInternational Patent Application No. PCT/US05/09322 filed Mar. 19, 2005,designating the United States, entitled “DEVICE AND METHODS TO TREAT APATIENT” and which is a continuation-in-part of U.S. Non-Provisionalpatent application Ser. No. 10/974,248 by Michael Gertner, M.D. filedOct. 27, 2004 now U.S. Pat. No. 7,255,675, entitled “DEVICES AND METHODSTO TREAT A PATIENT,” which claims priority to U.S. Provisional PatentApplication Ser. No. 60/556,004 filed Mar. 23, 2004 by Michael Gertner,M.D., entitled “BARIATRIC DEVICES AND IMPLANTATION METHODS,” to U.S.Provisional Patent Application Ser. No. 60/584,219 filed Jul. 1, 2004 byMichael Gertner, M.D., entitled “DEVICES AND METHODS FOR PERCUTANEOUSGASTROPLASTY,” and to U.S. Provisional Patent Application Ser. No.60/603,944 filed Aug. 23, 2004 by Michael Gertner, M.D., entitled“DEVICES AND METHODS TO TREAT MORBID OBESITY.” All of the abovementioned patents are incorporated herein by reference in theirentirety.

INCORPORATION BY REFERENCE

The Following additional patents and patent applications areincorporated by reference in their entirety: US20070250103,US20070250020, US20070250102, US20070250095, US20070250094,US20070250093, US20070250092, US20070250091, US20070250090,US20070250089, US20070250088, US20070250087.

FIELD OF THE INVENTION

The present invention relates to devices, methods and apparatus to treatobesity. Implantable devices, methods to implant implantable devices,and surgical devices to enable the implantation of the implantabledevices in, around, or near the walls of organs or vessels aredisclosed, including devices to appose the walls of the stomach.Feedback systems are also disclosed which enable multimodality therapysuch as gastric restriction in combination with electrical stimulationof the stomach, sensing of feeding parameters, and/or other efferent orafferent neural pathways in a patient. Methods and related devices arealso disclosed which relate to forming connections between body lumens.

DESCRIPTION OF THE RELATED ART

Obesity is a public health problem of extreme national and internationalimportance. There are an estimated 60 million obese adults and 2 millionobese adolescents in the United States as of 2004. By some estimates,there are 1 billion obese individuals worldwide. Indeed, to highlightthe worldwide importance of the disease, a recent report estimated thatover there are over 60 million obese individuals in China, a 10-foldincrease since 2000. Obesity affects the life quality and productivityof those effected and leads to long-term health related complicationssuch as diabetes and heart disease. Some researchers estimate that ifthe obesity epidemic is not brought under control, it could quicklyoverwhelm societal resources.

To date, surgery is the only proven method for inducing substantialweight loss. The mechanism behind the success of surgery is, in manycases, not known because obesity is such a complex, multifactorialdisease. Some researchers propose that surgery does no more than providebiofeedback for appetite retraining. Other researchers maintain thatsurgery alters the physiology of the patient such that satiety isinduced earlier or fewer nutrients are absorbed. Nonetheless, theconsensus among most obesity researchers is that at the current time,long-term weight loss is only possible by surgical means and that thesuccess of surgery is due to a multifactorial set of changes.

Over the past four decades, there have been numerous surgical proceduresand devices developed to treat those who suffer from morbid obesity. Ingeneral, there are two physiologic components of all past and currentprocedures: malabsorption and mechanical restriction/volume reduction.Newer methods and devices include stimulation devices such asneurostimulators and muscle stimulators. In general, these devices willrequire further research and development before they will be used totreat obese patients as a single therapy.

Many of the procedures performed in the past have proven to beimpractical, dangerous, and/or detrimental to patient health and are nowof historical importance only. One example of a failed procedure was thejejuno-ileo bypass in which a malabsorptive state was created throughthe bypass of a large portion of the intestine through the creation of asurgical anastomosis between the jejunum and the ileum. While patientsinitially lost a great deal of weight, liver failure or liver damageoccurred in over one-third of the patients, necessitating reversal ofthe surgical procedures.

One of the first restrictive type surgical procedures was the so-called“stomach stapling” operation in which a row of horizontal staples wasplaced across the upper stomach and then several staples were removedfrom the staple line to create an opening, the “os,” for a small amountof food, but not too much food. This procedure was mostly restrictive,leading to an early feeling of satiety. This surgery was abandonedbecause 70%-80% of patients had inadequate weight loss due to stapleline dehiscence (i.e. the staples pulled through the stomach wall). Aprocedure to stabilize the staple line was performed by Smith et. al.(Lindsay B. Smith; Modification of the Gastric Partitioning OperationFor Morbid Obesity. Am. J. Surgery 142, December 1981) in which thestaple line was buttressed in the region where the staples were removedusing teflon pledgets with sutures passing through the middle of thepledgets. The purpose of the pledgets was to buttress the suture anddistribute the load across the suture to the pledget, thereby preventingthe suture from pulling through the stomach and therefore stabilizingthe os. The outcomes showed that the suture buttress was unequivocallyable to prevent the suture from tearing through the stomach wall;indeed, over 90% of the patients showed excellent weight loss at 18months.

The Roux-en-Y (The Roux) bypass operation has become the most commonlyperformed surgical procedure to treat the morbidly obese in the UnitedStates. It combines a small degree of malabsorption with a 90% reductionin the volume of the stomach. In the United States, 150,000 Rouxprocedures were performed in the year 2004. This number is expected torise to 500,000 procedures by 2007. The procedure actually has beenperformed since the late 1970's but has evolved substantially over thepast three decades into a relatively safe and effective procedure;indeed, the long-term data are very good. The advent of laparoscopicsurgery and hence the laparoscopic Roux-en-Y bypass in combination withexcellent follow-up results from the open (and laparoscopic) procedureare reasons for the proliferation of the Roux procedure.

Despite the efficacy of the Roux procedure and the recent laparoscopicimprovements, it remains a highly invasive procedure with substantialmorbidity, including a 1-2% surgical mortality, a 20-30% incidence ofpulmonary morbidity such as pneumonia, pulmonary embolism, etc., and a1-4% chance of leak at the anastomotic site which can result in aspectrum of consequences ranging from an extended hospital stay todeath. Furthermore, it is not a good option for adolescents in whom thelong-term consequences of malabsorption are not known. In addition, manypatients resist such an irreversible, life altering procedure.

The Roux procedure requires general anesthesia and muscle paralysiswhich, in the morbidly obese population, is not of small consequence.There is also a substantial rate of anastomotic stricture which resultsin severe lifestyle changes for patients. As an example, many patientsare forced to vomit after meals. Furthermore, although minor whencompared to previous malabsorptive (e.g. jejuno-ileal bypass)procedures, the malabsorption created by the Roux-en-Y procedure candramatically affect the quality of life of patients who undergo theprocedure; for example, they may experience gas bloating, symptoms ofthe dumping syndrome, and/or dysphasia. In addition, these patients canexperience very early fullness such that they are forced to vomitfollowing meals.

Recently, minimally invasive procedures and devices which create afeeling of early satiety have been introduced into the marketplace in anattempt to address some of the issues above. The LAP-BAND™ is a bandwhich encircles the stomach at the region of the fundus-cardia junction;it is a restrictive procedure similar to stomach stapling. It requiresgeneral anesthesia, a pneumoperitoneum, muscle paralysis, and extensivedissection of the stomach at the level the gastroesophageal junction. Italso requires continual adjustment of the band, or restriction portionof the device. Although less invasive than the Roux procedure andpotentially reversible, the LAP-BAND™ is nonetheless quite invasive. Italso does not reduce the volume of the stomach by any great extent andsome patients report a feeling of hunger much of the time. Furthermore,once implanted, the Lap-Band™, although it is adjustable by percutaneousmeans, is in fact very difficult to adjust and many iterativeadjustments are required before it is made right.

Long-term clinical follow-up reveals that the banding procedure resultsin many complications. In a recently published article (Camerini et. al.Thirteen Years of Follow-up in Patients with Adjustable Silicone GastricBanding for Obesity: Weight Loss and Constant Rate of Late SpecificComplications. Obesity Surgery, 14, 1343-1348), the authors reported a60% prevalence of late band removal secondary to complications such aserosion, slippage of the band, infection, or lack of effectiveness.Nonetheless, the LAP-BAND™ as a procedure is becoming very popularacross the world as it is a less invasive and reversible procedure. Theweight loss in long-term trials is considered adequate by some andinadequate by many; across various studies, the average weight loss isapproximately 40% of excess body weight which is well below the weightloss in the Roux, VBG, and duodenal switch procedures (see below).

Other procedures which have been tried in the past and which offervarying degrees of weight loss include several variations of theoriginal “gastroplasty” procedures. These procedures represent anevolution of the so-called “stomach stapling” procedure discussed above.These procedures were attempted prior to and concomitant with theevolution of the Roux-en-Y. They became popular (despite offering lessweight loss than the Roux) because of their substantially less invasivenature and possible reversibility.

One such example is called the vertical banded gastroplasty, or VBG,which again, involves the creation of a restricting “os” for food. Inthe VBG, the border of the “os” is the lesser curvature of the stomachwhich is less apt to dilate than the fundus region of the stomach.Furthermore, the procedure completely excludes the fundus which isthought to easily dilate and in fact, is physiologically “programmed” todilate during meals . . . so-called “receptive relaxation.” Dilation ofthe fundus as a result of continued overeating is a major reason forfailure of the Lap-Band and in some cases the Roux procedure and thedevelopment of the VBG was intended to improve upon these outcomes. Oneissue with the VBG is that, as practiced today, it is not reversible,nor is it adjustable, and it is difficult to perform laparoscopically.As in the horizontal gastroplasty, the VBG utilizes standard staplerswhich, as in the horizontal gastroplasty, are unreliable when applied tothe stomach. In the case of the VBG, the row of staples runs parallel tothe lesser curvature of the stomach. An important reason for recurrentweight gain in the VBG is in fact recannulation of the staple line,leading to a so-called gastro-gastric fistula.

A recent, prospective, randomized trial, compared the VBG to theadjustable banding procedure and found that the VBG was overwhelminglysuperior to the banding procedure (Morino et. al. LaparoscopicAdjustable Silicone Gastric Banding Versus Vertical Banded Gastroplastyin Morbidly Obese Patients. Annals of Surgery. Vol. 238 (6) pps.835-842). Twenty five percent of the patients in the banding groupreturned to the operating room whereas there were no returns to theoperating room in the gastroplasty group. The degree of weight loss wasclose to 60% of excess body weight after three years in the gastroplastygroup and closer to 40% of excess body weight in the banding group.Although in this study, the VBG was successfully performedlaparoscopically, the laparoscopic VBG procedure is in fact, difficultto perform, because the procedure is not standardized and a “tool box”does not exist for the surgeon to carry out the procedure; furthermore,the procedure is not a reversible one and relies on the inherentlyunreliable stapler systems.

A recent meta-analysis and systematic review (Buchwald et. al. BariatricSurgery: A Systematic Review and Meta-analysis; JAMA vol. 292, no 14.pps 1724-1737) indicated that vertical gastroplasty (avg. excess weightloss of 68.2%) is superior to adjustable banding (avg excess weight lossof 47.5%) and gastric bypass (avg excess weight loss of 61.6%).

The Magenstrasse and Mill (M&M) procedure is an evolving gastroplastytechnique wherein the greater curvature of the stomach is separated(stapled and cut) from the path of food, leaving a tube of stomach, theMagenstrasse, or “street of the stomach,” which is comprised of thelesser curvature. This procedure is similar to the VBG except that thelongitudinal staple line of the stomach extends further along the lessercurvature and into the antrum. The theory behind leaving the antral“mill” is that it will continue to serve its normal function of mixing,grinding, retropulsion, and well-orchestrated expulsion of chyme intothe duodenum. An authoritative study on the operation is incorporatedherein by reference (Johnston et. al. The Magenstrasse and MillOperation for Morbid Obesity; Obesity Surgery 13, 10-16).

In summary, the vertical gastroplasty procedure appears to be superiorto the banding procedure. However, the vertical gastroplasty procedureis not easily performed laparoscopically and furthermore, it is noteasily reversible. Therefore, a need exists to standardize the verticalbanded gastroplasty and create a safer procedure which is also easy toperform, is durable, and is reversible.

The intragastric balloon is not a new concept. The intragastric balloonis meant to displace volume within the stomach such that a smallervolume of food leads to an earlier feeling of satiety. Currently,intragastric balloons on the market are not fixed to the stomach andconsequently, can lead to complications such as obstruction and mucosalerosion. To avoid these complications, the balloons are removed after amaximum of six months. In a prospective, non-randomized, unblinded study(Sallet et. al. Brazilian Multicenter Study of the Intragastric Balloon;Obesity Surgery, 14, 991-998), the average excess weight loss was 48.3%after 1 year. However, the incidence of nausea and vomiting was 40% andepigastric pain was 20%; balloon impaction occurred in 0.6% of patients.A balloon which is fixed to the wall of the stomach could potentiallyimprove the intragastric balloon device and allow longer-termimplantation.

More recently, there has been an effort to develop even less invasivedevices and procedures which do not involve incisions at all. For themost part, these procedures are performed from within the stomach withan endoscope and by a physician with a high degree of endoscopic skill.For example, U.S. Pat. No. 6,558,400 describes methods and devices tocreate partitions in the stomach. Anchors or staplers applied through anendoscope from within the stomach are used to accomplish the partitions.Similarly, U.S. Patent Application Publication No. 2004/0122456describes another set of methods and devices to reduce the volume of thestomach. Expandable anchors are deployed both on the anterior andposterior wall of the stomach using an endoscope. Flexible sutures arebrought out of the patient's mouth and the sutures are crimped togetherwithin the stomach in order to bring the walls of the stomach closertogether. The final configuration has a discontinuous connectorpositioned between the anterior and posterior anchors. Patentapplication U.S. Pat. No. 6,773,440 describes a device which is advancedthrough an endoscope and grasps or applies suction to a fold of mucosato apply anchors through the mucosal and serosal layers of the stomach.

Endoscopic procedures to manipulate the stomach can be time consumingbecause of the technical difficulty of the endoscopy; they also requirea large endoscope through which many instruments need to be placed forthese complex procedures. Due to the large size of the endoscope,patients typically will require general anesthesia, which limits the“non-invasive” aspects of the procedure. Furthermore, the proceduresrequire advanced endoscopic skill which would need to be acquired bymost endoscopic practitioners outside of academic institutions. Suchskill adaptation can take a significant amount of time, which will limitadoption of the procedure by the physician community. A further issue isthat there is a limitation on the size of the anchors and devices whichcan be placed in the stomach because the endoscope has a maximumpermissible size.

Percutaneous Endoscopic Gastrostomy (PEG) refers to a procedure in whicha gastrocutaneous tract is created using a percutaneous procedure (seebelow for definition). A recent update of the procedure can be found onthe Society of American Gastrointestinal Endoscopic Surgeons (SAGES)website, and is incorporated herein by reference. Briefly, the procedureinvolves insufflation of the stomach with and under visualization withan endoscope. A small incision is made in the skin and a needle isadvanced into the stomach (the stomach sits just under the abdominalwall when insufflated) under endoscopic visualization. A feeding tube isthen placed over the needle to create a gastrocutaneous tract with thefeeding tube inside the tract with the needle subsequently removed. Thefeeding tube is secured with an external bolster to creates a tubulartract from outside the patient through the skin of the abdominal walland residing inside the stomach. Over the ensuing weeks, a permanenttract evolves between the stomach mucosa and epithelium of the skin,after which, the bolster can be removed without consequence. When thefeeding tube is to be removed, the gastrocutaneous tract will close onits own as food will preferentially be delivered antegrade (the path ofleast resistance) to the duodenum, thereby allowing the tract to heal.

SUMMARY OF THE INVENTION

The present invention discloses implantable devices, instruments andmethods for treatment of obesity. In one embodiment, an implantabledevice is provided that includes an expandable main body memberconfigured to be positioned adjacent a portion of a stomach of apatient, within the abdominal cavity of the patient; an anchorconfigured to fix a portion of the main body member in a positionrelative to at least one internal body structure, without piercingthrough a wall of the stomach; an adjustment member having a port thatis accessible by an instrument to effect expansion or contraction of themain body, the adjustment member configured to be anchored to anabdominal wall or subcutaneously external to the abdominal wall; and aconduit connecting the main body with the adjustment member, wherein thedevice is configured to be implanted without piercing through thestomach wall.

A method of treating obesity in a patient is provided, wherein themethod includes: making a percutaneous opening to the abdominal cavityof the patient; passing an expandable device, while in a contractedconfiguration, through the opening; positioning the expandable deviceadjacent the stomach of the patient; expanding the expandable device;and anchoring the expandable device, relative to at least one structurein the abdominal cavity, without piercing through a wall of the stomach.

A method of treating obesity in a patient is provided wherein the methodincludes: making a minimally invasive opening to the abdominal cavity ofthe patient; passing an expandable device, while in a contractedconfiguration, through the opening; positioning the expandable deviceadjacent the stomach of the patient; anchoring the expandable device toat least one structure in the abdominal cavity, without piercing througha wall of the stomach; and expanding the expandable device.

A method of treating obesity in a patient is provided wherein the methodincludes: making a percutaneous opening to the abdominal cavity of thepatient; passing an expandable device, while in a contractedconfiguration, through the opening; positioning the expandable deviceadjacent the stomach of the patient; expanding the expandable device tooccupy a volume of space and substantially prevent the stomach fromexpanding into the volume of space; and anchoring the expandable deviceto at least one structure in the abdominal cavity, without piercingthrough a wall of the stomach.

A method of treating obesity in a patient is provided wherein the methodincludes: making a minimally invasive opening to the abdominal cavity ofthe patient; passing an expandable device, while in a contractedconfiguration, through the opening; positioning the expandable deviceadjacent the stomach of the patient; passing an intra-gastric expandabledevice within the interior cavity of the stomach; expanding theintra-gastric expandable device to a predetermined size or pressure;expanding the expandable device to displace a portion of the stomachwall; monitoring the expanding of the expandable device and displacementof the portion of the stomach wall; and ceasing expanding the expandabledevice when the distance between the portion of the stomach wall beingdisplaced and the intra-gastric expandable device reaches apredetermined distance or when a predetermined pressure is monitored viathe intra-gastric expandable device.

A kit for treatment of obesity is provided including: an implantable,expandable body member configured to be positioned adjacent a portion ofa stomach of a patient, within the abdominal cavity of the patient; andan intra-gastric expandable device configured to be passed trans-orallyinto the interior cavity of the stomach, the intra-gastric expandabledevice comprising an inflatable main body configured to be received inthe cavity of the stomach, and a conduit of sufficient length to extendout of the mouth of the patient when the inflatable main body is fullyreceived in the cavity of the stomach.

A delivery device is provided for delivering an expandable device fortreatment of obesity, percutaneously into an abdominal cavity of apatient. The device includes an elongated outer cannula havingsufficient length to receive the expandable device when the expandabledevice is in a contracted configuration; an introducer nosecone, atleast a proximal portion of which is configured to be received within adistal opening of the elongated outer cannula; a rod passing through theelongated cannula and interconnecting the introducer nosecone distallywith a drive handle proximally, the rod being dimensioned to receive theexpandable device thereover when the expandable device is in acontracted configuration, and the rod extending proximally of a proximalend of the outer cannula, by a distance greater than or equal to alength of the expandable device in a contracted configuration; a stop onthe rod configured to be positioned proximally of a proximal end of theexpandable device in a contracted configuration when the expandabledevice is mounted on the rod, to prevent backsliding of the expandabledevice; and a locking mechanism to prevent sliding of the elongatedcannula proximally with respect to the rod when the locking mechanism isin a locked configuration, and to permit sliding of the elongatedcannula proximally with respect to the rod when the locking mechanism isin an unlocked configuration.

An implantable device for treatment of obesity is provided which isconfigured to assume a contracted configuration as well as an expandedconfiguration, wherein the contracted configuration reduces across-sectional area of the device to a cross-sectional area suitablefor passing the device through a port into the abdominal cavity using aminimally invasive procedure, and when in the expanded configuration,the device occupies a volume to prevent the stomach of a patient fromexpanding into the volume. The device further includes an anchorconfigured to fix the device in a position relative to at least oneinternal body structure, without piercing through a wall of the stomach.

An adjustment member configured to be anchored to a patient externallyof a body cavity is provided, wherein the adjustment member isconfigured to be in fluid communication with a conduit leading into thebody cavity. The adjustment member further includes a port that isaccessible by an instrument to deliver fluid therethrough; and a homingmechanism configured to home a delivery needle into the port.

An adjustment member and a delivery device are provided, wherein theadjustment member is configured to be anchored to a patient externallyof a body cavity. The adjustment member is configured to be in fluidcommunication with a conduit leading into the body cavity. Theadjustment member further includes a port that is accessible by adelivery needle of the delivery device to deliver fluid therethrough.The delivery needle includes a side opening for delivering fluidtherethrough when a distal end of the delivery needle engages the port.

An implantable device for treatment of obesity is provided thatincludes: an expandable main body member configured to be positionedadjacent a portion of a stomach of a patient, within the abdominalcavity of the patient; an anchor configured to fix a portion of the mainbody member in a position relative to at least one internal bodystructure, without piercing through a wall of the stomach; an adjustmentmember having a port that is accessible by an instrument to effectexpansion or contraction of the main body, wherein the adjustment memberis located in the expandable main body member; and a removable conduithaving an expandable tip wherein upon implantation of the expandablemain body the removable conduit is attached to the adjustment member andafter expansion of the expandable main body the expandable tip isretracted and the removable conduit is removed.

A method of treating obesity is provided that includes: placing a spaceoccupying device within an abdominal cavity in proximity to a stomach;expanding the space occupying device to reduce the space available forthe stomach to expand; and leaving the space occupying device inproximity to the stomach for sufficient time to remodel the stomach.

A method of treating obesity is provided that includes: placing a spaceoccupying device within an abdominal cavity in contact with a stomach;and expanding the space occupying device to constrain the stomach to acurved tubular shape.

A method of creating a feeling of satiety is provided, to include:positioning an expandable device in proximity to a stomach withoutpenetrating a wall of the stomach; and expanding the expandable deviceto reduce an achievable maximum volume of the stomach, wherein thestomach is free to move.

A method of treating obesity is provided, including: positioning anexpandable device in proximity to a stomach; and expanding theexpandable device to surround portions of the stomach so as to constraina largest capable dimension of the stomach by fifty percent or more.

These and other features of the invention will become apparent to thosepersons skilled in the art upon reading the details of the devices,methods, instruments and kits as more fully described below.

At least one method embodiment comprises the steps of: passing a device,including an expandable member in a collapsed configuration, through anopening in the skin of the patient, and into the abdominal cavity of thepatient; anchoring at least a portion of the expandable member, relativeto at least one structure in the abdominal cavity, without piercing thestomach; and expanding the expandable member to an expandedconfiguration in a space in the abdominal cavity to perform at least oneof: prevention of expansion of the stomach of the patient into thespace; and compression of a portion of the stomach.

A method of implanting a weight-loss treatment device by connecting thedevice to an anchoring frame is provided, including the steps of:passing the anchoring frame into the abdominal cavity of the patient;anchoring the anchoring frame to at least one structure in the abdominalcavity, without piercing the stomach; passing the device, including anexpandable member in a compressed configuration, into the abdominalcavity of the patient; and passing the device over the anchoring frameto anchor the device to the anchoring frame.

A method of implanting a weight-loss treatment device by connecting thedevice to an anchoring frame is provided, including: passing theanchoring frame into the abdominal cavity of the patient; passing thedevice, including an expandable member in a collapsed configuration,into the abdominal cavity of the patient; and passing the device overthe anchoring frame to mechanically lock the device to the anchoringframe and to anchor the anchoring frame to at least one structure in theabdominal cavity, without piercing the stomach.

An implantable device for inducing weight loss is provided, including:an expandable main body member configured to be positioned adjacent aportion of a stomach of a patient, within the abdominal cavity of thepatient; the expandable member being inflatable with pressurized fluid,wherein the expandable body member comprises a wall surrounding aninternal chamber, the wall being substantially impervious to thepressurized fluid; wherein the expandable main body member furthercomprises a safety valve configured to open when a pressure inside theexpandable main body exceeds a predetermined maximum pressure; and areserve chamber in fluid communication with the safety valve to receiveat least a portion of the pressurized fluid in the internal chamber ofthe expandable main body member when the safety valve opens.

An anchoring frame for anchoring a device to an internal structure in apatient's body is provided, including: an elongated main body havingproximal and distal ends; at least one channel running substantiallyover a length of the main body; a contact surface adapted to contact theinternal structure in the patient's body; anchors positioned in theanchoring frame for being driven through the contact surface and intothe internal structure; and a deployment driver slidable through atleast one of the at least one channels, wherein sliding the deploymentdriver through the at least one channel drives the anchors through thecontact surface.

A combination of an implantable device engaged with an anchoring frameis provided, wherein the implantable device include an expandable memberhaving at least one key extending therefrom or groove formed therein;the anchoring frame includes an elongated main body having proximal anddistal ends, and at least one channel or rail running substantially overa length of the main body; and wherein the rail is receivable in thegroove and the at least one key is receivable in the channel tomechanically connect the device with the anchoring frame.

An anchoring frame for anchoring a device to an internal structure in apatient's body is provided, including: an elongated main body havingproximal and distal ends; at least one channel running substantiallyover a length of the main body; a contact surface adapted to contact theinternal structure in the patient's body; anchors positioned in theanchoring frame for being driven through the contact surface and intothe internal structure; and a deployment driver slidable through atleast one of the at least one channels, wherein sliding the deploymentdriver in a first direction through the at least one channel contactsthe driver with first portions of the anchors and drives the anchorsthrough the contact surface, and wherein subsequently sliding thedeployment driver in a second direction through the at least one channelcontact the driver with second portion s of the anchors and retracts theanchors from extending through the contact surface.

An anchoring frame deployment tool configured to deliver an anchoringframe percutaneously to a surgical target area in a patient is provided,the tool including: a handle for manual operation by a user; anelongated shaft extending distally from the handle; and an engagementfeature provided on a distal end portion of the shaft, configured toengage a channel or a rail of the anchoring frame.

An anchoring frame deployment tool is provided, including: an elongatedshaft having a proximal portion and a distal portions rotatably linkedto the proximal portion; an actuator mechanically linked to the distalportion and operable by a user to rotate the distal portion in first andsecond opposite directions relative to the proximal portion; and arecess or cavity formed in the distal portion shaped and dimensioned toreceive the anchoring frame therein.

An anchoring frame unlocking tool is provided, including: a handle formanipulation by a user; an elongated shaft extending distally from thehandle; and a lock depressor extending radially from a distal endportion of the elongated shaft, the lock depressor configured to bemounted on and to slide over a rail of an anchoring frame, and todepress automatic locking structures as the lock depressor passes overthe automatic locking structures

An implantable device for treatment of obesity is provided, including:an expandable main body member configured to be positioned adjacent aportion of a stomach of a patient, within the abdominal cavity of thepatient; the expandable member being inflatable with pressurized fluid;two sets of looped tabs extending substantially along two lines in alongitudinal direction of the expandable main body member, wherein, inan un-expanded configuration in which the main body member liessubstantially flat, the two lines are offset, and wherein the main bodymember is configured to be rolled up, in the unexpanded configuration,into a compact configuration wherein the two lines align and set twosets of looped tabs align so that a shaft, rod or wire can be insertedthrough the looped tabs to maintain the expandable main body member inthe compact configuration.

An introducer configured to deliver an implantable device into anabdominal cavity of a patient via a percutaneous, laparoscopic ormini-laparoscopic procedure is provided, including: a proximal shaftportion; a splittable introducer housing forming a distal portion of theintroducer, the splittable introducer including a plurality of jawspivotally mounted to the proximal shaft portion and pivotable between anopen configuration and a closed configuration, wherein in the closedconfiguration, the jaws define an internal space configured anddimensioned for receiving the implantable device therein; and anactuator extending proximally of the jaws and operable by a user to openand close the jaws.

An introducer configured to deliver an implantable device into anabdominal cavity of a patient via a percutaneous, laparoscopic ormini-laparoscopic procedure, the introducer comprising: an inner sheath,the inner sheath comprising a distal end portion configured to receivethe device wrapped there around in a compact configuration; and an outersheath dimensioned to slide over the inner sheath and the device in thecompact configuration, to maintain the device in the compactconfiguration while delivering the device; wherein the outer sheath isretractable from the distal end portion of the inner sheath and thedevice, to expose the device to be extracted for implantation at asurgical target site, and wherein the distal end portion of the innersheath is bendable at an angled to a longitudinal axis of theintroducer, when the outer sheath is retracted, to reorient the deviceto facilitate extraction thereof.

An access member attachment system is provided, including: a tool havinga handle at a proximal end portion thereof; a working end at a distalend portion thereof, the working end including a socket shaped anddimensioned to receive an access member therein and to maintain anorientation of the access member relative to the working end duringattachment of the access member to a patient; and an anvil configured toslide over a conduit to which the access member is to be attached.

A method of attaching an access member to a conduit in fluid connectionwith an expandable member implanted in an abdominal cavity of a patientis provided, wherein the method includes: sliding an anvil over theconduit at a location external of the abdominal cavity; inserting theanvil through an opening in the abdominal wall while continuing to slidethe anvil over the conduit; orienting an anvil surface of the anvilagainst an inner surface of the abdominal wall; while holding the anvilsurface pressed against the inner surface of the abdominal wall, drivingthe access member against an outer surface of the abdominal wall,thereby driving attachment members of the access member through theabdominal wall and against the anvil surface, whereby the attachmentmembers are deformed against the anvil surface, thereby anchoring theaccess member to the abdominal wall.

An access member having undeployed and deployed configurations isprovided, including: at least one port adapted to be placed in fluidcommunication with a conduit, the access member having a first outsidediameter at a distal portion thereof, in the undeployed configuration,that is less than a second outside diameter of the access member at adistal portion thereof when in the deployed configuration.

A quick connect access member for attachment to a patient in fluidcommunication with a conduit in fluid communication with an expandablemember implanted in an abdominal cavity of a patient is provided,wherein the access member includes: a base having a contact surfaceadapted to abut an inner surface of an abdominal wall of the patient; atubular spacer having a length adapted to span a thickness of theabdominal wall, a proximal end portion of the spacer being provided witha lip; and an external portion connectable to the tubular spacer with asnap fit and configured to press against an external surface of theabdominal wall.

A quick connect access member for attachment to a patient in fluidcommunication with a conduit in fluid communication with an expandablemember implanted in an abdominal cavity of a patient is provided,wherein the access member includes: a base having a contact surfaceadapted to abut an inner surface of an abdominal wall of the patient,the base including a socket portion having one or more sets ofspring-loaded bearings or detents and a tubular spacer having a lengthadapted to span a thickness of the abdominal wall; and an externalportion connectable to the base portion, the external portion have adistally extending tubular portion have at least one annular recesscircumscribing an external surface thereof, configured to mate with theone or more sets of spring loaded bearings or detents.

A method of treating a patient is provided, including: passing a deviceincluding an expandable member through the skin of the patient, throughthe abdominal wall of the patient and into the abdominal cavity of thepatient; expanding the expandable member in a space in the abdominalcavity to perform at least one of: prevention of expansion of thestomach of the patient into the space; and compression of a portion ofthe stomach; and anchoring the expanded expandable member against theabdominal wall of the patient.

A method of treating a patient is provided, including: passing a deviceincluding an expandable member through a minimally invasive openingthrough the skin of the patient and the abdominal wall of the patient,and into the abdominal cavity of the patient; accessing a tether loopedthrough a positioning member on the expandable member from a secondminimally invasive opening; and drawing the tether through the secondminimally invasive opening and drawing on the position member toreorient the expandable member.

An implantable device for treatment of obesity is provided, including:an expandable main body member configured to be positioned adjacent aportion of a stomach of a patient, within the abdominal cavity of thepatient; the expandable member being inflatable with pressurized fluid;and an attachment tab extending from the expandable main body member.

In at least one embodiment, the attachment tab comprises at least onestructural member therein, the at least one structural member beingdeformable to facilitate passage through a small opening in a patient,and wherein the at least one structural member returns to an undeformedconfiguration upon entering the abdominal cavity to orient theattachment tab toward a structure in the abdominal cavity to attach theattachment tab to.

A method of f treating a patient is provided, with the method including:passing a flexible endoscope through an opening in the skin of thepatient, and into the abdominal cavity of the patient; passing a deviceincluding an expandable member in a collapsed configuration over theflexible endoscope and into the abdominal cavity of the patient;anchoring at least a portion of the expandable member, relative to atleast one structure in the abdominal cavity; and removing the flexibleendoscope from the patient.

A method of treating a patient is provided, including: passing aflexible wire through an opening in the skin of the patient, and intothe abdominal cavity of the patient; viewing through a distal endportion of the flexible wire; passing a device including an expandablemember in a collapsed configuration over the flexible wire and into theabdominal cavity of the patient; and anchoring at least a portion of theexpandable member, relative to at least one structure in the abdominalcavity.

At least one method embodiment comprises the steps of: passing a device,including an expandable member in a collapsed configuration, through anopening in the skin of the patient, and into the abdominal cavity of thepatient; anchoring at least a portion of the expandable member, relativeto at least one structure in the abdominal cavity, without piercing thestomach; and expanding the expandable member to an expandedconfiguration in a space in the abdominal cavity to perform at least oneof: prevention of expansion of the stomach of the patient into thespace; and compression of a portion of the stomach.

A method of implanting a weight-loss treatment device by connecting thedevice to an anchoring frame is provided, including the steps of:passing the anchoring frame into the abdominal cavity of the patient;anchoring the anchoring frame to at least one structure in the abdominalcavity, without piercing the stomach; passing the device, including anexpandable member in a compressed configuration, into the abdominalcavity of the patient; and passing the device over the anchoring frameto anchor the device to the anchoring frame.

A method of implanting a weight-loss treatment device by connecting thedevice to an anchoring frame is provided, including: passing theanchoring frame into the abdominal cavity of the patient; passing thedevice, including an expandable member in a collapsed configuration,into the abdominal cavity of the patient; and passing the device overthe anchoring frame to mechanically lock the device to the anchoringframe and to anchor the anchoring frame to at least one structure in theabdominal cavity, without piercing the stomach.

An implantable device for inducing weight loss is provided, including:an expandable main body member configured to be positioned adjacent aportion of a stomach of a patient, within the abdominal cavity of thepatient; the expandable member being inflatable with pressurized fluid,wherein the expandable body member comprises a wall surrounding aninternal chamber, the wall being substantially impervious to thepressurized fluid; wherein the expandable main body member furthercomprises a safety valve configured to open when a pressure inside theexpandable main body exceeds a predetermined maximum pressure; and areserve chamber in fluid communication with the safety valve to receiveat least a portion of the pressurized fluid in the internal chamber ofthe expandable main body member when the safety valve opens.

An anchoring frame for anchoring a device to an internal structure in apatient's body is provided, including: an elongated main body havingproximal and distal ends; at least one channel running substantiallyover a length of the main body; a contact surface adapted to contact theinternal structure in the patient's body; anchors positioned in theanchoring frame for being driven through the contact surface and intothe internal structure; and a deployment driver slidable through atleast one of the at least one channels, wherein sliding the deploymentdriver through the at least one channel drives the anchors through thecontact surface.

A combination of an implantable device engaged with an anchoring frameis provided, wherein the implantable device include an expandable memberhaving at least one key extending therefrom or groove formed therein;the anchoring frame includes an elongated main body having proximal anddistal ends, and at least one channel or rail running substantially overa length of the main body; and wherein the rail is receivable in thegroove and the at least one key is receivable in the channel tomechanically connect the device with the anchoring frame.

An anchoring frame for anchoring a device to an internal structure in apatient's body is provided, including: an elongated main body havingproximal and distal ends; at least one channel running substantiallyover a length of the main body; a contact surface adapted to contact theinternal structure in the patient's body; anchors positioned in theanchoring frame for being driven through the contact surface and intothe internal structure; and a deployment driver slidable through atleast one of the at least one channels, wherein sliding the deploymentdriver in a first direction through the at least one channel contactsthe driver with first portions of the anchors and drives the anchorsthrough the contact surface, and wherein subsequently sliding thedeployment driver in a second direction through the at least one channelcontact the driver with second portion s of the anchors and retracts theanchors from extending through the contact surface.

An anchoring frame deployment tool configured to deliver an anchoringframe percutaneously to a surgical target area in a patient is provided,the tool including: a handle for manual operation by a user; anelongated shaft extending distally from the handle; and an engagementfeature provided on a distal end portion of the shaft, configured toengage a channel or a rail of the anchoring frame.

An anchoring frame deployment tool is provided, including: an elongatedshaft having a proximal portion and a distal portions rotatably linkedto the proximal portion; an actuator mechanically linked to the distalportion and operable by a user to rotate the distal portion in first andsecond opposite directions relative to the proximal portion; and arecess or cavity formed in the distal portion shaped and dimensioned toreceive the anchoring frame therein.

An anchoring frame unlocking tool is provided, including: a handle formanipulation by a user; an elongated shaft extending distally from thehandle; and a lock depressor extending radially from a distal endportion of the elongated shaft, the lock depressor configured to bemounted on and to slide over a rail of an anchoring frame, and todepress automatic locking structures as the lock depressor passes overthe automatic locking structures.

An implantable device for treatment of obesity is provided, including:an expandable main body member configured to be positioned adjacent aportion of a stomach of a patient, within the abdominal cavity of thepatient; the expandable member being inflatable with pressurized fluid;two sets of looped tabs extending substantially along two lines in alongitudinal direction of the expandable main body member, wherein, inan un-expanded configuration in which the main body member liessubstantially flat, the two lines are offset, and wherein the main bodymember is configured to be rolled up, in the unexpanded configuration,into a compact configuration wherein the two lines align and set twosets of looped tabs align so that a shaft, rod or wire can be insertedthrough the looped tabs to maintain the expandable main body member inthe compact configuration.

An introducer configured to deliver an implantable device into anabdominal cavity of a patient via a percutaneous, laparoscopic ormini-laparoscopic procedure is provided, including: a proximal shaftportion; a splittable introducer housing forming a distal portion of theintroducer, the splittable introducer including a plurality of jawspivotally mounted to the proximal shaft portion and pivotable between anopen configuration and a closed configuration, wherein in the closedconfiguration, the jaws define an internal space configured anddimensioned for receiving the implantable device therein; and anactuator extending proximally of the jaws and operable by a user to openand close the jaws.

An introducer configured to deliver an implantable device into anabdominal cavity of a patient via a percutaneous, laparoscopic ormini-laparoscopic procedure, the introducer comprising: an inner sheath,the inner sheath comprising a distal end portion configured to receivethe device wrapped there around in a compact configuration; and an outersheath dimensioned to slide over the inner sheath and the device in thecompact configuration, to maintain the device in the compactconfiguration while delivering the device; wherein the outer sheath isretractable from the distal end portion of the inner sheath and thedevice, to expose the device to be extracted for implantation at asurgical target site, and wherein the distal end portion of the innersheath is bendable at an angled to a longitudinal axis of theintroducer, when the outer sheath is retracted, to reorient the deviceto facilitate extraction thereof.

An access member attachment system is provided, including: a tool havinga handle at a proximal end portion thereof; a working end at a distalend portion thereof, the working end including a socket shaped anddimensioned to receive an access member therein and to maintain anorientation of the access member relative to the working end duringattachment of the access member to a patient; and an anvil configured toslide over a conduit to which the access member is to be attached.

A method of attaching an access member to a conduit in fluid connectionwith an expandable member implanted in an abdominal cavity of a patientis provided, wherein the method includes: sliding an anvil over theconduit at a location external of the abdominal cavity; inserting theanvil through an opening in the abdominal wall while continuing to slidethe anvil over the conduit; orienting an anvil surface of the anvilagainst an inner surface of the abdominal wall; while holding the anvilsurface pressed against the inner surface of the abdominal wall, drivingthe access member against an outer surface of the abdominal wall,thereby driving attachment members of the access member through theabdominal wall and against the anvil surface, whereby the attachmentmembers are deformed against the anvil surface, thereby anchoring theaccess member to the abdominal wall.

An access member having undeployed and deployed configurations isprovided, including: at least one port adapted to be placed in fluidcommunication with a conduit, the access member having a first outsidediameter at a distal portion thereof, in the undeployed configuration,that is less than a second outside diameter of the access member at adistal portion thereof when in the deployed configuration.

A quick connect access member for attachment to a patient in fluidcommunication with a conduit in fluid communication with an expandablemember implanted in an abdominal cavity of a patient is provided,wherein the access member includes: a base having a contact surfaceadapted to abut an inner surface of an abdominal wall of the patient; atubular spacer having a length adapted to span a thickness of theabdominal wall, a proximal end portion of the spacer being provided witha lip; and an external portion connectable to the tubular spacer with asnap fit and configured to press against an external surface of theabdominal wall.

A quick connect access member for attachment to a patient in fluidcommunication with a conduit in fluid communication with an expandablemember implanted in an abdominal cavity of a patient is provided,wherein the access member includes: a base having a contact surfaceadapted to abut an inner surface of an abdominal wall of the patient,the base including a socket portion having one or more sets ofspring-loaded bearings or detents and a tubular spacer having a lengthadapted to span a thickness of the abdominal wall; and an externalportion connectable to the base portion, the external portion have adistally extending tubular portion have at least one annular recesscircumscribing an external surface thereof, configured to mate with theone or more sets of spring loaded bearings or detents.

A method of treating a patient is provided, including: passing a deviceincluding an expandable member through the skin of the patient, throughthe abdominal wall of the patient and into the abdominal cavity of thepatient; expanding the expandable member in a space in the abdominalcavity to perform at least one of: prevention of expansion of thestomach of the patient into the space; and compression of a portion ofthe stomach; and anchoring the expanded expandable member against theabdominal wall of the patient.

A method of treating a patient is provided, including: passing a deviceincluding an expandable member through a minimally invasive openingthrough the skin of the patient and the abdominal wall of the patient,and into the abdominal cavity of the patient; accessing a tether loopedthrough a positioning member on the expandable member from a secondminimally invasive opening; and drawing the tether through the secondminimally invasive opening and drawing on the position member toreorient the expandable member.

An implantable device for treatment of obesity is provided, including:an expandable main body member configured to be positioned adjacent aportion of a stomach of a patient, within the abdominal cavity of thepatient; the expandable member being inflatable with pressurized fluid;and an attachment tab extending from the expandable main body member.

In at least one embodiment, the attachment tab comprises at least onestructural member therein, the at least one structural member beingdeformable to facilitate passage through a small opening in a patient,and wherein the at least one structural member returns to an undeformedconfiguration upon entering the abdominal cavity to orient theattachment tab toward a structure in the abdominal cavity to attach theattachment tab to.

A method of f treating a patient is provided, with the method including:passing a flexible endoscope through an opening in the skin of thepatient, and into the abdominal cavity of the patient; passing a deviceincluding an expandable member in a collapsed configuration over theflexible endoscope and into the abdominal cavity of the patient;anchoring at least a portion of the expandable member, relative to atleast one structure in the abdominal cavity; and removing the flexibleendoscope from the patient.

A method of treating a patient is provided, including: passing aflexible wire through an opening in the skin of the patient, and intothe abdominal cavity of the patient; viewing through a distal endportion of the flexible wire; passing a device including an expandablemember in a collapsed configuration over the flexible wire and into theabdominal cavity of the patient; and anchoring at least a portion of theexpandable member, relative to at least one structure in the abdominalcavity.

The present invention provides methods, devices, tools and assembliesfor treating a patient to assist with weight loss. One method embodimentinvolves passing a device including an expandable member in a collapsedconfiguration and a buoyancy member into the abdominal cavity of thepatient, and anchoring at least a portion of the expandable member,relative to at least one structure in the abdominal cavity.

A method of treating a patient is provided that includes the steps of:passing a device into the abdominal cavity of the patient, wherein thedevice includes at least one attachment member extending from a mainbody portion thereof; positioning an inferior portion of the device inthe abdominal cavity; and anchoring that at least one attachment memberto an inner surface of the abdominal wall.

A method of treating a patient is provided that includes steps of:passing a guide rail into the abdominal cavity of the patient; passingan anchoring frame, guided by the guide rail, into the abdominal cavity;anchoring the anchoring frame to at least one structure in the abdominalcavity; passing a device, guided by the guide rail, into the abdominalcavity; and attaching the device to the anchoring frame.

A method of treating a patient is provided that includes steps of:passing a guide rail into the abdominal cavity of the patient, whereinthe guide rail is selected from one of: at least one guidewire; at leastone flexible wire facilitating viewing out of a distal end portionthereof from a proximal end portion thereof; at least one rod; or aflexible steerable catheter; passing an anchoring frame, guided by theguide rail, into the abdominal cavity; anchoring the anchoring frame toat least one structure in the abdominal cavity; passing a device, guidedby the guide rail, into the abdominal cavity; and attaching the deviceto the anchoring frame.

A method of treating a patient is provided, including steps of: passingan anchoring frame into the abdominal cavity of the patient; deliveringanchoring members, attached to the anchoring frame, through at least onestructure in the abdominal cavity that the anchoring frame is to beanchored to, through the skin and out of the patient; fixing theanchoring members externally of the abdominal cavity to anchor theanchoring frame to the at least one structure in the abdominal cavity;passing a device, into the abdominal cavity; and attaching the device tothe anchoring frame.

A method of treating a patient is provided, including steps of: passinga buoyancy member into the abdominal cavity of the patient; anchoringthe buoyancy member to at least one structure in the abdominal cavity;passing a device into the abdominal cavity; and attaching the device tothe buoyancy member.

A method of treating a patient is provided, including steps of: passinga device including an expandable member having at least onetrans-abdominally detectable marker; advancing the device into theabdominal cavity of the patient while tracking and guiding the advancingby trans-abdominally detecting the location of the at least one marker,relative to the patient's anatomy, as the device is advanced; andanchoring at least a portion of the expandable member, relative to atleast one structure in the abdominal cavity.

A method of monitoring functionality of a device implanted in theabdominal cavity of a patient to enhance weight loss is provided,including: providing a handheld monitoring device outside of thepatient; and wirelessly communicating with at least one sensor on thedevice located in the abdominal cavity.

A method of treating a patient is provided, including: providing adevice implanted in the abdominal cavity of the patient, wherein thedevice occupies a space in the abdominal cavity to perform at least oneof: prevention of expansion of the stomach of the patient into the spaceand compression of a portion of the stomach; wherein the device includesat least one electrode on a surface thereof in contact with the stomachof the patient, said at least one electrode being electrically connectedto a stimulation signal controller; and delivering a stimulation signalfrom the controller to the at least one electrode to stimulate at leastone contraction of at least one muscle in the stomach.

A method of treating a patient is provided, including: passing a deviceinto the abdominal cavity of the patient; anchoring at least a portionof the device, relative to at least one structure in the abdominalcavity; and occupying a space in the abdominal cavity with the device tosubstantially restrict expansion of the fundus of the stomach, andrestraining the stomach to a shape resembling a tube, but wherein atleast a portion of the antrum is left unrestrained.

A method of treating a patient is provided, including: passing a deviceinto the abdominal cavity of the patient; anchoring at least a portionof the device, relative to at least one structure in the abdominalcavity; and occupying a space in the abdominal cavity with the device tosubstantially restrict expansion of the fundus of the stomach, andrestraining the stomach to a shape resembling a tube, but wherein asmall pouch is left unrestrained at a superior end portion of thestomach.

An implantable device for treatment of a patient to assist weight lossis provided, wherein the device includes: an expandable memberconfigured to be positioned in an abdominal cavity of the patient, theexpandable member configured to be expanded from a contractedconfiguration to an expanded configuration after placement of the devicein the abdominal cavity, and to substantially maintain a size and shapeof the expanded configuration. The expandable member, in the expandedconfiguration, has a buoyancy characteristic relative to its surroundingwhen implanted in the abdominal cavity. The device further includes abuoyancy member having a buoyancy characteristic different from thebuoyancy characteristic of the expandable member, to alter a combinedbuoyancy characteristic of the device.

A method of making an implantable device for treatment of a patient toassist weight loss is provided, wherein the device includes anexpandable member configured to be positioned in an abdominal cavity ofthe patient, the expandable member configured to be expanded from acontracted configuration to an expanded configuration after placement ofthe device in the abdominal cavity, and to substantially maintain a sizeand shape of the expanded configuration, and a buoyancy member fixed tothe expandable member and contained within an internal cavity of theexpandable member. The method of making includes: providing a moldhaving a shape of the buoyancy member integral with a shape of theexpandable member; molding a wall of polymeric material over the mold;removing the molded wall of material from the mold; inverting a moldedbuoyancy member portion of the wall into an internal cavity defined by amolded expandable member portion of the wall; and sealing a slitremaining from the inverting.

An anchoring frame deployment tool is provided that includes: a recessor cavity formed in a distal portion shaped and dimensioned to receivean anchoring frame therein; needles and a driving mechanism for drivingthe needles through the distal portion and the anchoring frame; whereinthe needles have sufficient length to extend through an abdominal wallof a patient and out through the skin of the patient when the anchoringframe is contacted to an inner wall surface of the abdominal wall.

An anchoring frame for anchoring a device to an internal structure in apatient's body is provided, including: a plurality of beams linked to becompressed into a narrow configuration and expanded to an expandedconfiguration; and a mechanical linking feature on each of at least twoof the beams, the mechanical linking features configured to mechanicallyengage with mating features on the device.

An assembly of mating engagement members for engaging anintra-abdominal, extra-gastric implant device with an anchoring frame isprovided, wherein the assembly includes: a rail having a series oftransversely placed openings along a length thereof; a channelconfigured to receive the rail and having at least one detent configuredto pass through a wall of the rail through one of the openings; and anactuator for preventing the at least one detent from passing through thewall when in a first configuration; and allowing passage of the at leastone detent through the wall when in a second configuration.

In one embodiment, a fluid access port with a proximal end and a distalend is described, the proximal end operable to be accessed for fluidinjection and the distal end operable to receive fluid and deliver it toa fluid receiving structure in a patient. The fluid access portcomprises a pressure sensing system constructed to be handheld whereinthe pressure sensing system is hydraulically coupled to the fluid accessport and wherein the pressure sensing system comprises a pressure sensorand a circuit operable to receive a pressure related signal from thepressure sensor and generate an output signal. In other embodiments, thepressure sensing system of the fluid access port further comprises aphysically connected power source. In other embodiments, the fluidaccess port comprises a pressure sensing system which is rigidly coupledto the fluid access port. In other embodiments, the fluid access portcomprises a pressure sensing system which is constructed so as to beimplanted in a patient. In other embodiments, the pressure sensingsystem of the fluid access port is placed within a moisture proof andbiocompatible package. In yet other embodiments, the pressure sensingsystem of the fluid access port is coupled to the fluid access portthrough a needle placed through the skin of a patient. In otherembodiments, the fluid access port further comprises a circuit whichcomprises a transmitter capable of transmitting data through theabdominal wall of a patient. In other embodiments, the circuit of thepressure sensing system further comprises a microcontroller which isprogrammed to power on and power off between pressure samplings. In yetother embodiments, the circuit of the pressure sensing system comprisesan inductive circuit operable to transmit and receive electrical energyacross the skin of a patient. In other embodiments, the fluid accessport comprises a pressure sensing system which is reversibly attachableto the fluid access port when the fluid access port is implanted in apatient and the pressure sensing system is external to the patient. Inanother embodiment, the fluid access port of claim 1 further comprisesan elongate tube with a proximal end and a distal end, the proximal endarising from the pressure sensor and containing a fluid wherein thefluid is inert at least to the pressure sensor and the material of theelongate tube; a protective material coupled to the distal portion ofthe elongate tube, the protective material inert to the inert materialinside the elongate tube; and, wherein the combination of the inertmaterial inside the elongate tube and the protective material at thedistal end of the elongate tube maintain hydraulic continuity betweenthe access port and the pressure sensor.

In another embodiment, a system to manage a surgical implant isdescribed comprising a receiver constructed so as to communicate with apressure sensing system hydraulically coupled to an implant, thereceiver further configured to output information to a software program.The management system can further be configured so that the receiver ischosen so as to receive a signal transmitted wirelessly. The managementsystem can further contain a pressure sensing system which is externalto a patient. The pressure sensor in some embodiments can be internal tothe patient or external to the patient. In some embodiments, thesoftware comprises a patient algorithm and in some embodiments, datafrom the algorithm is used in combination with the acute data from thepressure sensing system. In some embodiments, the system to manage thepatients' logs the usage information related to transmitting data to thereceiver.

In some embodiments, a system to manage an implant comprises a sensingsystem coupled to the implant, a polymeric actuator hydraulicallycoupled to the implant and a microcontroller which interprets a signalfrom the sensing system and sends a signal to the actuator.

A Method for treating a patient comprising the steps of: penetrating theskin of the abdominal wall and entering the abdominal cavity; contactingan intra-abdominal structure with a first guiding device comprising acontact portion and a connecting portion; guiding a first surgicaldevice over the first guiding device; and contacting the externalsurface of the first intra-abdominal structure with the first surgicaldevice; the first surgical device can also comprise an electrocauterydevice; the first surgical device can further comprise a device tovisualize the first intra-abdominal structure. The method can furthercomprise a surgical device with an undeployed configuration and adeployed configuration. The first surgical device can be a balloon. Theballoon can be constructed so that its shape in the deployedconfiguration conforms to the region of the stomach close to thegastroesophageal junction. The shape of the balloon can be such that itsurrounds at least half of the circumference of an externalcross-section of the stomach when the balloon is in its deployedconfiguration. In some embodiments, the shape of the balloon can be suchthat it surrounds at least three quarters of the circumference of anexternal cross-section of the stomach when the balloon is in itsdeployed configuration. In another embodiment, the connecting portionfurther comprises a fastener. The fastener can be used to fasten thesurgical device or balloon to the first abdominal structure. The firstsurgical device is an expandable device in some embodiments. In someembodiments, the expandable device can be a retractor and can be placedbetween the liver and stomach to create a working space between theliver and the stomach. In other embodiments, a second guiding device ispassed through the skin, the second guiding device comprising a secondcontacting portion and a second connecting portion, and into theabdomen; the second guiding device is placed in contact with theexternal surface of a second intra-abdominal structure. This embodimentfurther comprises guiding a second surgical device over the secondconnecting portion, and contacting the external surface of the secondintra-abdominal structure with the second surgical device.

In another embodiment, a second surgical device is guided over a firstguiding device. This embodiment can further comprises injecting a tissuebulking agent into the external surface of the first abdominalstructure. These methods can further be used to apply electricalstimulation with the first surgical device.

In another embodiment, a method to treat an obese patient is describedwhich comprises: penetrating through the abdominal wall of a patientwith a balloon adapted to track over a connector, wherein the balloon isexpandable from a first undeployed configuration to a second deployedconfiguration, and wherein the balloon is fixed to a least two pointsinside the abdomen and wherein the balloon is further contoured tomaintain contact with the gastrointestinal organ.

In another embodiment, a method of treating an obese patient isdescribed and comprises advancing a guiding device through the skin of apatient and through the abdominal wall to contact an external surface ofan intra-abdominal structure; applying a surgical device over theguiding device to contact the external surface of the intra-abdominalstructure; applying a second device over the guiding device to lock thesurgical device in place along the guiding device; and activating thesurgical device via the guiding device.

In other embodiments, a device for application to the external stomachsurface of a patient comprising a first portion expandable from acollapsed state to an expanded state, a second portion coupled to thefirst portion contoured to fit an external portion of the stomachwithout encircling the stomach, a third portion coupled to the devicewhich is slideable over a flexible connector comprising a proximal endand a distal end. The device can have a first portion which is aballoon. The device further can comprise a fluid communication line incontact with said balloon. The device wherein said communication lineand said connector are the same structure. In another embodiment, saidfirst portion of the device and said second portion of the device areone in the same. The device wherein the second portion has a radius ofbetween 0.25 and 5 centimeters and is curved to fit the cardia of thestomach when the first portion is in its expanded state. The devicewherein the second portion is between 5 and 30 centimeters. The devicewherein the connector further comprises an anchor at its distal end. Thedevice can further contain a sensor.

In one embodiment, a system is described comprising a device expandablefrom a first configuration to a second configuration wherein said deviceis contoured to partially surround a portion of the stomach withoutfully circumscribing the portion of the stomach; a connector coupled tosaid device and operable to adjust the degree of expansion between thefirst configuration and the second configuration; A port incommunication with the connector said port operable to be accessedintermittently through the skin of a patient. The system furthercomprises at least one sensor which senses a force applied to thedevice. In another embodiment, the system comprises an actuator; in yetanother embodiment, the system further comprises a fastening elementattached between the device and outer layer of the stomach.

In another embodiment, a device to apply external compression to thestomach comprises a first structure with a first width and a secondsmaller width wherein the structure is constructed to bias toward thesecond smaller width unless a force is applied to maintain the firstwidth. A second structure is attached to the first structure andconstructed from a material which enables force to be applied to adjustthe width of the first structure. In another embodiment, the devicecomprises a second structure which is a fluid fillable structure. Inanother embodiment, the first or second structure of the devicecomprises nitinol. In other embodiments, the first or second structurecomprises an electroactive polymer. In further embodiments, the devicefurther comprises a communicating line. In other embodiments, thecommunicating line is a fluidic communicating line. In furtherembodiments, the communicating line is an electrical communication line.In other embodiments, the device comprises at least one sensor or anelectroactive polymer. In still further embodiments, the device furthercomprises a power supply and/or a microcontroller.

In another embodiment, a system comprises a flexible connector with aproximal and a distal end and a tissue interface at its distal end. Thetissue interface is operable to grasp tissue or anchor in tissue. Adevice to treat obesity is provided which is operable to be pushed alongthe flexible connector. The device to treat obesity can be operable tobe pushed along a connector by a grasping instrument, the graspinginstrument also operable to be pushed along the connector. The device totreat the stomach can be a stimulation device or the device can be acompression device. In some embodiments, an enabling device to performsurgery on the stomach is provided which is operable to slide along theconnector and perform a surgical task. In one embodiment, the surgeryenabling device is an energy generating or energy conducting device. Inanother embodiment, the surgery enabling device is a camera. In anotherembodiment, the surgery enabling device is an injector operable toinject a fluid into the wall of a gastric or esophageal lumen.

A device for application to the external stomach surface of a patientcomprising a first portion expandable from a collapsed state to anexpanded state, a second portion coupled to the first portion contouredto fit an external portion of the stomach without encircling thestomach, a third portion coupled to the device which is slideable over aflexible connector comprising a proximal end and a distal end. Thedevice wherein the first portion is a balloon. The device further cancomprise a fluid communication line in contact with the balloon. Thedevice wherein said communication line and said connector are the samestructure. In another embodiment, said first portion of the device andsaid second portion of the device are one in the same. The devicewherein the second portion has a radius of between 0.25 and 5centimeters and is curved to fit the cardia of the stomach when thefirst portion is in its expanded state. The device wherein the secondportion is between 5 and 30 centimeters. The device wherein theconnector further comprises an anchor at its distal end. The device canfurther contain a sensor

In one embodiment, a system is described comprising a device expandablefrom a first configuration to a second configuration wherein said deviceis contoured to partially surround a portion of the stomach withoutfully circumscribing the portion of the stomach; a connector coupled tosaid device and operable to adjust the degree of expansion between thefirst configuration and the second configuration; a port cancommunication with the connector, the port operable to be accessedintermittently through the skin of a patient. The system furthercomprises at least one sensor which senses a force applied to thedevice. In another embodiment, the system comprises an actuator; in yetanother embodiment, the system further comprises a fastening elementattached between the device and outer layer of the stomach.

In another embodiment, a device to apply external compression to thestomach comprises a first structure with a first width and a secondsmaller width wherein the structure is constructed to bias toward thesecond smaller width unless a force is applied to maintain the firstwidth. A second structure is attached to the first structure andconstructed from a material which enables force to be applied to adjustthe width of the first structure. In another embodiment, the devicecomprises a second structure which is a fluid fillable structure. Inanother embodiment, the first or second structure of the devicecomprises nitinol. In other embodiments, the first or second structurecomprises an electroactive polymer. In further embodiments, the devicefurther comprises a communicating line. In other embodiments, thecommunicating line is a fluidic communicating line. In furtherembodiments, the communicating line is an electrical communication line.In other embodiments, the device comprises at least one sensor or anelectroactive polymer. In still further embodiments, the device furthercomprises a power supply and/or a microcontroller.

In one embodiment, a method for approximating body lumens comprisingpenetrating through a first wall of a first gastrointestinal organ withan elongate structure comprising at least two expandable elementsslideable along the elongate structure, penetrating through a secondgastrointestinal organ with the elongate structure expanding a firstexpandable element of the elongate structure adjacent a first wall ofthe first gastrointestinal organ, expanding a second expandable of theelongate structure adjacent a second wall of the second gastrointestinalorgan, and urging the first and second gastrointestinal organs together.

In some embodiments, the methods further comprise positioning a materialbetween the first and second gastrointestinal organs. The methods canfurther include creating pressure between the first expandable elementand the second expandable element. The method of this embodiment canfurther involve applying energy to the region between the first andsecond gastrointestinal organs. The elongate structure can further beflexible. In some embodiments, the elongate structure can furthercomprise one, two, three, or more than three lumens therethrough.

In another embodiment, the elongate structure comprises an elementslideable along said elongate structure. In some embodiments, oneexpandable element is expandable independently of the other expandableelement.

In some embodiments, methods include locking one expandable element onthe elongate structure or locking one lumen of the elongate structurewith respect to the other lumen or lumens of the elongate structure. Inone embodiment, the methods further include measuring tension along theelongate structure while locking the expandable element or elements withrespect to the elongate structure or locking one lumen of the elongatestructure relative to the other lumen of the elongate structure.

In other embodiments, methods further include placing an adhesivematerial between the first and second gastrointestinal organs while inthe urged position. In further embodiments, methods include applying alight absorbing material between the first and second gastrointestinalorgans. In still further embodiments, the methods include applying acoherent light source to the region between the first and secondgastrointestinal organs with or without a material in between theorgans; other embodiments include applying a non-coherent or an LEDlight source to the region between the two organs.

In some embodiments, one or more anchors is expanded with a fluid orgas. In other embodiments, the connector and/or one or more of theexpandable elements are produced from a magnetic, paramagnetic, orferromagnetic material.

In some embodiments, a fluid access port is described which comprises aninflow and an outflow component, an access region for percutaneousaccess with a needle, and an attached material configure to improvecontrast to an ultrasonic imaging device.

In some embodiments, a fluid access port comprises an attached materialin the form of a continuous or discontinous ring around the fluid accessport. The fluid access port can comprises a material in the gas phase.The material of the fluid access port can further comprise a liquidphase.

In some embodiments, an electrode for implantation in the stomach of apatient comprises a flexible conducting material containing pores sizedto induce tissue ingrowth. In some embodiments, the flexible conductingmaterial comprises two different materials constructed as a compositestructure. In some embodiments, the electrode comprises two differentmaterials: 1) a current conducting material; 2) a tissue ingrowthmaterial. The electrode can further be of a size greater than 3 cm inlength and greater than 1.0 cm wide. The electrode of can furthercontain pores sized between 10 and 250 microns in at least onedimension. The electrode can further contain pores which are between 10and 100 microns in at least one dimension. In some embodiments, theelectrode contains pores which are greater than 50 microns in thelargest dimension. In other embodiments, the electrode contains poreswhich are between 5 and 100 microns in at least one dimension.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-1E are perspective views of embodiments of the posterior anchorand connector.

FIGS. 1F and 1G are side views of an inflatable embodiment of posterioranchor and connector.

FIGS. 1H, 1I, and 1J are views of suture-connector—posterior anchorcombinations in which the connector is separable from the posterioranchor.

FIG. 1K is a depiction of the continuous form of a posterior anchor.

FIG. 1L is a view of a connector-anchor combination in which the lengthbetween two anchors is adjustable.

FIGS. 2A and 2B are a perspective view and top view of one embodiment ofan anterior anchor, respectively.

FIGS. 2C and 2D are side sectional views of the embodiment of theanterior anchor of FIGS. 2A and 2B, taken along the line B-B in FIG. 2B,in its deployed and reduced profile configuration, respectively.

FIGS. 2E and 2F are side sectional views of another embodiment of ananterior anchor, taken along the same line as FIGS. 2C and 2D, in itsdeployed and reduced profile configuration, respectively.

FIG. 2G is a perspective view of an inflatable embodiment of an anterioranchor.

FIGS. 2H and 2I are side sectional views of the embodiment of theanterior anchor of FIG. 2G, taken along the line D-D in FIG. 2G, in itsdeployed and reduced profile configuration, respectively.

FIG. 3A is a perspective view of another embodiment of an anterioranchor.

FIGS. 3B and 3C are perspective views of the embodiment of the anterioranchor shown in FIG. 3A in its reduced profile and deployedconfiguration, respectively.

FIG. 3D is a perspective view of another embodiment of an anterioranchor.

FIGS. 3E-I detail the use of the connectors and anchors to facilitatethe connection of two body lumens.

FIGS. 4A and 4A′ are a side and blow-up view, respectively, of oneembodiment of a tissue grasping instrument with the distal end in itsopen configuration.

FIGS. 4B and 4B′ are a perspective and blow-up view, respectively, ofthe tissue grasping instrument of FIG. 4A with the distal end in itsclosed configuration.

FIGS. 4C and 4C′ are a perspective and blow-up view, respectively, ofanother embodiment of the tissue grasping instrument with the distal endin its closed configuration.

FIG. 5A is a side view of one embodiment of an anchor implantationinstrument.

FIG. 5B is a perspective view of the distal end of the anchorimplantation instrument of FIG. 5A and an anterior anchor and connector.

FIG. 5C is a side sectional view of the distal end of the anchorimplantation instrument of FIGS. 5A and 5B, taken along line C-C in FIG.5B, with the anterior anchor in its reduced profile configuration.

FIG. 6A illustrates the first step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen with the instrument of FIG. 4 inserted into thepatient's abdomen through a laparoscopic port.

FIG. 6B illustrates the next step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen with the instrument of FIG. 4 grasping the posteriorwall of the stomach and a needle being inserted into the potential spaceof the lesser peritoneal sac.

FIG. 6C illustrates the next step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen with the instrument of FIG. 4 grasping the posteriorwall of the stomach and a posterior anchor and connector deployed in theexpanded potential space of the lesser peritoneal sac.

FIG. 6D illustrates the next step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen with a posterior anchor and connector deployed in theexpanded potential space of the lesser peritoneal sac, with theconnector passing out of the patient's abdomen through a laparoscopicport.

FIG. 6E illustrates an alternative step and device to place theposterior anchor in which the posterior anchor is brought behind thestomach before the connector is attached.

FIG. 6F illustrates the steps in the methods to perform percutaneoussurgery on the stomach.

FIG. 7A illustrates the next step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen with the instrument of FIG. 5C placing an anterioranchor in the patient's abdomen adjacent to the anterior wall of thestomach.

FIG. 7B illustrates the next step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen with an anterior anchor in its deployed configurationon the connector, with the anterior and posterior walls of the stomachurged together.

FIG. 7C illustrates the next step in one embodiment of a method ofreducing the volume of the stomach. Shown is a side sectional view of apatient's abdomen after the connector has been cut flush with theanterior anchor.

FIGS. 7D-E illustrates a transgastric fastening assembly placed in aposition to close a fascial defect from a laparoscopic port.

FIG. 8A illustrates an embodiment of a method of reducing the volume ofthe stomach. Shown is a side sectional view of a patient's abdomen aftertwo posterior anchors and connectors have been deployed adjacent to theposterior wall of the stomach, with the connectors passing out of thepatient's abdomen through laparoscopic ports.

FIG. 8B shows the connectors of FIG. 8A with clamps placed on theconnectors outside the patient's body to temporarily hold the connectorsin a test position.

FIG. 9 is a perspective view showing three transgastric fasteningassemblies deployed longitudinally in a patient's stomach.

FIG. 10A illustrates one embodiment of a method for deploying a volumedisplacing device in the stomach. Shown is a side sectional view of apatient's abdomen after an uninflated balloon anchor has been insertedinside the patient's stomach with a connector passing out of thestomach, through the anterior stomach wall, and through a laparoscopicport.

FIG. 10B illustrates one embodiment of a method for deploying a volumedisplacing device in the stomach. Shown is a side sectional view of apatient's abdomen with the balloon anchor in its deployed position, heldin place by an anterior anchor and connector.

FIG. 11A illustrates a volume displacing device which resides outsidethe stomach and is shown in an undeployed state.

FIG. 11B illustrates a volume displacing device which resides outsidethat stomach and is shown in a deployed state and adapted to the contourof the stomach.

FIG. 11C illustrates a volume displacing device which resides outsidethe stomach and is fixed to the anterior wall of the stomach and to theabdominal wall with an anterior anchor and connector.

FIG. 11D is a cross-sectional view of an extragastric restriction devicewhich does not fully circumscribe the stomach and which optionally hastwo components, one of which can apply an inward force to the secondcomponent.

FIG. 11E is a mesh structure which partially or fully surrounds thestomach and can be combined with or without rigid structures andballoons.

FIG. 11F is cross-section of an extragastric restriction device with twocomponents

FIG. 11G is an extragastric restriction device with a flexible catheterrunning through its center, an optional tissue adhesion facilitatingdevice, and a tissue anchor at its distal end.

FIG. 11H is a representative example of an extragastric balloon whichcontacts a substantial portion of the exterior surface of the stomach.

FIG. 11I is a representation of a method to implant an extragastricexpandable device using a connector contacting the stomach, a balloonadapted to slide a balloon along the wire, and optional second surgicaldevices positioned along the wire.

FIGS. 12 a-c illustrate the steps in the laparoscopic method of placinga device in the stomach where the transgastric connector attaches asuture to a posterior anchor.

FIGS. 13 a-b illustrate another step in the laparoscopic procedure inwhich the anterior anchor is urged toward the posterior anchor over aconnector.

FIGS. 14 a-c illustrate another step in the laparoscopic procedure inwhich the anterior and posterior walls of the stomach are urged togetherand the connector and the transgastric suture are cut flush with theanterior anchor.

FIGS. 15 a-b illustrate the placement of a continuous posterior anchorin the laparoscopic procedure.

FIGS. 15 c-d depicts a horizontal row of transgastric anchors andconnectors after their placement in the stomach.

FIGS. 15 e-g depicts a configuration where both the anterior andposterior fasteners are connected by a continuous mesh implant.

FIGS. 15 h-i depict a transgastric device with an adjustable, expandablestructure inherent to the device

FIG. 16 depicts anchors of the present invention being used to secure anendoscopically placed gastric implant.

FIG. 17 a depicts a transgastric anchor assembly with afferent,efferent, and device end-effector pathways.

FIG. 17 b depicts a constricting band with afferent and efferentfeedback pathways.

FIGS. 18 a-d depicts various configurations of constricting bands withvarious sensor configurations.

FIG. 18 e depicts an electrical schematic of a pressure sensing systemconfigured to fit inside a percutaneous port.

FIG. 18 f depicts a patient management algorithm based on the pressuresensing system in the port.

FIG. 18G depicts another embodiment of a pressure sensor retrofit inwhich the sensor communicates with the line from the port but is aseparate device from the port.

FIG. 18H depicts another embodiment of a fluid receiving andtransmitting port in which a visualization rim is shown and a customizedpressure sensing system is shown attached.

FIG. 18I depicts a handheld external system for detecting pressure froman implanted device.

FIG. 19 depicts a surgical anastomosis outfitted with a sensory feedbacksystem.

FIG. 20 depicts a preferred embodiment of a gastroplasty device with acentral stoma and a feedback system for stimulation.

FIG. 21 depicts a schematic of a control system for a gastricrestriction device.

FIG. 22 depicts another schematic of a control system configuration withthe surgical procedure as the center of the control system includingsensory devices.

FIG. 23 depicts a clinical patient management system based on sensingparameters from surgical devices.

FIG. 24 depicts an extragastric device implanted in the abdomen of apatient.

FIG. 25 depicts a method of implanting an extragastric device in theabdomen of a patient.

FIG. 26 depicts and embodiment of an extragastric device and anassociated method of implantation in the abdomen of a patient.

FIG. 27 depicts an extragastric device in its operative position afterimplantation.

FIG. 28 depicts data resulting from implantation of an implantablepressure sensor in combination with a Lap-Band and in a dog model.

FIG. 29 depicts an image obtained from a fluoroscopy machine during 30day follow up of an extragastric balloon implantation.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Anatomy of the Stomach

The region behind the stomach is referred to as the lesser peritonealsac. It is a potential space between the retroperitoneum and theposterior wall of the stomach. The proximal limit of the lesser sac isthe cardia of the stomach and the distal limit is the pylorus of thestomach; the superior limit is the liver and the inferior limit is theinferior border of the stomach. To the left of the midline, theposterior wall of the stomach is generally free from the peritonealsurface of the lesser sac and to the right of the midline, the posteriorwall of the stomach is more adherent to the peritoneum of the lesser sacalthough the adherence is generally loose and the adhesions can bebroken up rather easily with gentle dissection.

The stomach is comprised of several layers. The inner layer is themucosa. The next layer is the submucosa followed by the outer muscularlayers. Surrounding the muscular layers is the serosal layer. This layeris important with regard to implants and healing because it is theadhesive layer of the stomach; that is, it is the layer which, whenbreached, heals with scar tissue formation. Implants adhering to thislayer are less likely, or not likely, to migrate into the stomachwhereas implants only placed in the mucosal or submucosal layers willmigrate. Reference to “stomach wall” or “wall of the stomach” as usedherein include the entire thickness of the stomach, including themucosa, submucosa, muscular layers, and serosa. The “anterior wall ofthe stomach” is the portion of the stomach closest to the muscularabdominal wall and the “posterior wall of the stomach” is the part ofthe stomach closest to the retroperitoneum.

“Transgastric fastening assembly” or “fastening system” refers to apermanent or semi-permanent implant and comprises at least one posterioranchor, at least one anterior anchor, and a connector to couple theposterior and anterior anchors. “Fastener” and “anchor” have theirordinary meaning and are used interchangeably in this disclosure. The“connector” can refer to any means of connection including but notlimited to a material connection, an electromagnetic or magneticconnection, or a chemical connection. As used herein, a “connector” is acoupler or linker used to materially connect the anterior and posterioranchors. As used herein, the “posterior anchor” is the anchor in apreferred embodiment which is adjacent to the posterior wall of thestomach when deployed. The “anterior anchor” is the anchor in apreferred embodiment which is approximated to the anterior wall of thestomach when deployed.

As used herein and when referring to portions of a surgical instrument,“proximal” refers to the end of the instrument which is closest to thesurgeon when the instrument is used for its intended purpose, and“distal” refers to the end of the instrument which is closest to thepatient and when the instrument is used for its intended purpose. Whenused to refer to the gastrointestinal tract, “proximal” is toward themouth and “distal” is toward the anus.

“Laparoscopic procedure” broadly refers to procedures which requirepneumoperitoneum and general anesthesia. “Percutaneous procedure”broadly refers to surgeries which do not require general anesthesia orpneumoperitoneum. These broad terms are mutually exclusive for thepurposes of the ensuing invention because the respective proceduresrequire different levels of patient preparation and peri-operativetreatments and therefore define specific embodiments. Similarly,“endoscopic procedure” refers to procedures that are performed entirelywith an endoscope. In some descriptions, the terminology “percutaneousmeans” is used which generically refers to placing a surgical instrumentthrough the skin of a patient and using the surgical instrument toaccomplish a surgical task; in this more generic case, “percutaneousmeans” can be used with or without laparoscopic means and inlaparoscopic procedures. Similarly, “laparoscopic means” genericallyrefers to procedures performed under the guidance of an internal cameraplaced through the abdominal wall (that is, percutaneous means); in thismore generic sense, laparoscopy can be used with or without percutaneousmethodology though in most cases percutaneous means are a requirementfor laparoscopic procedure. Similarly, endoscopic means refers toprocedures involving some level of endoscopic visualization but is notcompleted with the endoscope alone whereas “endoscopic procedure” refersto a procedure performed entirely through an endoscope. “Surgery,”“surgical procedure,” and “surgically created” have their ordinarymeaning and with regard to the inventions herein, is all-encompassing,and refers to laparoscopic surgery, open surgery, endoscopic surgery,and percutaneous surgery.

“Patient afferent pathway” refers to a pathway which transmits a signalto the sensorium of a patient; for example, the vagus nerve carriesafferent fibers to the hypothalamus and pain centers of the brain.“Patient end-effector pathway refers to a pathway which directly effectsa result in an end-organ; for example, stimulation of contraction in thestomach. Patient efferent and end-effector pathways can overlap andtherefore, the terms should not be considered mutually exclusive; forexample, stimulation of the stomach likely stimulates some nerve fibersthat travel to the sensorium and stimulation of the vagus nerve likelystimulates the stomach. “Device afferent pathway” refers to a pathwaywhich transmits a sensory signal to a restriction device; for example, asensor which senses food intake transmits its signal to the restrictiondevice through a device afferent pathway. “Device efferent pathway”refers to a pathway which transmits a signal from a restriction deviceto a separate structure (e.g. a device end-effector pathway describedbelow) or device (e.g. patient afferent pathway, a patient end-effectorpathway, or a device end-effector pathway). A “device end-effectorpathway” is a signal that directly effects a device state; for example,the connector of a transgastric assembly is shortened or the diameter ofa restriction band undergoes a change in its diameter size.

“Exogenous gastric feedback loop” or “exogenous satiety pathway” referto implantable systems which enhance the biologic pathways which alreadyexist in a patient (the endogenous feedback systems). For example, theVBG and the Lap-Band™ both “tell” the patient that he/she is “full,” andconsequently to stop eating. They induce a feeling of satiety throughdilation of the stomach proximal to the device (this is an example of anendogenous satiety pathway). Exogenous or enhancement of these pathwaysrefers to embodiments in which the satiety signal can be controlledand/or enhanced. For example, a sensor can be place on a restrictiondevice and then a pathway, such as vagal nerve stimulation, can beactivated in response to feedback from the sensor; therefore, satiety isinduced at an earlier stage than if the endogenous feedback systems(stomach dilation) were relied upon.

“Gastric volume reducing devices, procedures and systems” and “gastricrestriction devices, procedures and systems” have their ordinarymeanings and overlap in meaning when the walls of the stomach arebrought closer together. In these cases, all volume reducing proceduresand restriction procedures which bring the walls of the stomach closertogether necessarily overlap in meaning. “Gastric restriction devices”refer generally to any devices which restrict the stomach in some way.Included (but not limited to) are devices such as transgastric fasteningassemblies, laparoscopic bands (e.g. the Lap-Band™), and intragastricballoons.

“Constricting bands” or “restricting bands” have their ordinary meaningand also refer to gastric restriction devices which surround theproximal region of the stomach. The constricting bands cause weight lossby restricting the food intake of the patient. In many cases, therestricting bands are adjustable balloons which are adjustablepercutaneously by way of a port implanted at the time of surgery. Thesebands rely on the patient to inform the surgeon about eating habits anddiscomfort which may limit their utility because the patient can “cheat”themselves. Furthermore, the monthly or so follow up visits arepotentially too infrequent to be useful. “Gastric restriction system”refers broadly to the restricting devices including both adjustablebands and devices such as transgastric fastening assemblies.

Buoyancy is a physical principle and can be defined as the tendency orcapacity to remain afloat in a liquid or rise in air or gas. A devicewhich is less buoyant than its surroundings will tend to sink and adevice which is more buoyant than its surroundings will tend to floatrelative to its surroundings. A composite device can be more or lessbuoyant than its surroundings depending on the components of thecomposite. In some devices, buoyancy is adjustable. For example, aballoon filled with one fluid such as a liquid would tend to sink or benegatively buoyant in a surrounding fluid whereas the same balloonfilled with another fluid such as a gas would tend to be positivelybuoyant in a surrounding fluid. In one example, the device is filledpartially with gas and partially with liquid in which case it would tendto be positively buoyant relative to its surroundings depending on theamount of gas. Some devices can be positively buoyant with a materialsuch as a foam which traps a lot of gas inside. Some devices are morebuoyant than their surroundings even though one portion of the devicemay be less buoyant than its surroundings. For example, a compositedevice with a metal mesh in combination with an inflateable balloon. Inthis example, the composite can be positively buoyant while the metalmesh itself would be negatively buoyant. Buoyancy is intimately relatedto density although buoyancy refers to a device in combination with itssurroundings whereas density is an absolute measurement.

Furthermore, the following abstract presented at the 2007 SAGES meetingin Las Vegas, Nev. on Apr. 22, 2007 is incorporated into thisdisclosure. Associated slides and data are depicted in FIGS. 24-29.

ET012

-   -   STOMACH RESTRICTION WITH AN EXTRAGASTRIC BALLOON, Michael        Gertner MD, Stanford University    -   The objective of this developmental stage technology is        development of a gastric displacement device which resides        between the stomach and the abdominal wall. Because the        implantation procedure does not involve penetration of the        gastic wall and the device does not circumscribe the stomach and        apply a high pressure, it is anticipated that this device will        ultimately have an improved safety profile over the Lap-Band™.        This device is implantable with a modified PED procedure so that        minimal ansthesia will be required. The device was created by        dipping a plypropylene mesh into a medical grade silicone and        then forming the balloon over a semi-circular mold, implantation        of the balloon was performed by sliding the siliconized mesh        over polypropylene sutures. Position and restricting ability        were confirmed with a barium swallow. Pressure on the stomach is        accomplished with the balloon contracting the anterior portion        of the stomach with posterior support behind the stomach from        the retroperitoneum.    -   Over a 5 week period, increasing amounts of saling were added to        the balloon reaching a maximum of 100 cc at week 4. At the        higher balloon volumes, restriction of the stomach was noteable        on barium swallow. At 35 days, the balloon was still in firm        position. At necropsy, a capsule was noted around the balloon        and there was no evidence of erosion of the mesh or the balloon.        The device was easily removable after entrance into its capsule.    -   Ongoing work involves larger animal trials, a longer follow-up        period, and miniaturization of the device.

Transgastric Fastening Assembly

Referring to FIGS. 1A and 1B, one embodiment of the posterior anchor 14and connector 12 are shown in a deployed configuration (FIG. 1A), andreduced profile configuration (FIG. 1B). The connector 12 is preferablymade of a flexible, biocompatible polymer, but it can be made fromvarious kinds of suitable biocompatible materials known to those ofskill in the art including metals, such as titanium and platinum, metalalloys, such as stainless steel, nickel-titanium, and cobalt-chromium,man-made polymers, such as polyurethane, silicone elastomers,polyglycolic acid, polylactic acid, poly (C-caprolactone),polyvinylidene fluoride (PVDF), PTFE, FEP, polypropylene, or naturalfibers such as silk; bioartificial materials include allogenic andxenogenic collagen based products. These materials can be used singly orin combination (when the connector has two distinct components asopposed to one). For example, one portion of the connector may bebioabsorbable and another portion of the connector may be permanent; or,one part of the connector may be a sensor or active component, and theother part a coating. The connector can be continuous or discontinuous.The connector 12 can vary in thickness, shape, and rigidity. Forexample, in the embodiment shown in FIG. 1A, the connector 12 issubstantially rod-shaped, with a circular cross-section, and isflexible. Those of skill in the art will recognize that thecross-section of the connector can be any of a number of shapes, such assquare, hexagonal, oval, etc. In other embodiments, the connector 12 isthin and flexible, such as a surgical suture, and in still others it isrigid to like a guiding rail for an anchor which travels over the rail.The connector can have a thickness ranging from 100 microns (e.g.suture) to several millimeters depending on the application. Although asingle connector is depicted as being attached to the posterior anchor,those skilled in the art will recognize that more than one, or severalconnectors can be connected to the anchor at different points on theanchor or as a combination attached to one point on the anchor (e.g. abundle). In some embodiments, the connector is made from athermoresponsive material such as a thermoresponsive polymer or metalsuch as shape memory alloy (e.g. nickel-titanium alloy). In otherembodiments, the connector is composed of at least one material whichconducts an electrical current through from the anterior anchor to theposterior anchor or from the posterior anchor to the anterior anchor.

In a preferred embodiment, the posterior anchor 14 is made from abiocompatible, radio-opaque, or magneto-opaque semi-rigid polymer; itcan also be made from various kinds of suitable materials known to thoseof skill in the art including metals, metal alloys, plastics, naturalmaterials or combinations thereof as discussed above in relation to theconnector 12. In some embodiments, the anchor is made from a conductivematerial and in other embodiments the anchor is made from a combinationof conducting, non-conducting, and/or semi-conducting materials. Theposterior anchor 14 can be solid, or alternatively, can be porous,mesh-like, lattice-like, or umbrella-like. In some embodiments, theanchor contains a potential space on the inside which can be expanded bya fluid (e.g. gas or liquid). In a preferred embodiment, the posterioranchor is porous or has a porous mesh attached to it to encouragefibrous ingrowth such that it becomes permanently attached to thestomach or intestinal wall. Coatings can be added to the anchor toencourage tissue ingrowth; of course, such coatings do not limit theability for the interior of the anchor to be a potential space forexpansion by a fluid. In other embodiments, the posterior anchor issolid and/or treated to discourage tissue ingrowth (e.g. with a siliconecoating). In other embodiments, the posterior anchor has a xenograft orallograft material attached to the anchor. In a preferred embodiment,the posterior anchor 14 is disc-shaped, but those of skill in the artwill recognize that other embodiments are possible, such as those shownin FIGS. 1C and 1D, or disclosed in U.S. Patent Application PublicationNo. 2004/0122456 which is herein incorporated by reference; noteparticularly the description of anchor structures. The posterior anchor,in other embodiments, can be rectangular or diamond shaped. Theposterior anchor can also be bioabsorbable in whole or in part in someembodiments. The largest dimension of the posterior anchor can rangefrom less than 1 mm to about 15 cm depending on the application and themanner in which it is implanted (see below). In the case where theposterior anchor is a disc shape, the diameter is considered the largestdimension.

In the embodiment shown in FIGS. 1A and 1B, the connector 12 is fastenedto the posterior anchor 14 at an attachment point 16 which is preferablya permanent, e.g. welded or molded, connection. Such a weld orconnection can comprise, for example, a thermoformed polymer, a metallicweld, or a molded or other integral structure. In a preferredembodiment, a biocompatible thermoformed polymer is used because of itsflexibility and ability to yield to the continuous motion of thestomach. More preferably, the connector and posterior anchor areproduced as a single, continuous structure (e.g. through an injectionmolding process).

Other suitable means of fastening the connector to the posterior anchorare also contemplated and do not necessarily result in a connector andposterior anchor becoming permanently attached. For example, in oneembodiment shown in FIG. 1C, one end of the connector is passed througha hole 20 near the center of the posterior anchor 22, and a stop 24,such as a knot or enlarged molded region, is formed on the end of theconnector to prevent its passage back through the hole in the posterioranchor. In this embodiment, the posterior anchor 22 can be free to movealong the length of the connector 26, but is prevented from beingremoved from one end of the connector by the stop 24.

In the embodiment shown in FIGS. 1A and 1B, the posterior anchor 14preferably has a deployed configuration (FIG. 1A), and a reduced profileconfiguration (FIG. 1B). The posterior anchor 14 can be deformed to afolded configuration wherein its profile is reduced to facilitateinsertion of the anchor through a laparoscopic port or through the wallsof the stomach or other tissue as described in more detail below. In oneembodiment, the posterior anchor 14 is made of a semi-flexible materialhaving shape memory, so that once the anchor is deployed within thepatient, it will return to its original shape shown in FIG. 1A,preventing it from being easily pulled back through the tissue.Preferably, the posterior anchor is inflatable in place of, or inaddition to, having shape memory, which allows for a much largerdeployed profile relative to its undeployed profile (see below). In oneembodiment, the anchor can have both shape memory as well asinflateability in which case it can be made more or less buoyant thanthe surrounding tissue. For example, in one embodiment, the anchor canbe inflated with a liquid, a liquid and a gas, or just a gas dependingon the buoyancy desired within the system. In some embodiments, theshape memory is activated by passing a current through the material. Insome embodiments, the posterior anchor contains an intrinsic magnetic,ferromagnetic, electromagnetic, piezoelectric, paramagnetic,magnetorheologic or other electrically or thermally adjustable materialand can apply a force to another part or portion of the anchor assembly;for example, an electroactive polymer or a metal such as nitinol can beused. These materials can also serve as components of sensors (e.g.strain, pressure, tension, stress, accelerometry). In some embodiments,the posterior anchor contains electrodes placed at the surface of thematerial such that they integrate with the organ they contact (e.g. thestomach).

FIGS. 1D and 1E show an alternative embodiment of the posterior anchor30 and connector 32 in a deployed configuration (FIG. 1D) and a reducedprofile configuration (FIG. 1E). In this embodiment, the posterioranchor 30 is elongated, having major and minor dimensions, andpreferably having a rod or bar shape. By aligning the connector 32substantially parallel to the posterior anchor 30, its profile isreduced to facilitate insertion of the anchor through the walls of thestomach or other tissue. When the anchor leaves its surrounding sheath(see below), tension on the connector 32 in the direction of the arrowin FIG. 1E will urge the posterior anchor 30 into a substantiallyperpendicular orientation relative to the connector 32, as shown in FIG.1D, preventing it from easily being pulled back through the tissue. Theconnection between the posterior anchor 30 and the connector 32 can behinged. Alternatively, the connector 32 can be made of a semi-rigidmaterial which is permanently connected or welded to the posterioranchor 30. If the connector is deformed to a bent position, shown inFIG. 1E, it will return to its original straight shape shown in FIG. 1Donce the anchor is deployed within the patient, preventing the posterioranchor from easily being pulled back through the tissue. This anchor 30can be inflatable as well, which allows for a much larger deployedprofile relative to its undeployed profile.

In a preferred embodiment, shown in FIGS. 1F and 1G, the posterioranchor is inflatable. The anchor has an inflatable disc-shaped body 34which is readily deformable when in its reduced profile (e.g.,uninflated) configuration as shown in FIG. 1F. In the preferredembodiment, the posterior anchor body 34 is disc-shaped, but those ofskill in the art will recognize that other embodiments are possible,such as those shown in FIGS. 1C and 1D, or in which the inflatableanchors are square shaped, rectangular, or amorphous, or have a shapedisclosed in U.S. Patent Application Publication No. 2004/0122456 whichis herein incorporated by reference; note particularly the descriptionof anchor structures. The body can be inflated with a substancedelivered through a hollow connector 35. When the interior space 36 ofthe anchor body is inflated, the anchor assumes its deployedconfiguration shown in FIG. 1G. Once the body is inflated, it can becomesubstantially less compliant yet remain soft and pliable. The anchor canbe inflated from its reduced profile to its deployed profile. The sizeof the reduced profile can be less than 1 cm or less than 5 mm and thesize of the deployed profile can range from 1 cm to greater than 5 cm orgreater than 10 cm. In the reduced profile, the anchor can fit into aconduit having a length inside the conduit which is longer than it widthso as to fit through the conduit.

The inflatable posterior anchor can have a valve 38 located between theanchor body 34 and the connector 35. Alternatively, the valve is locatedin the portion of the connector located outside the patient, the valve(e.g. stopcock type valve) being controlled by the operator until theanterior anchor is placed (see below). In this alternative embodiment,the filling substance is trapped in the posterior anchor after theanterior anchor is deployed and the connector is cut and sealed,preferably flush with the anterior anchor (see below). The fillingsubstance can be a gas, liquid, or material which changes phase withtime (i.e. it may harden, cure, polymerize, or become a gel with time).Other materials such as magnetorheologic fluids (for example, magneticparticles immersed in an oil) can be used as well and such fluids wouldinterface with the electrical systems described below. Preferably, thesurface of the posterior anchor adjacent to the posterior wall of thestomach has a mesh fixed to it to encourage tissue ingrowth. In someembodiments, part or all of the anchor material is comprised of abiodegradable material.

In some embodiments, the anchor assembly and in particular the posterioranchor and connector combination are used for “extragastric volumereduction” of a region of the stomach (see below for more detail). Inthis embodiment, the posterior anchor can be adapted to be anextragastric restriction device and the anterior anchor-connector systemis used for fixation of the device to the abdominal wall. In thisembodiment, it may be desirable for the extragastric restriction deviceto have a shape that conforms to an area of the stomach such as the GEjunction. The connector can serve as a conduit to fill the extragastricballoon and can further be equipped with a valve to fill theextragastric balloon and prevent leaking of its contents. The transversewidth of the GE junction is typically 0.5 cm to 10 cm in almost theentire population and 1 cm to 5 cm in the majority of the population.The extragastric balloon should be shaped such that it can surround180-270 degrees of the GE junction or from 90 degrees to 360 degrees. Insome embodiments, the balloon can completely surround the GE junctionand in these embodiments, the balloon can be continuous ordiscontinuous.

In some embodiments, the extragastic restriction device is filled withgas, liquid, a gel, or a combination of these fluids. As describedbelow, the extragastric compression device can have multiplecompartments and each can be filled with a gas, liquid, or a combinationof liquids and gases.

FIG. 1H depicts another embodiment of posterior anchor of the currentinvention. The posterior anchor 37 and the connector 39 are separable inthis embodiment. In one embodiment, the first connector has an innerdiameter with a second connector (e.g. a suture) traveling through itslumen. A second connector 33 is disposed within the first connector 39.The second connector 33 can be one or more sutures for example. Thisfastening assembly would be used in a laparoscopic procedure where theconnector 39 would be placed through an organ before engaging theposterior anchor 37. In some embodiments, the posterior anchor can be aslarge as the width of the organ (e.g. 8-10 cm in the case when the organis the stomach). In some embodiments, the anchor 37 can be as small as 5mm or 1 cm. The anchor 37 can also be adapted to accommodate severalconnectors (FIGS. 15 c-d) rather than one connector at a time. The firstconnector 39 is adapted to engage the posterior anchor 37 after passingthrough tissue (e.g. the stomach). After contact between the outerconnector 39 and the posterior anchor 37, the outer connector 39 isremoved, leaving the inner connector 33 (e.g. the suture or sutures)attached to the posterior anchor 37 (FIG. 1J). The connection of thesuture to the posterior anchor is accomplished by any mechanical meanswell known to those skilled in the art.

FIG. 1L depicts another embodiment of the current invention in which theconnectors 47 in this embodiment are configured so that their length orlengths is/are adjustable. In an example of this embodiment shown inFIG. 1L, the connector is split (e.g. two sutures are used). The housing45 is attached to one half of the connector 47 and this half of theconnector is attached to the posterior anchor 49. Within housing 45, theconnector 47 can be shortened (and the tension between the two anchorsincreased) by turning inner cylinder 48 which changes the distance (andthe tension on the connector) between the two anchors 49, 51. In anotherembodiment, a solenoid based motor system can adjust the pulley andchange the length of the connector 47. Such adjustment can be done withan endoscope or can be done automatically with a wireless basedtransmitting system; in this embodiment, the implanted anchor assemblywill have an integral source of power and a controller system. Theadjustment can be done after (e.g. days, months, years) implantation ofthe fastening system within an organ such as the stomach.

Although FIGS. 1 a-l depict a single connector contacting the posterioranchor, those skilled in the art will recognize that more than oneconnector can be used to contact the posterior anchor. The more than oneconnector can be placed in any arrangement along the posterior anchor(e.g. in a row, in a pattern along the perimeter, or concentrated in thecenter). The more than one connector can be bundled and attached in oneplace on a second anchor or in multiple points on a second anchor. Inthe embodiments where the posterior anchor is an extragastricrestriction device, the connectors fix the anchor to the abdominal wallwith additional anchors with the abdominal wall fascia.

Other methods of introducing adjustability of the transgastric anchorassembly exist as well and are useful in some embodiments. For example,the suture can be produced from a material such as nickel-titaniumalloy, the tension of which can be adjusted with an electrical currentor other means of introducing a temperature increase in the alloy. Insome embodiments below, the tension of the nickel-titanium alloy can beadjusted depending on an input parameter such as for example, the outputfrom a sensor integral to a gastric restriction device (see below formore detail). In another embodiment, a nickel-titanium alloy is a novelcomponent of a restricting band such as the Lap-Band™ (see below) or anextragastric restriction device which does not completely surround thestomach. In some embodiments, both a transgastric assembly and arestricting band are implanted in the patient and in some embodiments,the transgastric fastening assembly has an adjustable nitinol connectorand in other embodiments, the restricting band has a nitinol ring whichis adjustable via electrical means. In some embodiments both thetransgastric anchor and the restricting band both have adjustablenitinol components. Alternative electroactive materials includeelectroactive polymers.

In any of the embodiments above, the connector can serve as a sensor todetect the tension imposed on it by the two fasteners moving in oppositedirections. In embodiments where the connector serves as a sensor, theconnector can be composed of one or more different materials. One of thematerials can be a sensor or sensing material and the other serves as amaterial for mechanical strength. For example, a piezoelectric straingauge can be used as a strain sensor as can an electroactive polymer. Asdiscussed below, the connector (sensor) can serve as the afferent(device afferent) limb of a feedback loop. The efferent (deviceefferent) pathway of the feedback loop can be an electrical lead, whichcommunicates with, and stimulates a pathway such as the vagus nerve(patient afferent pathway), a sympathetic pathway such as the celiacplexus, or a device efferent pathway which (for example) can adjust thedegree of gastric volume reduction or restriction. When some or all ofthese efferent (neural and mechanical) pathways are stimulated, afeeling of satiety can be created and controlled in a patient. Suchpathways may decrease or eliminate problems with constricting band andstapled gastroplasties because they offer solutions to decrease theamount of pressure applied by the devices to the stomach until thepressure is needed (when the patient is eating for example). Suchmethods and devices can potentially decrease the problems with erosionand reflux. Furthermore, the adjustment of the device can be taken outof the hands of the patient and controlled by the device and thesurgeon. Furthermore, battery power can be conserved by apply electricalstimulation only when the patient is eating.

In an embodiment, the connector (or part of the connector) can take theform of a strain gauge in which a potential is generated which isproportional to the tension (stress) applied to it. The strainmeasurement in the connector can be transmitted wirelessly or through awired connection to an effector limb (patient or device efferentpathway) of the circuit or to an external receiver. In otherembodiments, the strain measurement is transmitted through a wiredcircuit (e.g. from the strain gauge directly to the efferent pathway ofthe feedback loop). In one example, the strain gauge is an electricallyactivateable polymer (electroactive polymer); in a separate embodiment,the efferent end of the feedback loop is also an electroactive polymer;in other embodiments, both the afferent and efferent limbs of thefeedback system are made from electroactive polymers. In someembodiments, the efferent effector pathway is stimulation of the stomachwall surrounding the fasteners or the stomach wall in a place somedistance away from the transgastric fastener assembly such as theperi-pyloric region. Stimulation of a patient end-effector (e.g. thestomach) pathway can be transmitted through the fastener itself orthrough a separately attached electrode.

In an alternative embodiment, the efferent limb of the feedback loop isan electrical lead which communicates with a cutaneous stimulator tonegatively enforce excessive feeding behavior. In this embodiment,feedback to the patient is not necessarily a satiety signal but acutaneous feedback signal which alerts the patient to an overfeedingstate. In another embodiment, the feedback pathway is a computeralgorithm which alerts the patient that they are overeating or saves thedata until sometime in the future, then printing out the data for thepatient or the physician. In other embodiments, the efferent limb of thefeedback system generates loud sounds or vibrations.

The algorithm between the afferent and efferent pathway can be a simpleone in which the efferent pathway has an on or off status depending onthe level of stimulation from the afferent pathway. Alternatively, therelationship between the afferent and efferent pathways is non-linear.For example, as the strain increases, the efferent signal increases two-three- or fold. If the strain increases further, the efferent signal canincrease in an exponential manner (for example, eight to ten-fold).Other patterns are possible as well and these patterns can be programmedinto the controller or signal generator and represent the algorithmicaspects of the stimulation system. Nevertheless, the relationshipbetween inputs and outputs of the system can be programmed from alocation external to the devices and system (e.g. the surface of thepatient or a remote location such as a physician's office).

FIGS. 2A (perspective view) and 2B (plan view) show an embodiment of theanterior anchor 40. The anterior anchor has a disc-shaped body 42 with ahole or other passageway 44 substantially in the middle of the body.Although the hole is shown in the center of the anchor, those skilled inthe art will recognize that the hole can be placed anywhere along theface of the anterior anchor and/or more than one hole can be created inthe anchor. Two or more gripping elements 46 project into the center ofthe hole or other passageway. With respect to the gripping elements,there can be as few as one or more than two. The gripping elements cancircumscribe the entire opening or they can be discrete components likekeys or ridges with a pitch 46. The gripping elements can be macroscopicas shown in FIG. 2A or they can be microscopic like sandpaper (notshown). The gripping elements may have teeth 50 angled toward the topsurface of the anchor. Optionally, two hooks 52, or other graspablerecesses, appendages, or structures, are located on the top surface ofthe anterior anchor. Hooks 52 allow for attachment of a surgicalinstrument during deployment of the anterior anchor in the patient asdescribed below. Alternatively, there can be none, one, two or more thantwo graspable recesses, appendages, or structures on the top surface ofthe anchor. In the preferred embodiment, the anterior anchor body 42 isdisc-shaped, but those of skill in the art will recognize that otherembodiments are possible, as disclosed in U.S. Patent ApplicationPublication No. 2004/0122456 which is herein incorporated by reference;note particularly the description of anchor structures. The anterioranchor (or the transgastric fastening assembly) can also be whollycomprised of or only partially comprised of one or more magnetic,magnetorheologic, or electromagnetic components. In these embodiments,an electric current is applied to the anchors which either causesattraction of the anchors (e.g. when the anchors containelectromagnets), or results in an increase in the viscosity within theanchors resulting in a resistance to the flow of food (magnetorheologicembodiment). Alternatively, in other embodiments, the anterior anchor(or the transgastric fastening assembly) carries one or more weightswithin it such that gravity causes the intestinal walls to come together(and provide a resistance to food) as a result of the weights within theanchors. In other embodiments, the anchor is made at least in part froman electroactive polymer.

FIGS. 2C and 2D are cross sections of the anterior anchor of FIGS. 2Aand 2B taken along the line B-B in FIG. 2B. FIG. 2C shows the anterioranchor in its deployed configuration with the connector 12 of FIG. 1Apassing through the hole or other passageway 44 in the body of theanchor. In the deployed configuration, the gripping elements 46 andteeth 50 engage the connector 12 with sufficient pressure to preventmovement of the anchor along the connector 12 in the direction of thearrow in FIG. 2C, which would increase the distance between the anterioranchor and posterior anchor (not shown). In the case where the connectoris a suture, the surface of the suture can be roughened to enablegripping by the anchor. In FIG. 2D, the anterior anchor 40 is in itsreduced profile configuration with the connector 12 of FIG. 1A passingthrough the hole or other passageway 44 in the body of the anchor.Preferably, the anterior anchor is made of a semi-rigid polymer whichallows the anchor to be deformed into a substantially foldedconfiguration illustrated in FIG. 2D. When in this configuration, thegripping elements 46 and teeth 50 do not significantly engage theconnector 12. This allows movement of the anterior anchor 40 along thelength of the connector 12 in the directions illustrated by the arrowsin FIG. 2D. Once the anterior anchor is in the desired position alongthe connector 12, the anterior anchor is permitted to return to theconfiguration shown in FIG. 2C, and the gripping elements 46 and teeth50 engage the connector 12, thus preventing movement between theconnector 12 and the anterior anchor 40. Importantly as described abovein some embodiments, the anterior fastener is slideable along theconnector in a reversible fashion. For example, when the fastener iscompressed to its undeployed configuration from its expandedconfiguration, the fastener can once again move (or be moved) along theconnector. This feature may be a highly desirable one as it will allowfor adjustability after deployment of the fastener because the processcan be reversed and the fastener repositioned.

In an alternative embodiment, it is contemplated that the connector 12can have notches 51, which interact with gripping elements 46 in aratchet-and-pawl mechanism similar to that used in cable ties, providinga one-way adjustability, in which the posterior and anterior anchors canbe moved toward each other, but not away from each other.

FIGS. 2E and 2F illustrate another embodiment of an anterior anchor 60which is similar to the one illustrated in FIGS. 2C and 2D. In FIG. 2E,the gripping elements 62 and teeth 64 are oriented so that the anterioranchor can be deformed such that the top surface of the anchor is foldedinward as illustrated in FIG. 2F. This is in contrast to the embodimentillustrated in FIG. 2D where the bottom surface of the anchor is foldedinward. The teeth 64 in FIG. 2E are angled toward the top surface of theanterior anchor and engage the connector 12 of FIG. 1A such that theyprevent movement of the anterior anchor along the connector 12 in thedirection of the arrow in FIG. 2E, which would increase the distancebetween the anterior anchor and posterior anchor (not shown).

FIG. 2G is a perspective view of a preferred embodiment where theanterior anchor is inflatable. The anterior anchor is inflatable from areduced state of approximately 5 mm or 1 cm to greater than 5 cm togreater than 10 cm. The anterior anchor has a hollow, inflatabledisc-shaped body 65 with a hole or other passageway 66 substantially inthe middle of the body to track the connector. Two gripping elements 67project into the center of the hole or other passageway, although therecan be as few as one or more than two gripping elements. The grippingelements can have teeth 68 angled toward the top surface of the anchor.Alternatively, in a preferred embodiment, the gripping elements are inthe form of a rough surface rather than the protruding elements as shownin FIG. 2G. Such a surface, which may be a sandpaper-like surface,creates enough friction to prevent movement in either direction alongthe connector. Optionally, two hooks 69 are located on the top surfaceof the anterior anchor. Hooks 69 facilitate grasping by a surgicalinstrument during deployment of the anterior anchor in the patient asdescribed below. Alternatively, rather than hooks, there can be one ormore graspable protrusions on the body. In yet another embodiment, thereare no hooks or graspable protrusions, and the body of the anchor isgrasped directly to manipulate the anchor. In another embodiment,protrusions 69 are magnetic or otherwise sticky (e.g. Velcro) in natureto facilitate attachment to a surgical instrument.

An inflation tube 63 is used to inflate and deflate the anterior anchor.This inflation tube may or may not have a valve. In one preferredembodiment, the anterior anchor is filled with gas or fluid through theinflation tube and the fluid is held inside the anchor through anexternal (e.g. stopcock) valve controlled by the operator. When theinflation tube is cut at the end of the procedure, the inflation line iscrimped closed thereby locking the inflating substance inside theanchor. Alternatively, the shears used to cut the inflation line can bemetal and an electrocautery current can be applied through the shearsand to the inflation line to weld it closed.

FIGS. 2H and 2I are cross sections of the anterior anchor of FIG. 2G,taken along the line D-D in FIG. 2G. The disc-shaped body 65 is readilydeformable when in its reduced profile (i.e., uninflated) configurationas shown in FIG. 2I. The body can be inflated with a substance deliveredthrough the inflation tube 63. When anchor body is inflated, the anchorassumes its deployed (i.e. inflated) configuration as shown in FIG. 2Hwith the connector 12 of FIG. 1A passing through the hole 66 in the bodyof the anchor. In the deployed configuration, the gripping elements 67and teeth 68 engage the connector 12 with sufficient pressure to preventmovement of the anchor along the connector 12 in the direction of thearrow in FIG. 2H, which would increase the distance between the anterioranchor and posterior anchor (not shown). Alternatively, rather thandefined gripping elements and teeth, the surface of body which definesthe sides of the hole or other passageway 66 can be configured such thatwhen the anchor body is inflated, the sides of the hole or otherpassageway expand to substantially close off the hole or otherpassageway and limit movement of the anchor relative to the connectorthrough friction between the connector and the anchor.

In FIG. 2I, the anterior anchor 65 is in its reduced profile (i.e.uninflated) configuration with the connector 12 of FIG. 1A passingthrough the hole 66 in the body of the anchor. When in thisconfiguration, the anchor body is readily deformable and the grippingelements 67 and teeth 68 do not significantly engage the connector 12.This allows movement of the anterior anchor 65 along the length of theconnector 12 in the directions illustrated by the arrows in FIG. 2I.Once the anterior anchor is in the desired position along the connector12, the anterior anchor is inflated by a filling substance deliveredthrough the inflation tube 63 and the anchor assumes its deployed (i.e.inflated) configuration as shown in FIG. 2H; the gripping elements 67and teeth 68 engage the connector 12, thus restricting movement of theanterior anchor 65 in one or both directions along the length of theconnector 12. The filling substance can be a gas, liquid, or materialwhich changes phase with time (i.e. it may harden, cure, polymerize, orbecome a gel with time). In some embodiments, the filler substance is amagnetorheologic fluid the viscosity of which can be changed with amagnetic field (e.g. it can be turned on or off).

FIG. 3A illustrates another embodiment of an anterior anchor 70consisting of two parts, an anchor body 72 and a readily deformablecollar 74. The anchor body and collar have a central hole or otherpassageway (76 and 78 respectively) through which the connector canpass. Preferably, the anterior anchor body is made of a semi-rigidpolymer which can be deformed into a folded configuration with a reducedprofile as illustrated in FIG. 3B. The collar can be referred to as aframe or anchoring frame in some embodiments. Preferably, the readilydeformable collar 74 is permanently deformable; i.e., once deformed, itdoes not return to its original shape. As illustrated by the arrow inFIG. 3B, both the collar 74 and anchor body 72 can move along theconnector 12 of FIG. 1A. Once the anchor body 72 is in the desiredposition, the collar or frame 74 is crushed, such that the collar 74engages the connector 12 and can no longer move along the length of theconnector 12. This prevents the anchor body 72 from moving along thelength of the connector 12 in the direction of the arrow illustrated inFIG. 3C, which would increase the distance between the anterior anchorand posterior anchor (not shown). FIG. 3D illustrates an alternativeembodiment of the anterior anchor 80, where the anchor body 82 anddeformable collar 84 are a single piece.

In this method, the anchoring frame can be placed inside the abdomen tocontact the stomach or abdominal wall. The frame can be passed over aconnector, rail, or suture and the locked against the stomach orabdominal wall. The anterior anchor can comprise a material which isless compliant than another region of the anchor, leading to adirectionality of movement as the anchor is inflated.

In a preferred embodiment, the anterior anchor is made from abiocompatible, radio- or magneto-opaque polymer, but it can also be madefrom various kinds of suitable materials known to those of skill in theart including metals, metal alloys, plastics, natural materials orcombinations thereof as disclosed above; the anchor material can also bea biodegradable material. The anterior anchor can be solid, oralternatively, can be porous, mesh-like, umbrella-like or lattice-like.

In a preferred embodiment, the anterior anchor is porous, mesh-like,umbrella-like or lattice-like to encourage fibrous ingrowth such that itbecomes permanently attached to the stomach wall. Coatings can be addedto the anchor, or a mesh material such as polypropylene can be fixed tothe anchor surface, such that it touches the anterior stomach wall andencourages tissue ingrowth. In other embodiments, the anterior anchor issolid and treated to discourage tissue ingrowth with materials such assilicone, PTFE, or FEP which are generally hydrophobic and non-reactive.In one embodiment, one side of the anchor is produced from PTFE and theother side of the anchor is produced from polypropylene. In otherembodiments, the anterior anchor has a xenograft or allograft materialattached to the anchor which can encourage tissue ingrowth. In apreferred embodiment, the anterior anchor is disc-shaped andsubstantially flat, but those of skill in the art will recognize thatother embodiments are possible; for example, the anterior anchor can beelongate and/or continuous and can range in size from 5 mm to 10 cm, inwhich case, it can traverse the length or width of the stomach. Asdescribed below, this anchor can be used as an extragastric restrictiondevice with one or more compartments or materials attached. Its buoyancycan be changed by these one or more materials or the buoyancy can bechanged by different amounts and/or combinations of fluids within theanchor.

In some embodiments, a system is described in which the multiple anchorsare connected by the connectors and the multiple anchors each have acharacteristic buoyancy depending on the combination of materials and/orfillers inside. This configuration can add flexibility to the system aseach anchor can be placed on different regions of the stomach. In someembodiments, the combination of anchors and connectors forms a ringaround the stomach or traverse the stomach from anterior to posterior.

In some embodiments, the anterior anchors can have electrodes which cancommunicate electrically with a tissue (e.g. the stomach) after theanterior anchors are positioned in contact with the tissue (e.g. thestomach). The electrodes can pass through the material to communicateelectrically with the connector traveling through the anterior fastener.The electrodes can communicate with other effector pathways (e.g. thevagus nerve or the muscle of the stomach) located at different anatomicregions from the anterior fastener. The electrodes can travel with oralong the connectors, delivering current to the anchors or the tissuesurrounding the anchors.

In any of the above embodiments, the anterior and posterior anchors aswell as the connector can have one or more magnets (electromagnetic,paramagnetic, magnetorheologic, or ferromagnetic materials) disposedwithin or on their surfaces. Such magnet can serve a variety ofpurposes. In one example, the magnets serve as actuators to forcefullymaintain the walls of the stomach together through their inherent andcontinuous (or discontinuous in the case of an electromagnet) magneticinteraction. In other embodiments, the magnets serve as sensors to sensethe amount of food taken in by a patient; in this embodiment, a changein a magnetic field (relative movement of the magnets) is detected as aninductive current and can be correlated to food intake. Such sensingmechanisms are well known in the mechanical arts. In another embodiment,the anchors contain a magnetorheologic fluid which can respond to anelectrical current. When stimulated with a magnetic field, themagnetorheologic fluid will undergo a change in viscosity and create amore or less compliant anchor or connector. In this embodiment, onceelectrically charged, the increase in viscosity will enhance the effectof the anchors in creating restriction or volume reduction (or both) ofthe stomach (for example).

Creation of an Anastomosis Between Two Body Lumens

The above devices and methods can further be adapted to create aconnection or an anastomosis (such as a gastrojejunostomy,jejunojejunostomy, or ileocolostomy) between two body lumens. Agastrojejunostomy is the major anastomotic component of the Roux-n-Ybypass procedure, the jejunojejunostomy being the second component.FIGS. 3 e-g depicts the cardia and fundus 88 region of a stomach. Anelongate tube, commonly referred to in the medical arts as a nasogastrictube 90, is adapted to serve a similar function to the connectorsdescribed above, the “nasogastric connector”; the nasogastric tube canfurther have one or more independent lumens 100 which are fixed ortranslateable with respect to the other lumen 90 or lumens 100 and thenfixable with respect to the other lumens. The proximal end of theelongate tube is accessible to an operator outside a patient and thedistal end of the elongate tube is manipulateable via the proximal endof the elongate tube 90.

The lumens (90, 100) can communicate with expandable elements or anchorsalong the connector and/or communicate with the gastrointestinal lumen.In one embodiment, one lumen communicates with one expandable element,and another lumen communicates with another expandable element on theelongate structure. In a further embodiment, an additional lumen (notshown) in the elongate structure communicates with the region betweenthe expandable elements so that the quality of a connection between thetwo body lumens can be interrogated.

An expandable element 92 is further associated with the distal end ofthe connector 90. As described above, the expandable element, or anchor92, can expand from an undeployed, to a deployed state, where thediameter of the tube in the deployed state is larger than the diameterof the tube in the undeployed state. Any of the materials, devices,and/or configurations mentioned above can be used in this embodiment. Inthis embodiment, a hole (e.g. enterotomy) in the body lumen 94 iscreated by a surgeon during a surgical procedure with or withoutassistance from the elongate structure; the enterotomy is approximatelythe size of the undeployed expandable element 92.

A second surgically created enterotomy 98 in a portion of a second bodylumen (for example, small intestine) 98 allows for theconnector-nasogastric tube to be further placed into the small intestine98. The diameter of the connector-nasogastric tube 98 defines theultimate diameter of the anastomosis between the stomach and the smallintestine. Typically, in the Roux-en-Y procedure, the diameter of theanastomosis is very difficult to define accurately. The diameter of theconnector-nasogastric tube can therefore be chosen to satisfy apre-specified requirement for the diameter of an anastomosis. Theexpandable element 92 is then expanded in the small intestine and servesto enable the small intestine to be urged against the stomach 88. Asdescribed above, the expandable elements can be produced from any of anumber of materials including shape memory materials, balloons, magnets,etc.

A second expandable element 99 (FIGS. 3G-H) is slideable along thenasogastric tube connector. In one embodiment, a separate lumen 100 cancommunicate and control the second expandable element 99. The separatelumen 100 can be slideable with respect to the first lumen of thenasaogastric tube 90 and is also lockable with respect to the firstlumen so that the first and second lumens (and therefore the first andsecond exapandable elements cannot slide with respect to each other).The individual lumens can be locked at the proximal end of thenasogastric tube-connector by the operator. Alternatively, the separatelumen 100 can be fixed with respect to the first lumen and the secondexpandable element 99 is itself slideable and lockable along theseparate lumen 100; the second expandable element 99 can communicatewith the separate lumen 100 for actuation into the expanded state. Oncethe first and second expandable elements are expanded, the body lumens(e.g. small intestine and the stomach) can be urged toward one anotherin compression 102 as shown in FIG. 3 g.

After the urging step, the nasogastric connectors or lumens can be fixedwith respect to one another so that compression 102 is applied betweenthe two expandable elements and hence between the serosa of the two bodylumens. The nasogastric connectors can be fixed temporarily (e.g. duringapplication of an adhesive 106) or more permanently (e.g. 3-7 days aftera procedure) with respect to one another depending on the method ofcreating an anastomosis between the two body lumens.

In one method of creating the anastomosis between body lumens, theexpandable elements (92, 99) are comprised of magnets or electromagnetswhich attract one another. In this embodiment, the nasogastricconnectors can be fixed by virtue of the magnets attracting one another,maintaining the nasogastric connectors fixed with respect to one anotherwith the body lumens in between. In another embodiment, the expandableanchors are held fixed with respect to one another by virtue of thelumens of the nasogastric connectors being fixed with respect to oneanother (described above). The amount of compression created by any ofthese embodiments can be sensed with a tensiometer via the nasogastricconnector or connectors. The compression between the body lumens can beapplied for any period of time in order to produce an anastomosis. Forexample, the compression can be applied for a period of time during anoperation when an adhesive 106 or sutures are applied to the apposedbody lumens. Alternatively, the compression is applied over a longerperiod of time to allow for natural healing (natural compressionanastomosis) of the anastomosis (e.g. 3-7 days). During a 3-7 day timeperiod, the patient can be fed through a lumen of the nasogastricconnector 90. A 3-7 day time period is long enough to allow for healingof an anastomosis or a leak from an anastomosis. With the currentembodiment, the degree of compression of the anastomosis can be definedby a tensiometer.

In another embodiment (FIG. 3I), an additional element 104 is appliedover the nasogastric connector or near the connector but around theapposition of the body lumens. This additional element 104 is applied tothe nasogastric connector during the surgical procedure or is acomponent of the nasogastric connector when it is placed into the bodylumens. The purpose of this additional element 104 is to facilitateconnection between the body lumens. In this capacity, element 104 can beadhesive in nature or can be activated to be adhesive in nature. Thiselement can be magnetic, paramagnetic, or ferromagnetic, potentiallyenhancing the magnetic power between the other two elements, 92, 94. Inone example, the adhesive element 104 is compatible with a tissue glue(e.g. cyanoacrylate, fibrin glue, polyethylene glycol based sealants,and glutaraldehyde based sealants) to enhance bonding to the outerportions of the body lumens. In one example, cyanoacrylate, was appliedto SIS™ (Surgisis; Cook Corp, Indianapolis, Ind.) after compression wascreated with a nasogastric connector. The burst pressure of theanastomotic connection was 59 mm of mercury and the anastomosis wascreated in three minutes.

In other embodiments, element 104 is responsive to activation by anelectromagnetic means such as radiofrequency energy or optical energy.In some embodiments, the material of the element is chosen to facilitateadhesion. Examples of such materials include biomimetic materials (seeabove) or adhesive nanomaterials (for example, US patent application20040250950 to Dubrow et. al. which describes devices comprisingsuperadhesive nanomaterials which can be used in this embodiment andherein incorporated by reference).

In some embodiments, element 104 is a sensor which, when in place, candetect the strain or stress of a peristaltic wave or a food boluspassing through the anastomosis. In other embodiments, element 104 is anadjustable restriction device, an electrical stimulator, or a componentof a closed loop feedback system. In another embodiment, element 104 isan electroactive polymer which can act as a sphincter on command from anelectrical signal.

In one embodiment (FIG. 3H), adhesive devices or systems can includesystems wherein light 108 is introduced through the nasogastricconnector or through a port external to a patient. The light actsdirectly on element 104, or in the case where element 104 is absent,directly on the tissue in order to bond the two body lumens to oneanother, or in other cases, when an adhesive 106 is applied directly tothe region between the two body lumens. The wavelength range of thelight source can be from about 250 nm to about 11 microns depending onwhich material is activated by the light. For example, tissue adhesivesmay be activated in the range of about 250 to 600 nm with or without aphotosensitizer and constituents of the extracellular matrix, such ascollagen, can be activated by the infrared wavelengths 800 nm to about11 microns.

In some embodiments, the nasogastric connector is applied not to createan anastomosis 111, but to protect an anastomosis 111 (FIG. 3K). Forexample, the system can be applied to an anastomosis 111 created bystaples or by hand. In these cases, compression is created between theanastomosed body lumens 111 by the expandable elements (92, 99) of thenasogastric connector which can then protect the anastomosis while it ishealing (e.g. over 1-3 days). The patient can be fed through a lumen 109of the nasogastric connector 90 while compression is applied to the bodylumens. In another embodiment, an additional lumen is provided withinthe nasogastric connector; this additional lumen allows for a fluid tobe placed in the space created between the body lumens. The fluid can beplaced under pressure because of the seal between the expandableelements; the fluid and can be a dye or a contrast material in someembodiments. A leak or fault in the connection between the body lumenscan then be detected by detecting leak of fluid either visually or witha pressure detector on the proximal or distal ends of the nasogastricconnector. If a leak is detected, then the anastomosis is already undercompression and is simply left in place for a longer period of timeuntil the leak goes away (i.e. the anastomosis heals). In thisembodiment, the nasogastric-connector can serve as a feeding tube, acompression device, a leak detector, and an anastomotic protectiondevice. If there is a fault or leak, the compression system is alreadyin place and the anastomosis will be protected.

Multi-Effector Gastric Restriction Structures and Devices

In some embodiments, the transgastric fastening assemblies, or otherrestriction devices, serve to reduce the volume of the stomach orrestrict the entry of food, and in addition, provide for electricalstimulation and/or sensing; furthermore, the gain, or the relationshipbetween an input parameter (e.g. a food bolus) and an output parameter(e.g. stimulation) of the device, can be assigned prior to implantationof the device and/or can be adjusted after implantation of the device.In these embodiments, an electrical signal runs through electrodes inthe transgastric fastening assemblies enroute from a sensor or enrouteto alter the contraction patterns of the stomach and/or to electricallycreate a feeling of satiety through one or more afferent patient nervouspathways (e.g. vagus nerve). Electrical stimulation can enhance or worksynergistically with volume reduction and/or the creation of arestriction to flow in the stomach. Thus, the fastener assemblies andrestriction devices of the present invention can serve as sensing and/orstimulation structures which are useful, for example, in the creation ofexogenous satiety feedback loops (see below). In one embodiment, asensor is provided on an anchor, connector, extragastric balloon, todetect the degree of buoyancy, or flotation, of the structure within theabdominal cavity.

In one embodiment, an exogenous gastric feedback loop (see FIG. 17 a) isdescribed; a satiety feedback pathway is created surgically byimplanting a transgastric fastening assembly 700 wherein the connector712 is adapted to be a strain gauge (or have a strain gauge as anintegral component) and the fastening assembly 700 is further connectedvia a device efferent pathway 720 to a patient afferent pathway such asthe vagus nerve 722. Additional examples of patient afferent pathwaysinclude the parasympathetic or sympathetic nervous system which containpatient afferent satiety nerve fibers. In other embodiments, the deviceafferent pathway (strain gauge sensor) communicates with a deviceend-effector pathway. For example, if the connector 712 were producedfrom a shape memory alloy such as nitinol (nickel-titanium), theconnector 712 could be induced to decrease in size (generate extratension) when an electrical current (heat) passes through it. In otherembodiments, an electroactive polymer can be used as an actuator and/ora sensor in this system. In some embodiments, the strain gauge islocated in proximity to the connector but is not the same device as theconnector.

In one example, when the strain gauge is activated (e.g. by food passingthrough the stomach), a message is transmitted to the connector at whichpoint the connector contracts to thereby prevent the flow of food intothe stomach. Alternatively (or in addition to) in another embodiment,activation of the strain gauge transmits a signal to the device efferentpathway 720 which in turn sends a signal to the patient afferent pathway722.

In addition, a gain controller 710 can be provided on the device in oneembodiment in order to adjust the relative action (increase in connectortension or degree of stimulation of the vagus nerve) related to thesensing parameter. This device configuration allows the device to applytension only when necessary (e.g. when food flows into the stomach). Insome embodiments, this device configuration can allow for minimaltension to be applied to the device except when required (e.g. when foodflows into the stomach). This configuration can save power, may alsolead to a decreased tendency for erosion of the devices, and/or mayprevent associated complications with devices such as the Lap-Band™, thecomplications of which include reflux. In one embodiment, anelectroactive polymer serves as a controllable actuator; when a foodbolus is sensed by the sensor, the polymer is stimulated to change shapeand therefore act as a flow restrictor. When the stimulation (i.e. foodbolus) ends, the voltage applied to the electroactive polymer isdecreased, thereby allowing food to enter the stomach once again. Inthis case, there is only gastric restriction during food boluses.

In another embodiment of an exogenous satiety pathway (FIG. 17B), arestricting band type device 815 is placed around a portion of thestomach. As is well-known to those in the art, restricting bandstypically contain a balloon contained within a rigid outer shell. Anadditional inventive feature is to endow the restricting device 815 withthe ability to sense circumferential tension or pressure such as, forexample, would be created when food flows through the distal esophagusand proximal stomach or when a peristaltic wave approaches therestricting structure. Surgical restricting devices which circumscribethe gastroesophageal junction are well-known in the art (see forexample, U.S. Pat. No. 64,653,213); these surgical constricting devicescan be further fitted with pressure or volume sensors (e.g. acircumferential strain sensor) 817 in order to create device afferentpathways 817 which respond to the feeding state and simulate (via deviceefferent pathways 821) patient end-effector pathways 822 (e.g. gastricmuscle), device end-effector pathways (e.g. nitinol or electroactivepolymer based bands), patient afferent pathways such as the vagus nerve820, or other elements of the visceral nervous system (e.g. sympatheticplexus). Sensor 817 can also communicate directly with a deviceend-effector pathway; for example, rather than a balloon, the band canbe produced from an electrically responsive material such asnickel-titanium. In this embodiment, the material (and therefore theentire constricting band) can be induced to contract when electricity isrun through the material, which generates heat to induce a shape changein the material (in this case to generate an increase in tension). Inthis embodiment, the tension of the band and therefore its restrictingability are controllable through the shape memory material. In otherembodiments, the restricting material is produced from an electroactivepolymer which can respond to an electrical field.

In some embodiments, the band also has a balloon which is adjusted bynickel-titanium or by a magnetorheologic fluid (for example), which canalso be used to fill the balloon portion of the band. After detecting afeeding state, an electric current passes through the magnetorheologicfluid or through an electromagnet which allow the band to become firmer,more viscous, or less compliant, and thereby more difficult for food topass through the band. In states when the patient is not taking anyfood, the fluid inside the balloon is soft and does not apply pressureto the stomach wall.

By detecting the flow of food through the region of the restrictiondevice and inducing restriction electrically in these embodiments, thestress on the stomach can be limited to predominantly the “on” time ofthe restricting device. This arrangement can limit the tendency forerosion exhibited by implantable devices and can also limit the powerrequirement for electrical stimulation or to change the diameter of theband. In other embodiments, the device end-effector pathways whichadjust the restriction elements run in parallel with the sensor but arecomposed of separate materials. In some embodiments, these devices arefurther equipped with gain control in which the relationship between theinputs and outputs can be modified. Such gain controls can further bemodified externally with a wireless type transmitter.

Exogenously created satiety pathways can further contain a controlsystem 819 (FIGS. 17B, 21, 22) which can communicate externally through(for example) wireless transmitters 827 for recording and gainadjustment. The control system 819 can incorporate device afferentpathways 815 (integral sensor 817 such as a strain gauge in oneembodiment) such that recording of pressure or volume changes in thedistal esophagus, pH in the stomach, relative movement of the afferentsensor, strain or stress on the transgastric connector orcircumferential bands, or relative movement of the fasteners of thetransgastric fastening assembly, can be fed to the control system 819.Furthermore, the control system 819 has controllable or programmablegains such that the response (e.g. the patient afferent 820, deviceafferent 815, device efferent 825, device end-effector 831, and patientend-effector 833 pathways) to stimulation is increased or decreased. Thegain control can occur with a wireless type 827 transmitting device insome embodiments. Importantly, the schematics of the control system inFIGS. 21, 22 are only one depiction of many possible pathways of inputand output flow. The various boxes, lines, sensors, and actuators can bemixed and matched in any combination to provide a beneficial effect fora patient. Additional sensors and actuators can be added to the systemas well. Some actuators may even be placed outside the abdomen to alertpatients or physicians of patient behaviors.

In another embodiment, a sensor (device afferent pathway) 817 isimplanted using the methods and devices described herein (e.g. theconnector-fastener system and implantation tools described above andbelow); the sensor 817 can communicate with or be a component of thestimulator and/or the restriction device. In one embodiment, a sensor isplaced in the stomach wall (with or without a restricting structure) andsenses stretch in the stomach; in another embodiment, the sensor detectstransgastric stress and strain or circumferential stress or strain. Thissensor can communicate with the stimulator or restricting device tocreate a feedback loop in which stretch is sensed (the sensor) and thena signal is sent to the stimulator portion of the system (e.g. thedevice efferent pathway) wherein a nerve (e.g. the patient afferentpathway), for example, the vagus nerve or sympathetic plexus, isstimulated to prompt the patient to slow their intake of food. Theend-effecter (patient end-effector pathway) of the feedback loop doesnot have to be a nervous structure and in some embodiments is a muscularportion of the stomach or duodenum such as the pyloric channel, theantrum, the cardia, or the fundus. In some embodiments, the patientend-effecter pathway is a stimulus such as a small electrical currentunder the skin to inform the patient that the stomach is full and tostop food intake. In another embodiment, the patient end-effector is anaudible alarm. In some embodiments, the device end-effector pathway isan actuator on the gastric band or near to the band and the end-effectorcan have its power output automatically adjusted. In one embodiment, atransgastric fastening assembly serves to reduce the volume of thestomach as well as provide for electrical stimulation. In thisembodiment, an electrical signal runs through electrodes in thetransgastric fastener assembly to possibly alter the contractionpatterns of the stomach or to electrically create a feeling of satietyin addition to reducing the volume of the stomach and creating arestriction to flow in the stomach. Thus, fastener assemblies of thepresent invention can serve as electrodes which are useful, for example,for gastric electrical stimulation.

In one embodiment, an exogenous satiety pathway is recreated surgicallyby implanting a transgastric fastening assembly wherein the connector isadapted to be a strain gauge. In this embodiment, transgastric anchorsserve as anchors and/or stimulators and/or sensors in addition toreducing volume or causing mechanical restriction. The fasteningassembly is further connected via a device efferent pathway to a patientafferent pathway. Examples of patient afferent pathways include theparasympathetic or sympathetic nervous systems which contain patientafferent fibers which can induce satiety.

In another embodiment, a satiety pathway is recreated surgically byplacing a constricting device around a portion of the stomach where theconstricting device is able to sense circumferential tension or pressuresuch as, for example, would be created when food flows through thedistal esophagus and proximal stomach. Surgical constricting devicesinclude devices such as the Lap-Band™, transgastric anchor assemblies,or the extragastric restricting devices (e.g. a balloon) discussedbelow. Any or all of these devices can also be placed around or near ananastomosis such as a Roux-en-Y anastomosis. FIG. 17B, 18, 21, 22 depicta constricting device 815, 1000 within an obesity treatment system.Sensor 1010 detects a stimulus, the signal is interpreted by the devicecontrol system 825, and the signal is delivered to a patient efferent,device end-effector (for example, further constriction of a nitinolbased or electroactive polymer band or balloon), device efferent, and/orpatient end-effector pathway.

FIG. 23 depicts a patient management system 2300 which utilizes patientinformation logged by an implantable device or non-implantable device.The patient can be an obese patient but doesn't have to be an obesepatient. For example, heart failure patients can be managed with thispatient management system as well. A signal from a device is received bythe receiver 2320, which transmits the information to the patientmanagement software. The receiver can be a wireless receiver or it canbe connected to the pressure sensing system via a wire (in either theimplantable or external handheld embodiments). After the data enters thepatient management software, it can be displayed on a screen or aprintout, stored, sent to a physician, or interpreted by an algorithm.In one example shown in FIG. 23, the algorithm is based on the stressfrom the implantable device reaching a threshold level 2370 in whichcase the force created by the implanted restriction device is decreased.Alternatively, the stress on the implanted device is too low, in whichcase, the stress created by the implanted device is increased 2390. Thealgorithm in some embodiments can make use of data stored in a database2330. In some embodiments, a fee for usage is built in to the patientmanagement system 2350. For example, a fee can be charged for using thesystem or for the procedure of measuring the stress on the implanteddevice. Alternatively, a billing agency 2350 is made aware of the systemusage and a fee is charged based upon usage. Insurance companies canalso be directly charged for system use.

In FIGS. 18 a-c, a surgically placed banding system 1000 is depictedaround the proximal stomach 1005. The band system 1000 comprises a rigidrestricting structure 1030 and balloon 1010 which acts to restrict theflow of food into the stomach relative to the pressure in the balloonwhich initially is dependent on the volume of fluid in the balloon 1010;in this embodiment, the balloon can be fitted with a sensor (e.g.pressure sensor) to provide information about feeding habits includingfrequency of meals, volume of meals, and consistency (e.g. caloricintake). The pressure sensor 1020 can be incorporated into the fluidfillable balloon 1010 of constricting system 1000. When food passesthrough the lumen of the restricting device, the pressure increasesinside the balloon 1010, signaling patient ingestion. The pressuressensor 1020 can detect changes in balloon pressure as a bolus of foodpasses through the constricting device system 1000. Although onepressure sensor is used in one preferred embodiment, in otherembodiments, one or more pressure sensors (1020 in FIG. 18B), strain, orother sensors can be coupled to one another or directly to the balloon.

In one embodiment (FIG. 18D), one or more pressure sensors 1085 areincorporated into the port 1080 of a laparoscopic band 1091. The port1080 communicates directly with the balloon. When fluid is introducedinto the port by a surgeon, the pressure in the balloon is measured inorder to determine and set the volume of the balloon. In thisembodiment, pressure sensors communicate directly with the fluid chamberof the port and therefore communicate directly with the pressure in theballoon. Sensing pressure directly in the port can be advantageousbecause the balloon and or surgery does not have to be modified to add apressure sensing to the treatment regime of the patient. Furthermore, inpatients whom already have a band in place, the port 1080 (because it isextra-abdominal) can be changed without having to worry about theballoon (the intrabdominal portion); therefore, a band which is alreadyin place can be outfitted to sense pressure via a relativelystraightforward extra-abdominal band change. Furthermore, the portalready in the marketplace can be retrofitted with pressure sensors, apower supply, and a telemetry without having to develop or change theballoon (the Lap-Band™) the patient already has in place. All of thesesensing devices can further be adjusted, changed or calibrated when theport is accessed percutaneously.

In one preferred embodiment, a pressure sensor can be incorporated intothe bottom portion of the port 1080 by cutting a hole in the port andplacing the pressure sensor through the hole so that it is in fluidcommunication with the fluid inside the port. The sensor can furthercommunicate with a transmitter (e.g. a wireless transmitter) 1090 andpower supply. The power supply does not have to be implanted; forexample, power can be delivered inductively and remotely to the pressuresensor through the skin. Furthermore, the pressure sensor cancommunicate with an automated system which fills and/or empties the portbased on measurements from the pressure sensor.

FIGS. 18E and 18H depict the Restriction Device Stress Sensing System1089 (in this embodiment, a pressure sensing system). Adjustment port1080 communicates with a restriction device (not shown). Underneath theport is the sensing system 1089. Integral to sensing system 1089 issnout 1100 which is a hydraulic coupling tube for communication with theport 1080. The tube can be made of any standard machineable or moldablematerial such as stainless steel, carbonized steel, cobalt chrome, etc.Pressure sensor 1085 is a low cost sensor such as that from FreescaleSemiconductor (MPX2300DT1). The snout 1100 is in communication with theinside of the port as well as the pressure sensor 1085. The snout can befurther filled with a fluid to maintain hydraulic continuity with theport 1080. Preferably, the fluid inside the snout is an inert fluid withrespect to the piezoelectric membrane within the pressure sensor 1085.In this embodiment, because the inert fluid is not water or distilledwater or any other fluid not compatible with a silicon pressure sensor(an example of an inert fluid can be silicone which would be compatiblewith a pressure sensor such as a silicon microfabricated pressure sensorwith a polysilicon membrane), the pressure sensor is protected withinthe system; the top portion of the snout can be covered with a membrane1105 which is inert to saline (for example, PTFE). The diaphragm orcovering membrane 1105 therefore retains the inert fluid inside thesnout yet hydraulically communicates with the fluid in the band; thisallows the diaphragm 1105 to transduce the pressure inside the port 1080to the pressure sensor 1085 over a long period of time (e.g. years)without degrading the pressure sensor.

In some embodiments, pressure sensor 1085 is not a micromachined devicebut is made from a material which otherwise responds to strain, stress,or pressure change. For example, an electroactive polymer is a device inwhich a capacitance is created by the polymer in between two electrodes.The capacitance is exquisitely sensitive to changes in pressure on oneor both sides of the polymer. This type of polymer sensor system canpossibly be manufactured from more naturally biocompatible materialsthan silicon.

Amplifier 1110 amplifies the signal generated by the piezoelectricpolysilicon membrane in the pressure sensor. The amplified signal isthen transmitted through the microcontroller system to the data loggerwhich records time and voltage (correlated with pressure) from pressuresensor 1085. The microcontroller 1120 converts the analogue signal fromthe amplifier to a digital signal for storage in the data logger 1140.The microcontroller is powered on by the power source in response to asignal from the timer 1130. It accepts power at every ½ or 1 secondinterval depending on the program within the device. The microcontrollercan be programmed to power up and sample pressure at even a faster ratethough this frequency may not be necessary from the clinical standpoint.The microcontroller is powered on and off so that overall power in thecircuit is conserved. For example, with a duty cycle of 10%, the powerrequired for weekly data transmission and sensing at ½ second intervalson a continuous basis allow the device to be powered for a year. In someembodiments, the timer calls for power through the circuit at a lengthyinterval (e.g. 5-30 minutes), and if the pressure is above a giventhreshold, then the circuit senses and logs pressure every fraction of asecond. In other embodiments, the pressure is sampled at a constantrate. The sampling rates and other microcontroller variables can becontrolled externally through the patient management system 2300.Although components are shown independently in FIG. 18E, those skilledin the art would recognized that any or all of: the data logger, thetimer, the RF transmitter, the amplifier, and even the pressure sensorcan all be condensed into one circuit.

FIG. 18H depicts a port 1080 fitted with a customized circuit 1089; thecircuit is similar to that shown in the schematic in FIG. 18E. Thethickness (T) of this custom circuit (without snout 1105) can be lessthan one mm or 1-3 mm or greater than 3 mm. It can contain an inductivecircuit to receive power and/or a capacitive circuit to store power.Alternatively, in some embodiments, the circuit has a power supply (e.g.a small coin type battery) built into it. The circuit within sensingsystem 1089 can further be adapted to enable programming of themicroprocessor via wireless transmission or via percutaneous accessthrough the skin. The radiofrequency transmitter, microcontroller, andpressure sensor are all built into the customized circuit of sensingdevice 1089. Snout 1105 is an addition to the pressure sensor placed onthe circuit after or concomitant with the pressure sensor. As describedabove, snout 1105 can isolate the pressure sensor from corrosive fluidssuch as water or saline yet maintain hydraulic continuity with the port1080 and the implanted restriction device.

In some embodiments (FIG. 18H), port 1080 further comprises avisualizing material 1087 which enables visualization of the port 1080under ultrasound guidance. Visualization material is one which providescontrast to the ultrasonic waves. Contrast is typically provided atfluid interfaces. Therefore, material 1087 can be a polymer whichcontains a gas or a mixture of a gas and a liquid (for example, air andwater). With enhanced visualization under ultrasound, port 1080 can beaccessed in locations which do not necessarily have fluoroscopic (X-ray)capabilities such as a surgeon's office.

In some embodiments (e.g. FIG. 18 f), a hydraulic pump 1170 communicateswith the adjustment port 1080. The hydraulic pump 1170 in one embodimentcan be manufactured with an electroactive polymer as the actuator. Thepump communicates with a fluid reservoir 1180. In the instance where thehydraulic pump is an electroactive polymer, the pressure sensor can be apart of the electroactive polymer membrane and in this embodiment, isthe sensor and the actuator. The hydraulic pump can functionautonomously to pump fluid into the port and then into the implant;alternatively, patient management system 2300 can be used to direct thehydraulic pump to fill the adjustment port 1080 to a given pressure. Inone embodiment, the hydraulic pump is utilized to change the buoyancy ofthe restriction device by injecting or removing air, liquid foam insidethe restriction device.

In other embodiments (FIG. 18G), a pressure sensing system 1089communicates with inflation tube 1087 from the implanted structure (e.g.an adjustable, stomach restricting band) 1091 in a T configuration. Inthis embodiment, port 1080 communicates with hydraulic line 1082 whichsplits off into a second hydraulic line 1087 which then communicateswith a pressure sensing system 1089. In this embodiment, the pressuresensor is not rigidly coupled but is hydraulically connected in aflexible manner.

Although certain embodiments have described an implantable system, thepressure sensing system can be a handheld system 1089 (FIG. 18I) whichcommunicates with a fluid line 1099 which then communicates with animplantable device 1093. In some embodiments, the handheld pressuresensing system 1089 for the implantable device can communicatehydraulically with the adjustment port 1080 through a fluid line 1093percutaneously introduced with a needle through the skin. When pressuresensing system 1089 is handheld and external to the patient, wirelessdata transmission is optional since data transmission could occur withan electrical cable leading to a patient. Pressure sensing system 1089can contain the snout and isolating system described above or thepressure sensor can be made to be disposable such that it is included inmanifold 1094 or is removable from the system 1089 itself. Inflator 1095is a manually powered device to inflate the implantable restrictiondevice 1093 while pressure is being measured via the pressure sensingsystem 1089 through the manifold 1094.

In summary, handheld device 1089 is part of a management system whichincludes the pressure sensors and retrofits described above. It maycontain the pressure sensor snout (isolator) and diaphragm describedabove as well. This handheld system can sense the pressure in the bandthrough the skin of a patient (via percutaneous access via the manifold1093) when the band is implanted in a patient. The patient can be givena food bolus or a water bolus and asked to swallow, after which apressure tracing will show up on a reader on the device 1089. The readercan be at the patient's bedside (e.g. as a component of device 1089) orthe reader can be separated from the patient (e.g. through a receiver ona PC); in some embodiments, a wireless transmitter is used. Connector1099 transmits pressure from the manifold 1094 to the sensing system1089. Fluid line 1093 communicates with the implanted device through aneedle introduced percutaneously through the skin of a patient.

In some embodiments (FIG. 18B), sensor 1020 is not a pressure sensor buta temperature sensor, pH sensor, strain gauge, camera etc. The pressuresensor 1020 is incorporated into obesity management system (e.g. seeFIG. 20) 1060; in one embodiment, obesity management system 1060 is anelectronic control system which incorporates the pressure sensor and theoutput 1050 (e.g. a stimulator). Output 1050 is any of the patient ordevice efferent or afferent outputs described above and below; in oneembodiment, the output pathway is a stomach muscle stimulator 1070 whichalso stimulates vagal afferents and/or vagal efferent pathways.Required, but not shown is a source of power which, as is well-known inthe art, is required for operation of the system and can be deliveredremotely or through an integral power supply.

FIG. 19 depicts a surgically created restriction system 1200 which canbe placed near or around an anastomosis (e.g. a Roux-en-Y) 1230. In oneembodiment, a band 1205 is utilized as the restriction as well as thestructure incorporating a sensor. In another embodiment, surgical clips,sutures, and/or staples 1230 are utilized as sensors for the system1200. In another embodiment, a port is attached to the constricting bandand contains a pressure sensor. In one embodiment, an effector system,such as a vagal nerve stimulator 1240, is incorporated into thesurgically created restriction system 1200. As described in otherembodiments, there are other system outputs which can be combined withor used in place of the vagal nerve stimulator 1240. Additionalcomponents of the other embodiments above and below can be incorporatedinto the system depicted in FIG. 19. These additional components includetelemetry, adjustable gain, power, etc. In addition, although arestricting band 1205 is depicted, other structures such as thetransgastric fastening systems or devices similar to the Lap-Band™ canbe used in place of the restricting band 1205 in this system 1200 at asurgically created anastomosis 1230.

FIG. 20 depicts a surgically created restriction system placed at theinlet of the stomach. In this embodiment, the restricting portion of thesystem 1300 is a transgastric assembly as described above. Sensingsystem 1060 communicates with the transgastric assembly 1300, processingthe physical parameter (e.g. stress/strain) associated with the assembly1300 and delivering an output signal to a device such as an electricalstimulator 1070.

In another embodiment of the current invention, a neurostimulator orneurostimulator lead is a component of the restriction or volumereducing device (but does not have to be an integral component; forexample, it can be distal in the stomach yet communicate with therestricting device) and is placed in the serosal layer of the stomach orsmall intestine to stimulate the muscular or nervous portion of thestomach or small intestine (e.g. the duodenum). In some embodiments, thestimulator contacts and acts on the parasympathetic, the enteric, or thesympathetic nervous system; in other embodiments, the stimulator acts onthe muscular portion of the stomach. The stimulator can be placedanywhere along the stomach including the anterior and/or posterior wallsof the stomach. In some embodiments, the stimulator contacts the mucosaand in other embodiments, the stimulator does not contact the mucosa. Insome embodiments, a sensor is placed as a component of the stimulator oras a separate device. In some embodiments, the stimulator furthercommunicates with a second or third stimulator through a wired orwireless connection.

FIG. 22 further depicts a system for weight control with a surgicallycreated restriction at the center 1100. The system contains one or moreoutput pathways such as gastric wall stimulation 1110 and/or visceralstimulation 1120. The system also can contain adjustable gain controls1130 which control the relationship between the restriction device 1100and the inputs and outputs. The gains are adjustable from a locationexternal to the patient, or in some cases, are internally adjustable(e.g. through an endoscope). A telemetry system 827 allows for outsidemonitoring and/or adjustment of the system.

A further component of the system is the ability of the system to detect1140, store, and transmit 827 sensory and motor information from theeffector pathways 1110 and 1120; that is, pathways 1110 and 1120 cansense currents (e.g. from the stomach, vagus, enteric, or sympatheticnerves) as well as provide therapeutic electrical current. The abilityto sense the currents can be used to optimize the therapeutic electricalcurrents or enable understanding of the patient's behavior. Thisinformation includes voltages, amplitudes and waveforms from neuralpathways such as the parasympathetic, sympathetic, gastric muscle, andenteric nervous pathways. When interpreted in relation to patientingestion and type of ingestion, these signals can be used to furtherunderstand satiety signals generated in reponse to ingestion. In thismanner, the system can essentially learn from itself and be optimizedfor each patient.

Extragastric Restriction Devices

In another embodiment, an extragastric balloon (FIGS. 11A-11C) is usedto reduce the volume of the stomach and/or create a barrier to the flowof food and a restrictor to the flow of food. Although balloon is usedin the description below, any device which expands from a contractedstate to a deployed state can be used. FIG. 11 a depicts the balloon (orother expandable device) 430 in the undeployed configuration. Theballoon is placed through a trocar port 306 after the trocar port hasbeen placed between the peritoneum and the anterior wall of the stomach(with or without general pneumoperitoneum) as described in detail aboveand below. FIG. 11B shows an embodiment of an extragastric balloon 430in its deployed state. The balloon 430 is attached to the abdominal wallby any of the percutaneous anchor-connector assemblies and methodsdescribed above. Stem 432 is the residual from the connector used toplace the balloon with an optional access port/valve for furtherinflation and/or deflation after the balloon is placed; for example, asurgeon can access the subcutaneous port using a needle placed throughthe skin. The access port can further be retrofitted with a pressuresensor to detect the pressure exerted by the balloon 430 on the stomachwall 302. A pressure sensor or other force transducer (e.g. a straintransducer) can also be placed in or around the balloon 430 itself.Anchor 434 is similar to the anterior anchors described above and can beplaced between the muscular portion of the abdominal wall 304 and thesubcutaneous fat or between the anterior layer of muscular fascia andthe muscle (e.g. the rectus muscle). In some embodiments, the balloon isplaced close to the pylorus or at the fundus of the stomach close to theGE junction and can optionally be contoured 430 to partially orcompletely surround the GE junction or the pyloric outlet. In someembodiments (FIG. 11 c), the posterior portion of the balloon is fixed436 to the outer or inner portion of the stomach using any of thefastening systems described above (two or more point fixation); forexample, the balloon can be delivered over a connector, a guidewire, ora rail to its position inside the abdomen. The balloon can be deliveredwithin a port The balloon can further be combined with a transgastricanchor assembly to aid its attachment, to (adjustably) control tensionon the transgastric assembly, or to synergize with the transgastricanchor assembly. The posterior portion of the balloon can be fixed tothe anterior gastric wall with an anchor delivered through the stomachwith an endoscope. The balloon structure can be used in combination witha VBG, a Ruox-en-Y, or any other surgical procedure.

In one embodiment, an anchor is used to fix the extragastric balloon tothe stomach using an endoscope in combination with a guidewire(guidewires are thin flexible wires which are well known in thecardiology and gastroenterology fields) which is also placed through theendoscope. In some embodiments, guidewires are used through laparoscopictrocars or directly through incisions in the skin of the abdominal wall;in some embodiments, guidewires are similar to the connectors discussedabove. In some embodiments, the balloon is attached to fixation pointsother than the abdominal wall 304 and stomach wall 302. For example, theballoon can be attached to the diaphragm, the liver, the colon, or theomentum. In some embodiments, an expandable device other than a balloonis used. For example, the expandable device can be an expandable cagewhich expands based on pre-stressed metal or polymer which then returnsto its pre-determined shape.

The extragastric balloon can be placed anywhere along the stomach, evenat a position 1-5 cm below the gastroesophageal junction at the sameplace where laparoscopically placed adjustable gastric bands arecurrently placed. The balloon can further be shaped to partiallycircumscribe, or form a lumen (fully circumscribe) around, a structuresuch as the gastroesophageal junction. The balloon can have roughenedregions to improve friction and/or adhesion with the stomach. Theballoon can further have support structures (either separate materialsor components of the same material with different mechanical properties)438 which are rigid or more rigid than the balloon and in someembodiments help to apply force toward the stomach.

Even though the balloon may completely circumscribe the stomach, it doesnot necessarily have to be a continuous ring and can be discontinuouseven though it forms a complete ring when fully expanded. For example,FIG. 11D depicts an expanding device 430 (e.g. a balloon) which does notform a complete lumen around the region of the stomach. The device 430can circumscribe up to approximately one-quarter of the circumference ofthe stomach, or from one-quarter to one-half the circumference of thestomach, or even one-half to three-quarters the circumference of thestomach. Support structure 438 can circumscribe a similar circumferenceor can circumscribe its own circumference of the stomach.

In one embodiment, device 430 is not an expanding device but is madefrom a material which tends to contract passively or actively. Forexample, device 430 can be made from a material such nitinol whichstarts at a first width and tends to move toward a smaller width unlessa force is applied to prevent contraction of the width. If the device inthis embodiment were designed for a region of the stomach 1-5 cm belowthe GE junction 302, the device may begin at a width of from 5-10 cm,then contracting to a width of between 0.5 cm and 4 cm. In anotherembodiment, it is supporting material 438 which is produced from amaterial that tends to contract passively or actively. Supportingmaterial 438 in this embodiment can be produced from a material such asnitinol which creates rigidity along one portion of the expandabledevice 430 or itself is adjustable; for example, structure 438 can be afluid fillable balloon as well, essentially creating a multi-compartmentfluid fillable structure. Support material 438 can also be placed insideof the expanding device, an expanding device inside an expanding device,or an inflateable device inside an inflateable device. The innerexpandable device can provide support for the outer supporting device orthe inner device can be used to increase or decrease the overall densityor buoyancy of the device.

Alternative materials for this embodiment include a variety ofelectroactive polymers and materials. Any of the sensors, actuators, andsystems described above and below can be incorporated into thisembodiment as well.

In one embodiment, a material configured as a mesh (FIG. 11E) 440 can beplaced within 1-5 cm from around the GE junction of the stomach;alternatively, the device 440 can be placed along the length of thestomach (FIG. 11H) or at the region of the pyloric valve. The mesh canbe made from materials such as nitinol, an electroactive polymer (seefor example U.S. Pat. No. 6,940,211 herein incorporated by reference inits entirety), and/or other materials which possess shape memory and/orcan be actively shape-controlled to apply pressure to the stomach andcreate a restriction to the flow of food through the stomach. Mesh 440can be made from any of the biocompatible materials above and/or belowand additionally can be produced from a composite material (FIG. 11F).

The material, which can be referred to as an anchoring frame, anchoringstructure, anchoring material, anchoring tab, or anchoring body can beplaced at any part of an implantation procedure. For example, thematerial can be placed prior to implantation of the anchor, insertingthe frame initially and then attaching the anchor afterward using asuture or a connector. The anchoring frame can also be placed into theabdomen and attached to the abdominal wall, a restriction devicesubsequently attached to the frame.

FIG. 11F depicts a cross-section of the mesh 440 shown in FIG. 11E(C-C′) at the level of the stomach 302 below the GE junction. Mesh 440is shown partially surrounding the stomach 302. Mesh 440 can further becoupled to a support structure 443, the support structure in someembodiments constructed to apply force which tends to constrict stomach302. In some embodiments, the support structure is a constricting bandplaced around the stomach and the mesh aids in attachment of theconstricting structure to the stomach 302. For example, the constrictingstructure can be any of the transgastric or extragastric structuresdescribed above and/or below. In one such embodiment, the constrictingstructure is removable and the mesh is permanent; therefore attachmentof the constricting structure relies on attachment of the constrictingstructure to a healed or healing mesh rather than the constrictingstructure being attached with surgical suturing.

FIG. 11G depicts an expandable structure (e.g. a balloon) 430 placedbetween the stomach wall and another structure, such as the abdominalwall, the liver, the diaphragm, and the omentum. The expandablestructure 430 can have a textured surface 439 and/or an anchor 436 whichaids in the positioning/attachment process of the expandable device; inthis capacity, it serves as a guiding structure or device. The texturedsurface can include mechanical interlocks which assist attachment of theexpandable structure to the anchor; for example, the textured surfacecan have a surface which conforms with a region of the expandablestructure so that they mate to one another to create a mechanicalinterface. In this embodiment, the anchor does not have to penetrate themucosal layer of the stomach. In some embodiments, the connector(guidewire and/or catheter) 432 is inserted directly through theabdominal wall or through a port such as a laparoscopic port. In someembodiments, connector 432 remains in place and becomes thecommunication line for the expandable device 430. In some embodiments,multiple guiding devices 432 are used in the abdomen. For example, afirst guiding device can be used to place an expanding device 430 and asecond guiding device can be used for retraction of organs (e.g. theliver) or for visualization of the procedures. In other embodiments,connector 432 further serves to transmit electrical current to at leasta part of the expanding structure (e.g. balloon) to stimulate thestomach or associated nervous structure(s).

FIG. 11H depicts another embodiment in which the expandable device (e.g.a balloon) substantially traverses the stomach in the horizontal and/orlongitudinal direction to substantially cover the external surface ofthe stomach. A typical human stomach may have a longitudinal length of20-50 centimeters and a width varying from 1-30 centimeters depending onwhere in the stomach the width is measured. An optional fluidcommunication line is provided to fill the balloon with a fluid orotherwise provide electrical or mechanical power. In another embodiment,balloon 430 (or any of the extragastric balloons mentioned above) arefillable using an endoscope which can penetrate the gastric wall andfill or deflate the balloons.

The extragastric balloons and/or other devices can further be configuredto act as stimulators which can deliver electrical current or can sensecertain parameters such as peristaltic contraction, food boluses, orother patient activity. Electroactive polymers and shape memory alloyscan also be used as sensors and/or actuators. In one example, anelectroactive polymer consists of multiple polymer layers wherein one ormore of the layers comprises a sensor such as a strain gauge or pressuregauge. This information can be used to increase or decrease the volumeof the balloon accordingly.

As described above, any of the extragastric balloon embodiments canfurther contain an integral sensor to detect changes in volume (forexample, volume and/or pressure changes) of the restricted portion ofthe stomach. Such changes in volume can then be used to create satietyfeedback loops to deter the patient from further food intake (asdiscussed above and below, for example, vagal nerve stimulation).

In some embodiments, mechanical fixation structures are used to attachthe balloon to the serosa of the stomach. Other means of attachingballoons to the stomach include adhesives, pledgets, expandable anchors,etc. The connector-anchor systems above are used to attach the balloonto the abdominal wall. The connector can further serve as an inflationvalve for the extragastric balloon.

In another embodiment (FIG. 11I), a flexible guiding device (e.g. aconnector) 432 is depicted as part of a system to operate or placedevices 430 in or around the stomach. Device 432 is placed through lumen437 of device 430. Device 430 can be expandable in some embodiments. Inone embodiment, anchor 436 is first implanted in the stomach after atrocar and/or camera is/are optionally placed in between the abdominalwall and the stomach. The anchor 436 could be a temporary anchor orcould be a grasper which temporarily grabs onto the stomach whiledevices are implanted over the guiding devices 432 (connectors). Anchoror grasper 436 can first grasp structures other than the stomachincluding the diaphragm, the liver, the omentum, a nervous structure, orthe crus of the diaphragm.

A device such as a camera 452 can optionally be placed close to theanchoring device 436. This camera can be flexible and of a CCD or CMOStype. The camera is slideable along the guiding device and can be usedto direct placement of the device 430 or used to direct the injection ofmaterials or to visualize the application of energy to the stomach wallor related nervous structure. The guiding device 432 allows forpositioning and fixturing inside the abdominal cavity. The guidingdevice can purely serve to guide devices to the stomach or it canultimately serve to conduct electrical or mechanical power to theexpanding device 430 or other surgical devices such as electrocauterydevices, retractors (e.g. liver retractor), graspers, or scissors.

Extragastric constriction systems can be particularly advantageous inpatients who have had bariatric procedures in the past (e.g. Roux-en-Y,Vertical Banded Gastroplasty, or a duodenal switch). Patients who havehad these procedures have anatomy posterior to their stomachs which istypically scarred and difficult to access. Therefore a device whichapplied pressure from the top or sides would be advantageous in thispatient population as access would be achieved through percutaneousmeans and possibly percutaneous surgery and would not involve encirclingthe stomach. The assumption is that compression from on top of thestomach is counteracted by the relative stability of the retroperitoneumbehind the stomach. This assumption is proven in the animalexperimentation described below.

In some embodiments, extragastric expanding devices are combined withtransgastric anchors (FIGS. 15H-I). In these embodiments transgastricrestriction devices have an extragastric balloon 772 to adjust stoma(passageway for food through the device) 770 size. Balloons 772 can beplaced on either side of the stomach. Balloons can be sensors orstimulators as can band 750 or 752.

FIG. 24 illustrates a device and associated implantation method toimplant the device. The inset FIG. (24′) depicts a perspective view of asheath placed under the liver which was placed through a percutaneousconduit 2520. Sheath 2510 can follow over a suture or over a wire suchas a guidewire introduced into the abdomen through percutaneous conduit2520, sheath 2510 carrying a device such as an extragastric restrictiondevice, a neurostimulator, a muscle stimulator, and even acircumferential restriction device, etc. In some embodiments, the sheath2510 follows both a suture and a guidewire and in some embodiments,sheath 2510 follows only a guidewire or only a suture. In the embodimentwhere a suture is placed into the abdomen and sheath 2510 passed overthe suture, the suture can be attached to an abdominal structure priorto the sheath being delivered over it. Such suturing techniques arereadily available in other parts of the field of abdominal surgery suchas for the placements of hernia meshes. Pre-knotted sutures can beplaced into the abdomen of the patient and sheath or devices then slidover the pre-knotted sutures. With reference to FIG. 24, a device 2600is shown being delivered from within sheath 2510 over a wire and/orsuture 2570. The device 2600 is being placed between the stomach 2550and the liver 2670. Tube 2580 can ultimately be utilized for access tothe device 2600 post-operatively. Access can include inflation ordeflation of the device 2600, charging of a battery of device 2600,downloading of data from device 2600, altering of a programming state ofthe device 2600, recharging the device, etc.

FIG. 25 further details a method of implanting device 2600. Once thedevice is shuttled over guide sutures (connectors) 2570, it ispositioned over the area of interest, in this example, the crus of thediaphgragm. In the embodiment where the device is attached to thediaphragmatic crus, the device is placed on the crus and knots tiedusing sutures 2570 (connectors). Port 2510 is then connected to filltube 2575 by sliding it over the tube and then removing the excesstubing 2575. Once the sheath 2510 has been removed from the abdomen,then the device 2600 can be anchored in placed using knots in thesuture. Device can be folded in such a way so as to minimize itsdiameter and so that it can fit into an access sheath to provide forminimal access surgical techniques. In FIG. 25′ the device 2600 is shownas it unfolds from an accordion like folding pattern. In an alternativeembodiment, crimping elements (described above) are used which areplaced over the guide sutures and crimped onto the sutures to hold thedevice on the structure within the abdomen.

FIG. 26 a-b further depicts structural features of device 2600. FIG. 26a depicts a cutaway of the device 2600 which resides between the stomach2550 and liver 2670. Subcutaneous port 2800 is attached to device 2600.When inflated, device 2600 exerts a force F on the stomach 2550 whichlimits expansion and creates compression in some regions of the stomach.For example, device 2600 and associated force F can compress the stomach2550 to create a tube like structure shown above (e.g. see reference tothe Magenstrasse and Mill procedure). In FIG. 26 b, device 2600 shows anattachment tab 2720, or a through lumen for a connector, a guidewire, asuture, etc. Region 2700 can be a coating or an attached materialoverlying the belly of the inflateable device 2600. In some embodiments,region 2700 is an attached mesh or other attached material which in somecases is itself inflateable and can be made from a material which isheavier or lighter than the expandable balloon to enable differentregions of relative buoyancy to be created on the device. Region 2700 insome embodiments is a mesh, a hydrophilic coating, a hydrophobiccoating, or separate material for attachment to other structures of thedevice 2600. Attachment member 2730 communicates with device 2600 and isresponsible for its inflation and deflation as well as creation of shapechanges.

FIG. 27 depicts the device in its implanted configuration. In oneembodiment, the device 2600 is tucked away underneath the liver in itsimplanted position. In this example, device 2600 was implanted usingsutures attached to the crus 2720 of the diaphragm. Additional tackingsutures 2760 were placed on the anterior wall of the stomach. Theseattachments float on the stomach and are likely necessary only in thebeginning of the procedure until a capsule forms around the implantabledevice and sutures, keeping it in place. Material 2710 can be a materialwhich aids in capsule formation or can be an attachment rail. Port 2800was attached to the connector which communicated with the expandabledevice 2600. As described above, one or more anchors or sutures can beused to fix the device to the abdominal wall and in some embodiments,only abdominal wall sutures are used for the extragastric balloon.

Experimental Verification of Extragastric, Non-Circumferential StomachRestriction

To provide experimental verification of the assumption that theone-sided balloon can provide for functional stomach restriction, aprototype of this assembly was placed in a porcine abdomen and fixed inits operative position according to the method described above anddepicted in FIG. 27. The device 2600 was attached to the crus of thediaphragm and attached to the anterior wall of the stomach usingfloating serosal knots which did not pierce the wall of the stomach inaccordance with FIG. 27. A gastrograffin swallow was performed one monthlater. With filling of 0-50 cc, the balloon exerted minimal force on theesophagus during the bolus of fluid. After the balloon was filled withup to 100 cc or more of saline, it was evident that the extragastricballoon indeed created a physiologic level of stomach restriction. FIG.29 depicts some of these results in the form of a schematic of a pictureobtained from a fluoroscopy performed during the procedure. The animalwas given a gastrograffin radiocontrast meal and fluoroscopy performed.As can be seen, at the 100 cc level of contrast swallowed 3020, theballoon 3000 constricted the stomach 3010 enough to practically preventall flow into the stomach from the esophagus 3040. The extragastricballoon was also filled with contrast material to evaluate its positionrelative to the esophagus 3040 and stomach 3010. Thus, it is evidentthat one-sided restriction, or non-circumferential restriction, or anextragastric balloon indeed can indeed utilize the retroperitonealregion behind the stomach to create enough pressure on food entering thestomach to create a back pressure within the esophagus and thereforeinduce satiety.

In accordance with these experimental data, a method is describedwhereby an extragastric balloon pushes on the stomach, pushing theposterior portion of the stomach against the retroperitoneum, therebycompressing the stomach walls together to create a resistance to foodentering the stomach, to create a sensation of fullness.

The procedure performed to evaluate the extragastric inflateable implantin the animal experiment is also useful in the clinic when treatinghuman patients. For example, in one method of treating a patient, theextragastric balloon is implanted in proximity to the stomach and filledwith fluid. In one embodiment, it is preferable to fill the balloon withradiocontrast saline so that it is visible under fluoroscopy and duringfollow up of the patient. In one embodiment, the balloon is filled witha small amount of fluid so that it can heel into place, forming acapsule around it and assisting in its anchoring to the stomach wall.After 15-30 days, the balloon can then be inflated to the proper volumeand level of stomach restriction. The balloon can be filled with a watersoluble contrast agent such as gastrograffin so that the balloon will bevisible at follow up clinic visits.

At explantation of the balloon in the experimental validation describedabove, the assembly was found to be adhered in place with a thin capsulearound it. At explantation, the volume within the assembly wasadjustable so that a large resistance was created at the entry to thestomach, creating a barrier to food entry into the stomach. Indeed, athigh enough levels (for example 100 cc), an enlarged esophagus was foundto have been created, a so called “mega-esophagus,” indicating that asingle-sided balloon can indeed create a back pressure within thestomach using the immobile retroperitoneum to provide the resistiveforce behind the stomach.

In the clinical environment, an extragstric assembly can therefore beused to prevent or limit the amount of food ingested by a patient. Thedevice can be filled with barium or gastrografin during implantation andthe effect on the esophagus can be used to determine the amount ofvolume utilized within the balloon to create satiety by viewing itseffect on the esophagus. Alternatively, a nasogastric manometer can beutilized to detect the back pressure on the esophagus and indicate theneed for tightening or loosening of the restriction device prior tosetting its final configuration prior to the end of surgery.

FIG. 28 depicts results from an implantable pressure sensor (describedin detail above) which was implanted in combination with a Lap-Band™from Inamed-Allergan but is generally applicable to any of therestriction devices provided herein. The gain of the pressure sensordevice was adjusted after implantation so that the signal (ingestion)would be separated from the noise (movement, peristalsis, etc.). Afterseveral days of continuous data collection at 1 Hz, the entire datasetwas downloaded wirelessly from the device through the animal, revealingthat the signal 2810 to noise 2820 ratio was indeed highly favorable todetecting ingestion 2810 of food in the animal versus noise 2820inherent in the system and relative to normal movement of the animal.This is an important result and can be utilized in many different ways.For example, the signal 2810 is essentially a snapshot of the backpressure on the food bolus as the bolus passes through the restriction.If the restriction device is not functioning, it loosens, or it slips,then the back pressure signal is decreased or non-existent. The slippagethen shows up as a decreased signal or no signal during ingestion and istherefore detectable by the pressure sensor and can be transmittedoutside of the patient to an operator such as a physician who can alertthe patient. On the opposite end of the spectrum, if the restrictiondevice is too tight or actually closes off the stomach passage, then thepressure signal will be sharper and larger in scale, again providing asignal to adjust the restriction device or that the device is too tight.The footprint of the signal can also be used as a baseline for a patientin that the quality of the signal can be benchmarked relative to weightloss or weight gain and the signal footprint therefore used as arelative indicator versus future changes.

The ingestion signals can also be used to couple to a therapeutic orbehavioral change in a patient. For example, the ingestion signal can beused to trigger a stimulator such as a muscle stimulator, a nervousstimulator, a cutaneous stimulator, etc. as described above.Alternatively, the ingestion signal can be used as an external auditorysignal to remind a patient of a diet.

In accordance with the data obtained related to the pressure sensingapparatus, a pressure sensor can be implanted into a patient at the timeof implantation of a restriction device. After implantation and healingof the device in place, the gain of the device can be adjusted so that asignal:noise ratio is obtained wherein the pressure sensor detectsphysiologically relevant signals related to food ingestion. Thephysiologically relevant signals can then be utilized by a physician toadjust the restriction device in order to optimize therapy with therestriction device.

Surgical Instruments

Surgical instruments which can be used to implant many of the devices ofthis invention are disclosed. The surgical instruments represent oneexample of the methods to implant the disclosed devices but not the onlypossible means for implantation. Any of the devices and/or methodsand/or features of the current inventions can be implanted with anendoscopic procedure in addition to endoscopic means to assist apercutaneous procedure or an endoscopic means to assist a laparoscopicprocedure.

FIG. 4A illustrates one embodiment of a tissue grasping instrument 200.The tissue grasper has a tubular outer sleeve 210 to which a portion ofa handle 212 is attached at the proximal end. As shown in more detail inthe blow-up, FIG. 4A′, disposed within the outer sleeve 210 is a tubularinner member 214 which has an outer diameter such that it can slidewithin the outer sleeve 210 in the longitudinal axis of the outer sleeve210 but cannot move substantially transverse to the longitudinal axis ofthe outer sleeve 210. At the proximal end of the inner member, a secondportion of a handle 216 is attached. At the distal end of the innermember is a pair of jaws 220 which is connected to the inner member at ahinge point 222. When the distal end of the inner member 214 isdisplaced from the inside of the outer sleeve 210 such that the hingepoint 222 is outside the outer sleeve, the jaws 220 assume their openposition as depicted in FIG. 4A. As the hinge point 222 is withdrawninto the outer sleeve 210, the outer sleeve forces the jaws 220 intotheir closed position, as illustrated in FIG. 4B. The opening andclosing of the jaws 220 can be accomplished by manipulation of thehandle portions 212 and 216.

The distal end of the grasping instrument 200 is configured to cut,puncture, or dilate tissue when the jaws 220 are in the closed position.In one embodiment shown in FIG. 4B, the jaws 220 havescrew-thread-shaped protrusions 224 on the surface. By rotating theinstrument as it passes through tissue, the protrusions 224 facilitatethe penetration of tissue, similar to a corkscrew. In another embodimentillustrated in FIG. 4C, the instrument has jaws 226 that form a sharptip 228 when closed. In yet another embodiment, the jaws form a bladewhich can cut through tissues when in the closed position. One of skillin the art would recognize that the above configurations can becombined, or that other configurations are possible which facilitate thepassage of the tip of the instrument through the wall of the stomach orother tissue.

It also should be realized to one skilled in the art that the closed endof the grasping device does not have to be the only instrumentresponsible for cutting through the tissue; the central lumen 230 of thedevice can be utilized to assist in tissue penetration. For example, aneedle (e.g. a Veres needle) 232 can be passed through the lumen and theneedle 232 can make the initial puncture through the tissue. Theconfiguration of the distal end of the grasper is meant to be a tissuedilator and facilitator of the entry into the stomach (or any otherhollow organ) after the needle makes the initial puncture. For safety,the needle can be retracted as the tissue grasper dilates the tissue.

In the embodiment of the tissue grasper 200 illustrated in FIG. 4A, theinner member 214 and outer sleeve 210 have a central tunnel 230 thatextends the length of the tissue grasper. The tunnel 230 allows for thepassage of an expanding means such as a needle 232, or other instrumentor device such as the posterior or anterior anchor described above (seefor example, the description above regarding the connector-suturecombination in which the suture is left behind and the outer sheath ofthe connector is pulled away), through the length of the tissue grasperas shown in FIG. 4A. The central tunnel is also adapted such that aradially dilating sheath can be inserted through it. The diameter of thecentral lumen is preferably at least 4 mm, but can be at least 5, 6, 7,8, 9, 10, 11, or 12 mm. In an alternative embodiment, the distal jawscan be configured to close through an electromechanical means, a purelymagnetic means, or via an electroactive polymer such that the innermember is not necessary.

FIG. 5A illustrates one embodiment of an anchor implantation instrument250 to implant the anterior anchor. The implantation instrument has atubular outer sheath 252 which has a handle 254 attached. At the distalend, the outer sheath flairs out to an increased diameter 255 toaccommodate the anterior anchor in its substantially folded position asillustrated in FIG. 5C. Within the outer sheath is an anchor graspinginstrument 256 similar to the tissue grasping instrument of FIG. 4A,made up of a tubular middle sleeve 260 and a tubular inner member 264.The tubular middle sleeve 260 has an outer diameter such that it canslide within the outer sheath 252 in the longitudinal axis of the outersheath 252 but cannot move substantially transverse to the longitudinalaxis of the outer sheath 252.

The tubular middle sleeve 260 of the anchor grasping instrument has aportion of a handle 262 attached at the proximal end 261 of theinstrument. Disposed within the middle sleeve 260 is a tubular innermember 264 which has an outer diameter such that it can slide within themiddle sleeve 260 in the direction of the longitudinal axis of themiddle sleeve 260 but cannot move substantially in transverse to thelongitudinal axis of the middle sleeve 260. At the proximal end of theinner member, a second portion of a handle 266 is attached.

The distal tip 263 of the instrument is illustrated in more detail inFIGS. 5B and 5C, with the inclusion of the anterior anchor 40 of FIG. 2Aand connector 12 of FIG. 1A. FIG. 5C is a side section view taken alongthe line C-C of FIG. 5B. At the distal end 263 of the inner member 264is a pair of hooking members 270 which are connected to the inner memberat a hinge point 272. When the distal end of the inner member 264 isdisplaced from the inside of the middle sleeve 260 such that the hingepoint 272 is outside the middle sleeve, the hooking members 270 assumetheir open position as depicted in FIG. 5B. As the hinge point 272 iswithdrawn into the middle sleeve 260, the middle sleeve forces thehooking members 270 into a closed position, as illustrated in FIG. 5C.The opening and closing of the hooking members 270 can be accomplishedby manipulation of the handle portions 262 and 266.

The instrument is designed such that the anterior anchor is easilymanipulated. When the anterior anchor is in its substantially folded orcompressed configuration as in FIG. 5C, the entire anterior anchorassembly can be manipulated along the longitudinal axis of the connector12. FIG. 5C depicts the assembly as it would be introduced over theconnector 12 and into the patient. The operator pulls the connector 12toward the operator such that the posterior anchor is urged toward theanterior anchor. When in position, the operator deploys anterior anchor40. To deploy anterior anchor 40, outer sheath 252 is pulled back towardthe operator. Middle sleeve 260 is then withdrawn proximally toward theoperator as well. Hooking members 270 tend to fan out as the middlesleeve is pulled back and will release hooks 52. Once deployed, anterioranchor 40 is now fixed in a longitudinal position along the connector12.

An important feature of the anterior anchor in some embodiments is thatit be grippable by a laparoscopic grasping instrument and able to betranslated through a laparoscopic port; further, the anterior anchor isreversibly translatable along the connector such that the surgeon canplace and replace depending on what is seen by the endoscopist or thetension indicated by the tensiometers. If the surgeon wants to re-adjustthe anterior anchor, connector 12 is manipulated so that the hooks 52 ofthe anterior anchor are brought into contact with hooking members 270;middle sleeve 260 is advanced distally from the operator, permittinghooking members 270 to engage the hooks 52; such contact is facilitatedby pulling back (proximally) on the connector 12. By manipulating themiddle sleeve 260 over the hooking members 270, the hooks 274 on theends of the hooking members 270 can engage the hooks 52 on the anterioranchor 40. The outer sheath 252 is then slid over the anterior anchor 40(or the anchor-middle sleeve complex is withdrawn into the outer sheath252), until it is compressed into an undeployed configuration as shownin FIG. 5C. As described above, when the anterior anchor 40 is in asubstantially compressed configuration, it can move along the length ofthe connector 12 in either direction.

In an embodiment where an inflatable anterior anchor such as the oneillustrated in FIGS. 2G-2I is utilized (or in the case that the anterioranchor is otherwise sufficiently compliant to be pushed through alaparoscopic port), a standard laparoscopic grasping instrument (withteeth) can be used to manipulate the anterior anchor. When theinflatable anterior anchor is in the uninflated position, it issufficiently compliant such that it can easily be passed through alaparoscopic port prior to inflation and deployment or after it has beendeflated for readjustment; the middle sheath may not be necessarybecause the compliance of the balloon enables easy compression into theouter sheath. The inflation tube 63 passes through the laparoscopic portand out of the patient. This allows the inflation tube 63 of the anchorto be temporarily opened or closed outside the patient allowing fordeflation and reinflation until the anchor is in place. The inflationtube is then sealed and cut off, preferably substantially flush to thesurface of the anterior anchor. Clearly, one skilled in the art willunderstand that this instrument can be used for extra-gastric balloonsor balloons attached to the abdominal wall or inside the abdominal wall.

Methods of Implantation

Percutaneous Procedure

FIG. 6A depicts the initial step of a preferred embodiment of a surgicalmethod to implant a transgastric fastening assembly. The first part ofone procedure embodiment, the “percutaneous procedure,” involvesentering the stomach with an endoscope 300 and insufflating the stomachwith a gas. When insufflated, the anterior wall of the stomach 302 ispushed toward the anterior abdominal wall 304 to create a potentialspace (the stomach interior). After insufflation of the stomach, anincision is made in the skin and a typical laparoscopic port 306 isplaced through the anterior abdominal wall 304 to a position wherein thedistal end is in the potential space between the abdominal wall 304 andthe anterior wall of stomach 302. The laparoscopic port 306 can be aradially dilating type port or similar port known in the art. Eventhough a laparoscopic port is used, in these steps, generalizedpneumoperitoneum is not required and this part of the procedure can bedone with minimal or no general anesthesia as discussed in the nextparagraph.

A particularly advantageous laparoscopic port is one which allowsvisualization (with a laparoscope) of the individual abdominal layers asthe laparoscope is being pushed through the abdominal wall (well knownto those skilled in the art). Use of such a port allows the surgeon to“see” the different layers of the abdominal wall from within the trocar(using a standard laparoscopic camera) as the trocar is advanced throughthe abdominal wall. The endoscopic light inside the stomach will be“seen” by the surgeon as the port approaches the inner layers of theabdominal wall because the endoscopic light source transilluminatesthrough the layers of the stomach wall and inner layers of the abdominalwall. Such visualization is advantageous if the patient has a very thickabdominal wall (e.g. in a morbidly obese patient) because the surgeonneeds to ensure that another organ (e.g. the colon) is not positionedbetween the stomach and the posterior wall of the abdomen. Once thetransillumination of the stomach is visible through the transparentport, the port 306 can be slipped in the abdomen between the abdominalwall and the anterior wall of the stomach. This portion of the proceduremay be done without pneumoperitoneum and without general anesthesia(e.g. local anesthesia).

At this point, the camera can also be used to visualize the anteriorwall of the stomach and/or it can be used to visualize placement ofdevices into the anterior wall of the stomach; examples of some devicesinclude stimulators, sutures, clips, drug delivery devices, sensors, andvolume displacing devices (extragastric balloons are discussed below).As described above, visualization of the surface of the stomach andimplantation of devices into the anterior wall (without puncturingthrough the stomach) can be achieved with this method and does notrequire general pneumoperitoneum. The camera can be slid along thestomach to reach virtually any portion of the anterior stomach, duodenalwall, or lower esophagus. Additional ports can also be placed in thespace between the abdominal wall and the anterior wall of the stomach.With the additional ports, additional instruments can be used which canfacilitate placement of the devices into the walls of the stomach.Suture passers, knot tiers, electrosurgical devices, and clip appliersare just some examples of instruments which already exist in thesurgical arts and which can be utilized to facilitate placement ofdevices into the walls of the stomach. Small incisions can be made inthe serosa of the stomach and a pocket can be made so that stimulatorscan be placed in a pouch in the stomach wall. Therefore, using theinventive technique of entering the abdomen without general anesthesiaand without pneumoperitoneum as detailed above, many different gastricoperations can be performed.

In FIG. 6F, a method for percutaneous gastric surgery is illustrated(also see FIG. 11I for the associated devices). Percutaneous gastricsurgery begins with at least one skin incision 370 after which asurgical device such as a connector (rigid or flexible) is pushedthrough the skin and abdominal wall to enter the space between thestomach and the abdominal wall 372. Abdominal structure(s) 374 is/arecontacted with one or more flexible or rigid connector device(s).Temporary graspers and/or anchors 376 can also be used to contactstructures within the abdomen such as the stomach, liver, omentum, andthe diaphragm; some of these temporary devices can be used to retractthe liver (for example) by sliding a retractor over the flexibleconnector to (for example) push the liver away from the stomach whilesurgery is being performed on the stomach. Once the abdominal structureis contacted or grasped with the flexible or rigid connector device(s),a surgical device 380 can optionally slide over the flexibleconnector(s) to perform surgery on the stomach; examples of surgicaldevices include electrosurgical hooks, organ retractors, graspers, andknot tiers. Spaces or grooves can be made with these devices on eitherside of stomach or GE junction. Once these spaces and/or grooves aremade on either side of the stomach, other devices 380 can be slid overthe connector to perform procedures, visualize a region, or implantdevices in the stomach. Examples of devices 382 and procedures includestimulators, balloons, ablation of nervous tissue, fundoplications, andinjection of bulking agents to treat reflux disease (for example). Insome embodiments, the temporary grasper serves as an anchor and theconnector becomes the outside communication path for a device such as anextragastric balloon (see below).

At this point in the procedure (or any other point), a therapeuticenergy device can also be applied to the stomach. For example, a laser(or other phototherapy device), a radiofrequency device, a microwavedevice, or an ultrasound device can be applied to the stomach.Furthermore, electrical and/or nervous mapping can be performed with thesurgical device in a position between the anterior wall of the stomachand the abdominal wall. In the embodiment where an extragastric balloonis being deployed (see above and below), such deployment can proceed atthis step. The ability to perform these procedures without generalpneumoperitoneum and with minimal anesthesia is enabled by the inventivemethods described herein and is considered advantageous. Furthermore, inthe embodiment where balloons are placed inside the stomach or neuro- ormuscular stimulators or other devices are placed in the walls of thestomach, these devices are implanted at this step and do not requirepneumoperitoneum or general anesthesia.

At this point in the percutaneous procedure (after entry into thestomach), the tissue grasping instruments 200 of FIG. 4A is insertedthrough the port 306 with the jaws 220 in the closed position (with orwithout a needle projecting in front of the instrument) and is passedthrough the anterior wall of the stomach 302. When the jaws of theinstrument are closed, the jaws define a sharp, dilating, and/or cuttingconfiguration which can more easily advance through the stomach wall.

FIG. 6B depicts the next step in the percutaneous procedure. The jaws ofinstrument 200 are used to grasp the posterior wall of the stomach.Although one method to approach the region behind the stomach is shownin the FIG. 6 b, there are many ways in which the posterior wall of thestomach can be accessed. For example, suction can be used, as canvisualization with an ultrasound probe, CT scan, MRI, and/orfluoroscopy. The posterior wall of the stomach 314 is lifted away fromthe retroperitoneum 316, allowing for access to the potential space ofthe lesser peritoneal sac 320. A needle 232, such as a Veres needle(well-known in the art, a Veres needle allows for easy and safe accessinto and between two serosal layers), is inserted through the centralchannel 230 of the instrument and passed through the posterior wall ofthe stomach 314 into the potential space of the lesser peritoneal sac320. The potential space of the lesser peritoneal sac 320 is expanded byinjection of a gas, such as carbon dioxide, through the needle 232. Inother embodiments, the potential space is expanded using a liquid, gel,or foam. Alternatively, the space can be expanded using a balloon orother space expanding or space filling device; alternatively, a surgicalinstrument (e.g. electrocautery and/or blunt ended grasper, etc.) can beused in place of a needle to access the lesser peritoneum or to expandthe potential space of the retroperitoneum 320. Preferably, the expandedspace of the lesser peritoneal sac can extend from the angle of His atthe gastroesophageal junction to the pylorus.

FIG. 6C depicts the next step in the “percutaneous procedure”embodiment. With a direct path from outside the patient to the lesserperitoneal sac 322, the needle 232 is withdrawn from the instrument 200.An optional dilation step can be performed at this stage in theprocedure using a device such as a radially dilating sheath (e.g.InnerDyne STEP™ system; Sunnyvale, Calif.) inserted through the centralchannel 230 of the instrument. The dilating device expands the openingin the posterior wall of the stomach in such a way that the openingcontracts down to a lesser profile after dilation. A posterior anchor324 and connector 326, such as those depicted in FIGS. 1B, 1E orpreferably 1F, in its reduced profile configuration, is passed throughthe central channel 230 of the instrument, through the posterior wall ofthe stomach 314, and deployed in the lesser peritoneal sac 322 as shownin FIG. 6C. Where the optional dilation step is performed, the posterioranchor 324 is passed through the dilating sheath. The connector 326 ispreferably of sufficient length to pass from inside the lesserperitoneal sac 322 through the central channel 230 of the instrument andout of the patient's body. FIG. 6D depicts the deployed posterior anchor324 and connector 326 after the grasping instrument is withdrawn fromthe patient and tension is applied to connector 326 to pull theposterior anchor 324 against the posterior wall of the stomach 314.

In an alternative embodiment, the space of the lesser peritoneal sac isnot expanded before the posterior anchor is placed. For example, in anembodiment where an inflatable posterior anchor is used, the potentialspace can be expanded by the anchor itself as it is inflated to itsdeployed configuration.

In another embodiment, the posterior anchor is directly implanted in theretroperitoneum rather than in the lesser peritoneal sac. In thisembodiment, the posterior anchor is placed in the retroperitoneum abovethe envelope of the lesser peritoneal sac. Above the envelope, theretroperitoneum is safe, being above the pancreas and splenic vessels.As is known to those skilled in the art of bariatric surgery, theLap-Band® is implanted at this spot in the retroperitoneum (however,implantation requires general anesthesia and pneumoperitoneum). ACat-Scan, MRI, fluoroscopy, or ultrasound can be used to assist in thisstep.

Laparoscopic Procedure

In the “laparoscopic procedure,” after insufflation (pneumoperitoneumand general anesthesia) of the abdominal cavity with a Veres needle, aretrogastric tunnel 500 is created as is well known in the surgical artsand is shown in FIGS. 15 a-i. The posterior anchors 510 are shown as acomponent of the retrogastric instrument 512 in FIGS. 12 and 15 a.Embodiments of the posterior anchors 308 are also shown in FIGS. 6E and1K. Depicted are single posterior anchors with one or more connectorsand continuous posterior anchors with one or more connectors. Thesuture-connector system 309, 311 depicted in FIG. 1H-J is also depictedin FIG. 6E and can be used in one of the laparoscopic embodiments.Connector 309 (in FIG. 6E) engages anchor 308 and locks suture 311 intoposterior anchor 308. Connector 309 is then slid over suture 311 priorto the anterior anchor (similar to the anterior anchor in FIG. 13 a;550) being slid over (tracking) the connector 311. FIG. 15B depicts theconfiguration of the transgastric anchor assemblies 700 after theanterior anchors are placed, tensioned, and the connectors are cut. FIG.15C depicts devices of the laparoscopic procedure where the posterioranchor 750 is continuous. Anterior anchors 755 are shown (FIG. 15D) asindividual anchors and as discs; however, in some embodiments, theanterior anchors can be rectangular or continuous.

FIGS. 12 a-c depicts some of the steps in one embodiment of a“laparoscopic procedure”; a laparoscopic instrument 500 is providedwhich has a reversibly attached anchor 510. Grips 520 reversibly gripanchor 510. Any of a variety of gripping mechanisms can be employed toretain the anchor 510 on laparoscopic tool 500. Connector 332 issubstantially similar to any of the connectors described above exceptthat in this embodiment, the posterior anchor 510 is not attached toconnector 332 when it is inserted through the anterior abdominal wall.The surgeon places laparoscopic tool 500 behind the stomach 428 of thepatient and connector 332 is advanced through the lumen of laparoscopicport 545 formed in patient's skin 535 and anterior abdominal wall 530.Connector 332 is then further advanced through first and second walls540 and 547 of stomach 428. In FIG. 12B, a suture 333 is an innercomponent of the connector 332 for the transgastric device; an outerportion of connector 332 is removable over the suture after the suture333 is attached to the posterior anchor 510; connector 332 is thenremoved from the patient (FIG. 12C).

In some embodiments, a suture is provided on the posterior anchor 510(not shown) prior to insertion of the connector 332; connector 332 isadapted to pull the suture through the stomach and thence through theabdominal wall after being inserted through the anterior and posteriorwall of the stomach. This results in a configuration similar to FIG.12C. Subsequent attachment of the anterior fastener/s and subsequenturging step where the anterior and posterior walls are brought togetheris similar as outlined above.

When the connector 332 reaches the posterior anchor 510, grippingelements 520 are released by the surgeon through a mechanism which isintegrated into the laparoscopic tool 500. Connector 332 is fixed toposterior anchor 510 through a locking mechanism. Mechanisms of lockingconnector 332 to posterior anchor 510 are well-known to those skilled inthe art of mechanical fixturing. Some or all of the fixturing mechanismsmay reside on the connector or on the anchor. In another embodiment, thegripping force of the grippers 520 can be overcome by force applied bythe surgeon on connector 332. Reversible locking means other thanmechanical means also exist and include magnetic, electromagnetic, andadhesive means.

An anterior anchor 550 (FIG. 13 a) is then placed over the connector 332by the methodology and devices described in the next paragraph; themechanism of deploying the anterior anchor is the same in both the“laparoscopic” and “percutaneous” procedures. The walls of the stomachare urged together (FIG. 14 a) to create a resistance to the flow offood within the stomach or to reduce the volume of the stomach. Stomachregion 570 depicts one side of the stomach after the walls of thestomach are urged together. Region 570 is the side of the stomach wherethe food enters. Its (the stomach) volume and capacity are now reducedas compared to its original volume and capacity. Although not shown,connector 332 is subsequently truncated at the level of the anterioranchor 550 after the anterior anchor is deployed by any of themechanisms described and depicted above. FIG. 14B depicts thetransgastric assembly after the anterior anchor 550 is deployed. FIG.14C depicts a cutting tool which is threaded over the connector andallow cutting of the connector after deployment of the anterior anchor.

FIG. 7A illustrates the step of implanting the anterior anchor in oneembodiment. The connector 326 is inserted through the hole or otherpassageway of an anterior anchor 40 of FIG. 5C, and the anchorimplantation instrument 250 of FIGS. 5A, 5B and 5C is used to slide theanchor 40 through the laparoscopic port 306 into the abdomen of thepatient. The anterior 302 and posterior 314 walls of the stomach areurged together, either by using the anchor implantation instrument 250to urge the anterior wall 302 toward the posterior wall 314, or bypulling on the connector 326 and posterior anchor 324 to urge theposterior wall 302 of the stomach toward the anterior wall 314, or by acombination of the two methods. Once the anterior anchor 40 is in thedesired position, the anterior anchor 40 is placed in its deployedconfiguration by manipulating the anchor implantation instrument 250 asdescribed above.

In a preferred embodiment, the inflatable anterior anchor of FIGS. 2G-2Iis used, and the use of the implantation instrument of FIG. 5A isoptional. After the anterior anchor is in the desired position, theanterior anchor is inflated with a filling substance through theinflation tube until it is in its deployed configuration. The grippingelements 67 and teeth 68 are thus engaged against the connector 326, (12in FIG. 2I). The anchor implantation device 250 (FIG. 5A) can then bewithdrawn from the patient's abdomen.

In another embodiment (FIG. 15 e-g), both the posterior anchor 750 andthe anterior anchor 752 are continuous along both the anterior andposterior portions of the stomach. In this embodiment, connectors 765are suture like or are more rigid as described above. Strain gauges orflexible electrodes may be incorporated into any or all of theconnectors 765. Region 770 is the where food flows through therestriction system. In some embodiments, it is desirable to transect 758a part of the stomach with staplers well known in the surgical arts,creating a region 756 between the staple lines.

In some embodiments (FIG. 15H-I), a fluid expandable component 772 isincluded in the laparoscopically placed anchors 750, 752. the fluidexpandable component 772 combines the best of the banding procedures andthe surgical procedures such as the VBG.

With the transgastric fastening assembly complete, the surgeon canexamine the resulting configuration of the stomach using an endoscope.If one or more anterior anchors is/are not in the desired location, itsplacement along the connector can be adjusted as described above.Alternatively, in another embodiment, the anterior anchor can be urgedcloser to the posterior anchor simply by pushing it along the connectorwithout using the implantation device to capture the anchor and deformit into its reduced profile configuration.

In another embodiment, the anterior anchor can be deflated, allowing theanterior anchor to be repositioned (the anterior anchor is reversiblyfixed to the connector), and then reinflated to engage the connector.FIG. 7B illustrates the transgastric fastening assembly with theanterior anchor 40 in its deployed configuration on the connector 326and the anchor implantation instrument removed from the patient'sabdomen. The anterior 302 and posterior walls 314 of the stomach havebeen urged closer together by the transgastric fastening assembly.Whether the walls of the stomach are urged into contact or not isdetermined by the surgeon. Contact between the mucosal surfaces can beloose such that food can go through yet a significant resistance to foodis provided; alternatively, mucosal surfaces are urged together andtouch; however, food cannot pass through the apposed surfaces.

FIG. 7C depicts a transgastric fastening assembly in its finalconfiguration after deployment. Once the surgeon is satisfied that thetransgastric fastening assembly is properly placed, a cutting implement,well-known to those of skill in the art, is inserted through thelaparoscopic port and the connector 326 is cut, preferably flush to theanterior anchor 40. In some embodiments, the cutting instrument isplaced over the connector with the connector as a guide. In anembodiment, where inflatable anchors are used, the hollow connector andinflation tube are sealed prior to, or as a result of, cutting,preventing anchor deflation. Alternatively, if a filling substance whichhardens with time is used, it may not be necessary to seal the connectoror inflation tube prior to cutting if the filling substance issufficiently hard or viscous such that it will not leak from theconnector or inflation tube.

When more than one transgastric fastening assembly is to be implanted,it is sometimes preferred to insert all of the posterior anchors andconnectors before attaching any or all anterior anchors. For example, inFIG. 8A, posterior anchors 330 are show in a position posterior to thestomach with connectors 332 outside the abdomen. Anterior anchors cannow be placed over the connectors 332 and the tension independentlyadjusted under endoscopic visualization. In some embodiments, aninstrument to measure and quantify tension is used to measure thecompression of the stomach mucosa prior to the operation. In someembodiments (FIG. 8B), test blocks 336 are placed on the laparoscopicports 334. The tension on connectors 332 can now be tested withoutplacing an anterior fastener on the connector. This type of parallelfastener placement and quantification allows the operator to control thetension of each individual fastener across a row of fasteners. Testblocks 336 are adapted to engage connectors 332 and the optimal tensionon the connectors 332 can be quantified using a standard tensiometerattached to connectors 332. The degree of volume reduction can also betested with this setup and by visualization with endoscope 344. Once theoptimal tension has been determined, the anterior fastener is placedover the connector at the pre-determined tension. Tensioning ofindividual fasteners is in contrast to attempting place transgastricfastening assemblies in series. While possible to individually placetransgastric assemblies in series, if one were to do so, each successiveassembly would be more difficult to place because the volume of thestomach would be progressively reduced, resulting in more difficultvisualization each time.

FIG. 8A depicts an embodiment in which two posterior anchors 330 andconnectors 332 are deployed in the expanded lesser peritoneal sac. Inthis embodiment, there is one laparoscopic port 334 for each connector332. In an alternative embodiment, there may be more anchors placed thanincisions and laparoscopic ports. Depending on how far apart the anchorsare placed, a given laparoscopic port can be used to implant a pluralityof transgastric implants. This can be accomplished because there issignificant mobility of the stomach and/or abdominal wall which allowsfor different points along the anterior wall of the stomach to beaccessed without having to create another hole through the abdominalwall.

In an alternative embodiment, the stomach is fastened to the abdominalwall rather than there being a free space between the anterior gastricwall and the peritoneum of the abdominal wall (not shown). The initialsteps are as discussed above. After the posterior anchors are placed,their position can be tested as depicted in FIG. 8B to simulate theconfiguration after the anterior anchor is placed. Next, the outerlaparoscopic port is pulled back so that the anchor deploying instrumentdirectly contacts and sits within the tissues of the muscular abdominalwall. Once the outer laparoscopic port is pulled back, the anterioranchor can be deployed within the abdominal wall musculature and theconnector can be cut flush with the anterior anchor. In an embodimentwhere the inflatable anterior anchor is used, after the anterior anchoris deployed within the abdominal wall musculature, the inflation tube iscut, preferably flush with the anterior anchor.

Method of Reversal

The connector 326 (e.g. a suture) of a preferred embodiment of thedeployed transgastric fastening assembly, as illustrated in FIG. 7C, canbe cut at a point between the anterior and posterior anchors, whichresults in reversal of the gastric volume reduction. The connector ispreferably made to resist corrosion from stomach acid, but is able to becut by a cutting implement advanced through an endoscope into thestomach. In the Smith paper (Smith, L. et. al. Results and Complicationsof Gastric Partitioning. The American Journal of Surgery. Vol. 146;December 1983), a nylon suture was used to traverse the stomach in theanterior-posterior direction and attach the pledgets to the walls of thestomach. The nylon material was suitable for use for over 3 yearswithout any indication of corrosion. Other materials suitable to preventcorrosion and yet allow cutting include plastics such as polyurethane,silicone elastomer, polypropylene, PTFE, PVDF, or polyester, metals andmetal alloys such as stainless steel, nickel-titanium, titanium,cobalt-chromium, etc. Once the connector is cut, the walls of thestomach are free to move away from one another, thereby reversing theprocedure. Reversal of the procedure can occur at any time (days toyears) after the procedure. In a preferred embodiment, the anchorsremain in the gastric wall permanently even after the connector is cutor otherwise divided; the anchors are made from a material whichfacilitates permanent integration into the gastric wall (or otherintestinal wall); suitable materials include polypropylene, Alloderm™,Surgisis™, and polyesters. Alternatively in other embodiments, theanchors can, in part or in whole, be manufactured from a bioabsorbablematerial such that the anchors will eventually be absorbed by the body.In the case of bioabsorbable anchors, it is preferable to have aconnector which is at least in part bioabsorbable. In anotherembodiment, substantially all of the elements of the transgastricfastening assembly are made of bioabsorbable materials, with the intentthat over the desired period of time, the entire assembly will beabsorbed by the body, reversing the procedure without any additionalactions required by a doctor. In another embodiment, the anchors aremade of a non-reactive material such as silicone. In this embodiment,reversal of the procedure requires a “laparoscopic procedure;” that is,pneumoperitoneum so that the connectors can be cut and the fastenersremoved. The connector is cut with the endoscope and then the anchorsare removed with standard laparoscopic instrumentation; being composedof silicone, the anchors in this case will be easily removed.

Even if there is some degree of fusion between the mucosa around theconnector at the region of the assembly, once the connector is cut orabsorbed, the walls will tend to move apart over time. Alternatively, aballoon or other dissection device is introduced through an endoscopeand used to urge apart the walls of the stomach at the point of fusion.

Additional Embodiments of the Disclosed Devices, Instruments, andMethods

The devices, methods and instruments disclosed above and below can beused to treat other diseases, such as gastroesophageal reflux disease(GERD). In this embodiment, a transgastric fastening assembly is placedin the cardia region. Such a configuration would maintain the positionof the GE junction in the abdomen and potentially create a barrier toreflux contents. Similar to the devices above, feedback systems can beinstituted so that the reflux prevention is initiated as a response to astimulus such as pH or peristalsis rather than applying continuouspressure to the tissue even when reflux is not present. Furthermore,GERD devices can be equipped with patient controlled features such thatwhen the patient feels symptoms, the antireflux features are activated.Reflux disease can also be treated with sutures or plications placedwith a percutaneous procedure and in the region of the GE junction.Placement of the sutures (with or without pledgets) with a percutaneousprocedure would not require general anesthesia and would be advantageousin many patients.

In many of the embodiments discussed above, a transverse row offasteners is depicted which is one method of creating volume reductionor flow restriction. FIG. 9 depicts and alternative embodiment in whichthree transgastric fastening assemblies 400 are deployed longitudinallyin the stomach; such a configuration of anchors results in a tubularconfiguration of the remaining portion of the stomach. The dashed linesrepresent boundaries of the divisions of the stomach: the cardia of thestomach 402, the fundus of the stomach 409, the body of the stomach 406,the antrum of the stomach 408, and the pyloric sphincter 410. In oneembodiment, the fastening assemblies are not implanted in the antrum 408(but are implanted longitudinally in the stomach as shown in FIG. 9) inorder to maintain the normal digestion process of the stomach. Normaldigestion therefore occurs in the antrum which precedes passage of foodinto the duodenum. In stopping short of the antrum 408, the implantsreplicate the degree of volume reduction of the Magenstrasse and Mill(M&M) procedure (discussed above in the background).

Food ingested by the patient follows a physiologic pathway for digestiondepicted by the arrow in FIG. 9. It travels through the esophagus 412and enters the cardia of the stomach 402. The food is digested in thestomach and pushed toward the duodenum 414 as chyme for furtherdigestion. The preserved antrum 408 allows for relatively physiologicdigestion and emptying into the duodenum 414 akin to the M&M procedure.With transgastric fastening assemblies 400 in place, food which leavesthe esophagus 412 and enters the stomach, results in increased walltension on the lesser curvature of the stomach 416 as the greatercurvature of the stomach 418 will be restricted from the food pathway.The path of least resistance will be the path toward the pylorus 410 andduodenum 414. The increased wall tension of the stomach will result in afeeling of satiety by the patient, leading to decreased food intake andweight loss. As discussed further above, any of the transgastricassemblies in this embodiment can have feedback systems whichcommunicate with patient end-effector, patient afferent pathways, deviceefferent, and/or device afferent pathways. Although three assemblies areshown in FIG. 9, there may be as few as one or as many as ten or moredepending on the degree of volume reduction desired. Such flexibility innumber of devices as well as the ability of the surgeon to tune thetension between the anterior and posterior anchors is advantageous. Suchflexibility may enable, for example, reversal of a few anchors ratherthan all the anchors, such that the volume reduction procedure ispartially reversed. As described above, any or all of the anchors, orparts of the anchors, can be biodegradable and therefore, the gastricreduction procedure would be reversible by virtue of the implantedbiodegradable anchors. Furthermore, in some embodiments where there aremultiple transgastric connectors which are produced from an electricallyactive material, different ones of the multiple connectors can beadjusted. In some embodiments, an electrical current is applied to thestructures in order to reverse the procedure. For example, some metalsand polymers will dissolve (corrode) in response to current.

In another embodiment, a transgastric fastening assembly is placed inthe antrum 408 or the region just proximal to the pyloric sphincter 410if deemed necessary by the gastroenterologist and/or surgeon. Such aconfiguration would not reduce the volume of the stomach but would causea feeling of fullness similar to a gastric outlet obstruction, leadingto decreased food intake and weight loss. The anchors in this region canalso conduct a current to electrically stimulate the pyloric region tosimulate satiety.

In another embodiment, a transgastric fastening assembly may be requiredat the region of the cardia 402 to treat morbid obesity in a similarmanner to that utilized with the LAP-BAND™ (Inamed Corp., Santa Barbara,Calif.). In this embodiment, the transgastric fastening assembly is notutilized to reduce the volume of the stomach, but to create arestriction to the inflow of food. In this embodiment, the fasteningsystem can traverse the cardia but does not necessarily completelyoppose the mucosal surfaces of the anterior and posterior walls of thestomach. In some embodiments, the transgastric assemblies do in factcompletely appose the walls of the stomach together but allow food topass through by not completely traversing the cardia, leaving a spacefor flow of food stuffs. The assembly can further be configured toprovide electrical signals to the anterior and/or posterior portions ofthe stomach in this region. The active region of this embodiment can bequite large, in some cases ranging up to 10-15 cm, large enough totraverse almost the entire width of the cardia.

In another embodiment, the disclosed methods in combination with thetransgastric fastening assemblies can be adapted to attach agastrointestinal organ to the abdominal wall which, in addition toreducing volume, can also create a kink in the organ (e.g. the stomach).The kink may cause a resistance barrier (in addition to volumereduction) to gastrointestinal contents and can be useful to treatreflux disease or morbid obesity. Such a kink would also fix thegastrointestinal region to the abdominal wall as well as maintain thereduction of a hiatal hernia in the abdominal compartment (e.g. inreflux disease). A major component of reflux disease is a hiatal herniain which the gastroesophageal junction freely slides from the abdomen tothe mediastinum. A percutaneously placed suture or anchor in the regionof the gastric cardia and/or fundus can tether the junction to theabdominal wall and confine the junction to the abdomen.

In other embodiments, the devices and methods of this invention canassist in the implantation of devices such as stents, meshes, stitches,or tubes in the gastrointestinal tract. A major technical difficultyencountered in placing stents, tubes, balloons, stimulators, and meshesinside the lumen of the gastrointestinal tract is that they tend tomigrate because the walls of such devices do not adhere to slipperymucosa. A transgastric or transintestinal anchor, implanted with thecurrent instrumentation, could solve this problem. Such a method wouldbe particularly useful in the attachment of the stent part of thestent-sleeve system outlined in patent application US20050075622A1, orthe mesh of patent application US20040172141A1. In another example,devices such as those disclosed in U.S. Pat. No. 6,773,441 attempt toplace an endoscopic stitch to tether the cardia of the stomach to thefundus to treat reflux disease. Such stitches are tenuous in the longterm because they do not necessarily penetrate the serosa. Even if thestitches penetrate the serosa, they tend to erode through the wall withtime because of their thin profile and an inability of the endoscopicoperator to control tension on the suture when it is placed. With themethods and devices of this invention, such an endoscopic suture can bebuttressed with a percutaneously placed anchor.

Although the described methods are focused on the implantation oftransgastric fastening assemblies to reduce the volume of the stomach orto increase the resistance to the flow of food in the stomach, themethods and devices can easily be expanded to the implantation of othertypes of devices such as neurostimulators, gastric muscle stimulators,gastric balloons, and bulking devices inside the wall of agastrointestinal organ using the percutaneous procedures and devicesdescribed herein.

The methods disclosed herein (e.g. the percutaneous procedure) canfurther be used to apply an energy source to an internal organ withouthaving to give general anesthesia or pneumoperitoneum. For example, themethods and devices of the current invention can be used to applyradiofrequency probes, microwave probes, ultrasound probes, andradioactive probes (to the serosa) in similar ways as disclosed in U.S.Pat. No. 6,872,206. The energy sources can be temporary or permanent andcan be activated remotely through the abdominal wall in the case wherethey are implantable. The methods can further be used for diagnosticpurposes prior to performing a surgical therapy. In one example, themethods and devices are used to identify specific nerves or nerveplexuses prior to delivering a specific therapy. In another example,specific hormone producing regions, such as ghrelin, are identifiedprior to delivering a specific therapy. Following the methods anddevices outlined both above and below, instruments can be placed in theabdominal cavity under percutaneous guidance. Any of the layers of thestomach can be accessed and stimulation, ablation, or diagnostic devicescan subsequently be placed without anesthesia and withoutpneumoperitoneum. For example, a stimulation device can be placed in anylayer of the stomach wall such as the serosa or muscular layers forexample.

Similarly, the anchor assemblies and anchors are applied to solid organssuch as the spleen, kidney, liver, and pancreas to urge the edges of adefect together to promote healing; in other embodiments, the anchorassemblies are applied to the blood vessels such as arteries or veins;for example, the aorta or vena cava.

In still further embodiments, fascial defects can be closed with theanchoring assembly described above. FIGS. 7 d-7 e for example shows ananchor being delivered into a fascial defect caused by a laparoscopicport. Using similar methodology to that described above, except appliedto a fascial defect, a posterior anchor 362, a connector 360 and ananterior anchor 366 are shown in FIG. 7D. A laparoscopic port 364 isshown as well. After anterior anchor 366 is threaded over connector 360,the connector is 360 is trimmed as described above (shown in FIG. 7E).When the anchoring assembly is in place as shown in FIG. 7E, the defectcreated by port 364 is effectively closed and the connector stabilizedin the anterior abdominal wall. Typically, laparoscopic fascial defectsare closed with sutures which can be very difficult in an obese patient.The anchor-connector-anchor assembly shown in FIGS. 7D-E is a possiblesolution to having to close fascial defects with sutures in obesepatients.

In some embodiments, the methods and devices described herein are usedto place devices inside or outside the stomach; inside or outside thelesser sac of the peritoneum; inside or beside a structure within theretroperitoneum; inside, beside, or outside the duodenum, pylorus, orgastroesophageal junction. Implanted devices include but are not limitedto the anchor devices and transgastric fastening assemblies describedabove; stents, meshes, stent-grafts, stitches, stimulators, and bulkforming agents can be implanted individually, in combination, and as acomponent of the same device.

In some embodiments, a transgastric method of placing such stimulatorsis described which in some embodiments enable placement of stimulatorsin the lesser peritoneal space where they can stimulate the sympatheticsystem or directly stimulate structures in the lesser peritoneal sac(such as the pancreas). In these and other embodiments, the transgastricaccess method to the lesser peritoneal sac is used to place stimulatorsand stimulate and/or inhibit pain fibers in and around the celiacganglion. This type of procedure is used to treat patients with severepain from a tumor or from pancreatitis.

Devices that circumscribe the gastroesophageal junction are well-knownin the art (see for example, U.S. Pat. No. 64,653,213); the surgicalconstricting balloons can be retrofitted with sensors in order to createdevice afferent pathways which detect overeating and simulate (viadevice efferent pathways) patient afferent pathways such as the vagusnerve or the visceral nervous system.

The methods and devices of this invention can also be used to placesutures in the stomach or pylorus to treat reflux disease or obesity.Such suturing would be facilitated by the placement of multiple portsthrough the walls of the stomach. Any of these methods and devices couldbe used in combination with or in place of the transgastric fasteningassemblies to induce weight loss in a patient.

In another embodiment, the novel methods, implantation devices, andanchors of this invention are used to implant devices in one wall of agastrointestinal organ without volume reduction. One example of such anembodiment is illustrated in FIGS. 10A and 10B in which a balloon-likedevice is deployed in the stomach to displace volume rather than toreduce volume from the outside. The internal balloon 430 is similar tothe posterior anchors in some of the embodiments described above. In oneembodiment, after initial insufflation of the stomach and placement of alaparoscopic port 306 percutaneously and without pneumoperitoneum (asdescribed above) between the abdominal wall 304 and the anterior wall ofthe stomach 302, an instrument is used to penetrate only the anteriorwall of the stomach 302 and place an inflatable intragastric balloon430. Inflation is achieved through the connector lumen 432 and theballoon is placed within the interior of the stomach 428, as illustratedin FIG. 10A. When inflated, the balloon 430 is preferably spherical inshape such that it occupies a substantial portion of the stomach volumewhen inflated. In the embodiment shown, the connector also acts as theinflation tube for inflating the intragastric balloon. In anotherembodiment, in addition to the connector, there is a separate inflationtube similar to embodiments presented above. As discussed above, a valvecan be located between the anchor and the connector, or alternativelyoutside the patient. Preferably, after the intragastric balloon isinflated and an anterior anchor 434 is deployed on the connector 432, asdescribed previously. The connector 432 is also cut, preferably flushwith the anterior anchor, and the laparoscopic port is removed, as shownin FIG. 10B. The anchor portion of the intragastric balloon 434 is thenfixed in the wall of the stomach. In the preferred embodiment where aninflatable anterior anchor 434 is used, the inflation tube is also cut,preferably flush with the anterior anchor. Other devices which may onlybe implanted in one gastric wall with similar methods and with similaranchoring devices include neurostimulators, muscular stimulators,sensors, and pharmaceutical delivery devices.

FIG. 16 embodies another use for the current invention. The sleevedevice 620 is disclosed in US patent application publicationUS2004/02206882. A major difficulty with this sleeve device is that itis not easily fixtured for stability inside the stomach. Fasteningsystem 610 is used to assist in fixation of the device 620 to thestomach wall; fastening system 610 is any of the devices discussed aboveand is implanted by any of the methods discussed above.

In another embodiment, a surgical anastomosis is surrounded with theorgan spanning anchors and anchor assemblies of the current invention.In this embodiment, the anchors can buttress the anastomosis to protectthe integrity of the anastomosis. The buttresses can support bothhand-sewn and stapler anastomotic techniques. To prevent or the anchorsare placed around or through the anastomosis. In a similar embodiment, atransgastric anchor system (or constricting band) can be used at agastrojejunostomy in a Roux-n-Y bypass procedure. Both the transgastricanchor system and constricting band can further have associatedelectrically activateable elements by which flow through the anastomosiscan be controlled.

The anchors (and bands), as described above, can also be used to controlthe flow of material through an anastomosis. Flow control is attainablewhen an anchoring assembly is applied across an anastomosis and arelinked by means of a connector through the anastomosis. The distancebetween the anchors determines the amount of flow through theanastomosis and therefore, the flow rate can be adjusted quite readilywith the device of the current invention. The flow rate is adjustable atanytime during or after the operation. Luminal devices to control theflow rate through an anastomosis can be found in US patent applicationnumber 20050022827. The devices of the current invention can be used toaccomplish the goal of controlling flow through an anastomosis byplacing anchors on either side of the anastomosis with a connector thattraverses the anastomosis. Furthermore, the anastomotic flow controldevice can further have automated control using the materials, methods,and control systems described above in order to automatically adjustflow control or tension on the anastomosis.

In another embodiment, the anchor assemblies are applied to the lung totreat chronic obstructive pulmonary disease (COPD) via functional lungreduction. Rather than removing a portion of the lung (the surgicalprocedure), the anchors of the current invention are placed through thediseased portion of the lung to close off or at least create a largeresistance in one portion of the lung and broncheoalveolar tree so thatinspired air does not reach a malfunctioning portion of the lung.

In other embodiments of the current invention, the fastening systems andtools to implant the fastening systems are used to secure closure orrepair of blood vessels. The blood vessels can be named vessels such asthe aorta, vena cava, pulmonary veins, pulmonary arteries, renal vein,renal artery, inferior mesenteric vein and/or artery, splenic veinand/or artery, portal vein and/or hepatic artery, or the saphenousand/or deep veins. Alternatively, the vessels are unnamed such as in thecase of the mesentery of the colon or small bowel. Vessel closure withthe current system is possibly more efficient than current laparoscopicmeans of vessel closure which involve staple or clip occlusion of thevessels; staples and clips do not penetrate the vessel and therefore areoften inadequate, or at least do not replicate what a surgeon would doin an open procedure which is place a suture through the vessel to“suture ligate” it as is well-known in the art.

It is also possible that a part of, or any or all of the devices andmethods described above are performed with an alternative imaging means;for example, fluoroscope, MRI, ultrasound, and CAT scan.

Although the present invention has been described in the context ofcertain preferred or illustrative embodiments, it should be understoodthat the scope of the exclusive right granted by this patent is notlimited to those embodiments, but instead is the full lawful scope ofthe appended claims.

Furthermore, any of the devices, methods, surgical instruments, andfeatures can be used singly or together in order to treat any of thedisorders or diseases mentioned above.

1. A method for treating obesity in the subject comprising: implanting,with respect to a gastrointestinal tract, a restriction device with asensor configured to detect and store data signals indicative ofingestion and comprising a gain control to control the output of thesensor relative to the pressure changes; adjusting the sensitivity ofsaid sensor so that a data signal indicative of ingestion is detectableover a data signal in the non-ingestion state; and increasing thefrequency of detection of data signals when the data signal indicativeof ingestion exceeds a threshold.
 2. The method of claim 1 furthercomprising: wirelessly downloading the stored data, relative to the gaincontrol, to a module outside the subject, and adjusting said gain basedon said downloaded data.
 3. The method of claim 1, further comprisingsending a signal to the subject.
 4. The method of claim 3 wherein thesignal communicates with the restriction device or attached componenttherein.
 5. The method of claim 3 wherein said signal to the subject isa signal to an implanted gastric stimulator.
 6. The method of claim 1wherein said device is non-circumferential restriction device.
 7. Themethod of claim 1 wherein said device is a trans-gastric restrictiondevice.
 8. The method of claim 1 further comprising: programming thesensor to detect signals indicative of ingestion at a rate of greaterthan 1 per second.
 9. The method of claim 1 wherein said device is acircumferential restriction device.
 10. A system for detecting ingestionsignals in a gastrointestinal tract comprising: a device configured tocreate restriction in a gastrointestinal organ; a pressure sensoradapted to be implanted in hydraulic continuity with the restrictiondevice and adapted to receive signals and transmit signals; a gainadjust within the pressure sensor circuit to adjust the gain within thecircuit; a power supply adapted to be implanted with the pressuresensor; and an algorithm wherein said pressure sensor samples pressureat less than a defined frequency and when a signal above threshold isdetected, samples pressure at greater than a defined frequency.
 11. Thesystem of claim 10 wherein said device is a circumferential restrictiondevice.
 12. The system of claim 10 wherein said device is anon-circumferential restriction device.
 13. The system of claim 10further comprising: a memory circuit, adapted to sample and recordpressure at a rate of at least 1 Hz.
 14. The system of claim 10 whereinsaid gain adjust is adapted to be programmable through a wireless signaltransmittable through the skin of the patient.
 15. The system of claim10 wherein said pressure sensor is surrounded by a fluid to protect thepressure sensor from degradation and communicates with the fluid used toadjust the restriction device by a diaphragm.
 16. The system of claim 10further comprising an output signal configured to induce satiety in apatient.